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Healthy sleep is vital to health and wellbeing at all life stages.  But for many women, achieving 
restorative and satisfying sleep consistently throughout pregnancy is challenging.  Because 
vulnerability to experiencing depressive symptoms increases with poor sleep and poor sleep 
influences the development and trajectory of depressive symptoms, sleep is an important and 
modifiable factor in the prevention and treatment of depression.  Pregnancy is also considered 
a key teachable life stage as mothers wish to be healthy in order to protect their unborn baby.  
Yet research investigating non-pharmacological sleep education interventions for preventing 
perinatal depression is scarce.  
This thesis comprises three studies that investigate the relationship between maternal sleep 
health and depression.  It presents findings from a scoped review examining sleep health 
throughout pregnancy; a longitudinal analysis of depression trajectories from late pregnancy to 
three years post-birth and the association of different sleep dimensions to trajectory group 
membership; and, the development, implementation and efficacy of a sleep education pilot 
intervention designed to promote sleep health and reduce the likelihood of depressive 
symptoms throughout pregnancy. 
Findings from the scoped review showed that while sleep in pregnancy is highly variable from 
one woman to the next, significant changes to sleep throughout pregnancy were not indicated 
for women who were considered physically and mentally healthy.  However, the results of the 
longitudinal analysis revealed that for a sub-group of women, poor sleep was significantly 
associated with clinically elevated and persistent depressive symptoms throughout the perinatal 
period and into their child’s preschool years, with the probability of experiencing depressive 
symptoms especially pronounced for Māori women.   
ABSTRACT 
ii 
The Sleep HAPi pilot study found recruiting and retaining previously depressed women into a 
longitudinal perinatal sleep education study achievable and the study design highly acceptable 
to participants.  Similar to the results of the scoped review, self-reported sleep duration, quality, 
timing, continuity and daytime sleepiness remained stable throughout pregnancy, and at 
intervention end none of the women in this study were experiencing clinically elevated 
depressive symptoms.  Sleep HAPi women were compared to a control group from a previous 
study with no sleep education component; Sleep HAPi mothers had significantly better sleep 
initiation and experienced fewer depressive symptoms at intervention completion, though 
results require confirmation in a larger randomised control group study.  
Collectively, the findings from these studies highlight the strong relationship between sleep and 
maternal mental health.  Sleep education interventions, such as Sleep HAPi, show promise for 
minimising depressive symptoms, and optimising sleep for pregnant women.  These findings 
have important health care practice and policy implications and the potential to improve 










“Without enough sleep we all become tall two-year-olds.”  
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What a blessing man acknowledges in sleep, whose soft oblivion makes an 
island of every day, and breaks the hold of continuous care; that cools the hot 
brain, and bathes the weary eye-lids, and lets the buffeted and foundering 
heart cast anchor every night in some harbour of happy dreams. He feels the 
beneficence of that law which makes even misery halt, and besieging fortune 
strike its tents, and in the great democracy of nature levels the children of 
men in common helplessness and common need. 







Chapter 1 introduces the contextual setting of the thesis, evaluating current knowledge about 
its three foundations; sleep, pregnancy and depression, and their interactions (figure 1.1).  It 
also describes the conceptual frameworks that guided the research, including evolving 
definitions of health and Buysse’s (2014) model of sleep health and lastly, an overview of sleep 
education interventions during pregnancy.  Because the findings of this research are presented 
in publication format (Chapters 3 to 6), Chapter 2 provides a more thorough description of the 





Figure 1.1 Thesis foundations: Sleep, pregnancy and depression 
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Chapters 3 to 6 present the findings of the three studies that comprise this program of research.  
Study 1 is a scoped review exploring what normal sleep looks like for a healthy pregnant woman 
(Chapter 3).  Study 2 is a trajectory analysis of maternal depressive symptoms from late 
pregnancy to three years post birth, and examination of the dimensions of sleep that are related 
to those trajectories (Chapter 4); and Study 3 explores the development and implementation of 
a sleep education intervention beginning in the first trimester and aiming to minimise 
depression symptoms throughout pregnancy, with assessment of its feasibility and acceptability 
(Chapter 5) and efficacy (Chapter 6).  Because the journal manuscripts presented in chapters 5 
and 6 involve the same study, there are some overlap in the introduction and methodology 
sections.   
Finally, Chapter 7 integrates the findings from these chapters and concludes with a discussion 












“If sleep does not serve an absolutely vital function, then it is the biggest 
mistake the evolutionary process has ever made.” 
Allan RECHTSCHAFFEN, University of Chicago, 1978 (cited in Walker (2011)) 
We spend around a third of our lives asleep.  By the age of 50, approximately 17 years will be 
spent asleep.  Sleep has persisted throughout evolution, even though it temporarily prevents us 
meeting other primary human needs, as we cannot consume, reproduce, nurture or work while 
asleep.  It is against the logic of natural selection and evolution to have preserved sleep unless 
it serves vital functions (Rechtschaffen, 1998). 
Sleep, nutrition and exercise are increasingly recognised as the three pillars of health and are 
fundamental to wellbeing (Heffron, 2014).  Optimal sleep allows crucial somatic and neural 
functions to occur, such as muscle growth and tissue restoration, memory consolidation, 
downregulation of metabolism and homeostatic balance (Okun, Roberts, Hall, & Marsland, 
2009).  Many of these restorative and integrative processes occur predominantly, if not only, 
during sleep.  Sympathetic nervous system activity and metabolic demands on the body are 
decreased during sleep, while tissue regeneration is increased.  The active neural connections 
made during sleep allow memory consolidation, stability and retention, stimulating the idea that 
long-term memory formation is a function of sleep (Rasch & Born, 2013).  Growth hormone, 
critical for muscle growth, is primarily released during slow wave sleep (Van Cauter & Plat, 1996), 
as is prolactin, an important immune system regulator (Spiegel et al., 1995; Van Cauter & Plat, 
1996).  Cardiorespiratory synchronisation occurs during sleep, assisting in the replenishment of 
neurons (Jerath, Harden, Crawford, Barnes, & Jensen, 2014).  Overall, sleep allows the whole 
body to recalibrate, restore and develop (Smetacek, 2010).   
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1.2.1 Defining sleep 
A simple behavioural definition explains sleep as: 
 “Sleep is a reversible behavioural state of perceptual disengagement from, 
and unresponsiveness to, the environment. Sleep plays a crucial role in 
allowing the brain to work properly, enhancing learning ability and 
remembering information. Without enough sleep, malfunctions occur in 
many vital areas of the body starting from impaired memory and thought 
processes to more serious conditions such as depression, decreased immune 
response, fatigue, increased pain perception, and ultimately in chronic health 
outcomes.” (Carskadon & Dement, 2017). 
To an outside observer, sleep may seem like a unitary state.  However, it is far from a single state 
of being, but rather a neurologically and physiologically dynamic and complex process.  Sleep 
architecture describes the cyclic pattern of sleep stages defined by distinct electrical activity in 
the brain, eyes and muscles, recorded via electroencephalography (EEG), electrooculography 
(EOG) and electromyography (EMG) respectively, known collectively as polysomnography (PSG).   
There are two distinct sleep states identified by PSG: REM (Rapid Eye Movement); and NREM 
(Non-Rapid Eye Movement).  NREM sleep involves a progressive slowing of many physiological 
systems and is further sub-categorised into sleep stages: Stage 1 (NREM1), Stage 2 (NREM2) and 
Stage 3 (NREM3).   Sleep is commonly entered through NREM1, the state of consciousness 
between sleep and wake.  It is easy to be roused in this stage, and although muscles lose some 
tone, they are still active.  In this sleep state, alpha waves are predominant in the EEG, slow 
rolling eye movements are seen in the EOG, and lower muscle tone in the EMG.  NREM2 is a 
deeper stage of sleep, and conscious awareness of the external environment disappears.  Theta 
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waves are observed, as are sleep spindles and K-complexes, both of which are unique to this 
stage of sleep.  The EMG shows further loss of muscle tone and slow rolling eye movements are 
no longer seen on the EOG.  Deep Sleep and Slow Wave Sleep (SWS) are interchangeable 
terminologies with Stage NREM3 sleep.  In NREM3 sleep, body temperature, respiration, heart 
rate, cortical activity and energy consumption are at their lowest compared to the other stages 
of sleep.  NREM3 sleep is considered deep sleep because it is hard to rouse an individual from 
this sleep stage, and therefore there are fewer arousals or awakenings. 
REM sleep, however, is a highly active state of sleep with cortical activity similar to that of wake.  
REM is punctuated on the EOG by rapid movements of the eye, hence the term REM.  During 
REM, the EEG shows brain activity similar to NREM1 but is differentiated by the inclusion of “saw 
tooth” waves. Other physiological behaviours unique to this phase of sleep include muscle 
paralysis and irregular heart rate, breathing and body temperature.  REM mentation is 
characterised by emotional, vivid dream experiences.  Healthy adults have around five REM 
cycles during a nocturnal eight-hour sleep period, but it is usually only the dream at the point of 
awakening that is remembered. 
Each sleep stage is equally as important as another.  Moorcroft (2013) suggests that instead of 
visualising sleep as a sliding scale, it can be helpful to view sleep as rooms in a house that are 
moved in and out of.  The quality of life is not gained from spending all of one’s time in just one 
room but comes rather from moving into different rooms when the respective activity is 
required (e.g. cooking in the kitchen, showering in the bathroom). 
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Over the course of a normal nocturnal sleep period, humans progress through four to six sleep 
cycles of NREM and REM sleep, with longer periods of slow-wave, NREM3 sleep earlier in the 
night and longer periods of REM in the later part of the night (figure 1.2).  In a healthy young 
adult NREM sleep (NREM1, NREM2 & NREM3) totals about 75-80% of a sleep period, while the 
REM component comprises the remaining 20-25%.  Awakenings during the night are a normal 




Figure 1.2  Sleep cycles throughout the sleep period in a young healthy adult.  (Tan, van 
Egmond, Partinen, Lange, & Benedict, 2019)  
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1.2.2 Sleep/wake regulation 
Two key processes are currently understood to regulate the timing and quality of sleep: The 
circadian time keeping system and a homeostatic drive for sleep. 
A circadian master clock in the suprachiasmatic nuclei (SCN) of the hypothalamus governs the 
timing of sleep and underlies the human propensity to be alert during the day when it is light, 
and sleep during the night when it is dark (Assefa, Diaz-Abad, Wickwire, & Scharf, 2015).  The 
clock genes that make up the molecular machinery for generating circadian rhythms are located 
in every cell in the body, however the master pacemaker orchestrates the synchrony of different 
rhythms (Borbély, Daan, Wirz-Justice, & Deboer, 2016) and is regulated (synchronised) by 
factors in the external environment (predominantly light).  The SCN controls down-stream 
oscillators and rhythms via direct outputs to other brain regions and indirectly via its regulation 
of hormonal rhythms (primarily melatonin and cortisol) and behavioural rhythms, notably the 
sleep/wake cycle and feeding patterns (Czeisler & Buxton, 2017).  
The SCN receives light information primarily from photosensitive cells in the retina.  These cells 
contain a particular light-sensitive pigment called melanopsin, which is sensitive to short 
wavelength “blue light”. The light-sensitivity of the SCN enables it to keep physiological and 
behavioural rhythms in step with the day/night cycle and drive our innate preference for sleep 
at night.  Melatonin plays a major role in inducing sleep onset, supporting healthy sleep 
architecture and coordinating physiological and behavioural functions while sleeping (Hickie, 
Naismith, Robillard, Scott, & Hermens, 2013).  Towards the end of the sleep period, melatonin 
provides feedback to the SCN to inhibit the sleepiness signal, in turn promoting wakefulness 
(Hickie et al., 2013).  If light, dark and other environmental cues are removed, most people adopt 
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an endogenous circadian cycle slightly longer than 24 hours (Sack, Brandes, Kendall, & Lewy, 
2000). 
Attempting to sleep during an inappropriate time of the circadian cycle, such as when melatonin 
is declining and body temperature is rising, will likely result in shorter sleep durations with more 
awakenings (Dijk, Duffy, Riel, Shanahan, & Czeisler, 1999).  Circadian system disruptions, such 
as jet lag or shift work, are associated with negative outcomes such as shorter sleep, poorer 
sleep quality, poor mood, decreased cognitive functioning and adverse health outcomes (Zee & 
Goldstein, 2010). 
Individual variability in preferred sleep times is well described in humans yielding a continuum 
of chronotypes, ranging from ‘morning’ chronotypes who prefer earlier bedtimes and rise times, 
to ‘evening’ chronotypes who prefer later bedtimes and rise times (anecdotally known as ‘larks’ 
or ‘owls’ respectively) (Wittmann, Dinich, Merrow, & Roenneberg, 2006).  At extreme ends of 
this normal distribution are individuals whose preferred sleep times are well outside population 
‘norms’. 
The second component regulating sleep is the homeostatic sleep drive that increases 
exponentially across time awake and decreases exponentially across time asleep.  Typically, after 
a consolidated, good quality sleep period, the homeostatic drive for sleep will be fully dissipated.  
However, when a sleep opportunity is interrupted, the homeostatic drive for sleep may not be 
fully dissipated and the next wake period will start with residual sleep pressure. 
The anatomical structures and physiological processes that underly homeostatic sleep pressure 
are unclear.  Authors have suggested that NREM and REM may have separate homeostatic 
mechanisms (Franken, 2002; Ocampo-Garcés, Molina, Rodríguez, & Vivaldi, 2000) as suggested 
by NREM sleep being recovered first after a period of sleep restriction (Saper, Cano, & Scammell, 
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2005), and REM rebound following selective REM deprivation also a common phenomenon 
(Datta, Mavanji, Ulloor, & Patterson, 2004; Shea et al., 2008). 
The interaction of the circadian effects on sleep and homeostatic sleep pressure is described by 
the two process model of sleep regulation (Borbély, 1982).  For healthy individuals, the two 
processes interact during the day to produce stable levels of wakefulness, and during the night 
to provide a consolidated period of sleep.  The homeostatic sleep pressure is considerable early 
in the night.  During the second half of the night, the sleep drive begins to weaken but the 
circadian system sends signals to support sleep.  At the end of the night the sleep drive is sated, 
wake signals from the circadian system emerge, and together they prompt the emergence from 
sleep to wake.  Figure 1.3 illustrates the two-process model highlighting how the two systems 
interact.  
 
Figure 1.3 Two process model of sleep.  The solid line illustrates the homeostatic 
pressure to sleep, which is low upon waking and gradually increases during 
the day.  The dotted line, the rhythmical sleep alerting signals from the 
circadian system, demonstrates how the circadian signals maintain sleep 
even when homeostatic drive is low (Beersma & Gordijn, 2007). 
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Understanding the processes regulating sleep allows important insights into what happens 
when these processes become disrupted.  When in synchronisation, the circadian and 
homeostatic processes ensure correctly timed and sufficient sleep (Dzaja et al., 2005).  When 
out of synchrony with each other, (i.e. time zone changes, shiftwork) sleep and wake are forced 
to inappropriate times in the circadian clock cycle and both become impaired.  Fortunately, jet 
lag is a temporary condition, but of greater concern are chronic disruptions to the body clock.  
Such evidence has come through epidemiological studies revealing significantly higher risks of 
cancer, cardiovascular disease, obesity and depressive disorders in people employed in shift 
work (Hastings, Brancaccio, & Maywood, 2014).  Furthermore, consistency in wake–sleep cycles 
may also help improve a variety of psychiatric disorders, such as depression and anxiety 
disorders (Saper et al., 2005). 
1.2.3 Sleep health 
1.2.3.1 Health as an asset or deficit 
In developed countries, the rapid increase in chronic disease prevalence, such as heart disease, 
diabetes, respiratory disease, obesity, cancer, asthma, mental health and dementia, are far 
surpassing the reductions in acute infectious diseases.  In New Zealand, the Global Burden of 
Disease Study shows that between 1990 and 2013, chronic conditions make up 87% of all health 
loss (New Zealand Ministry of Health, 2016).  In comparison, injuries (i.e. accidents and falls), 
only contribute 9% of health loss.  Furthermore, life expectancy has increased at a faster rate 
than health expectancy, resulting in humans living longer with poor health (New Zealand 
Ministry of Health, 2016). 
However, the organisational structure of medical care in the 21st century is still rooted in an 
acute care approach, focussing on the urgent instead of the important.  Additionally, societal 
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behaviour favours instant gratification and quick fix solutions, even when considering health 
care.  Political drivers are also evident with short term electoral cycles requiring short-term 
visible results.  Preventative health care efforts for chronic disease and disorders are too often 
marginalised due to their long-term investments.  For example, although chronic disease rates 
are rising and a third of chronic disease is preventable, only 5.9% of the 2005/2006 New Zealand 
health care budget was spent on preventing disease. 
However human health is increasingly being defined by wellness and longevity.  This precipitates 
actively seeking, promoting and facilitating the benefits of good health, a perspective outlined 
in the World Health Organisation’s (WHO) Constitution (World Health Organization, 2019) so 
that humans are able to live full and satisfying lives (Liburd & Sniezek, 2007).   By identifying 
health assets rather than health deficits the focus can shift to “fostering people to be 
reconnected with their health and become co-producers” (Hunter, 2008). 
By employing these terms of assets and deficits, health can be further conceptualised as a 
‘resource’; capital that can be invested in to achieve positive health returns (Williamson & Carr, 
2009).  Most currently and relevantly, the New Zealand Mental Health Inquiry (Government 
Inquiry into Mental Health and Addiction, 2018) incorporates the notion of health assets by 
recommending a new mental health system that has a vision of mental health and wellbeing for 
all at its heart: where a good level of mental wellbeing is attainable for everyone.  Encouragingly, 
the World Health Organisation further state that given the long duration of chronic disease 
manifestation, there are numerous opportunities for prevention and intervention with 
appreciable economic benefits (World Health Organization, 2005b).  As such, there is ample 
research and analysis of the high levels of poor health, disease and disorder and also a sizeable 
body of work on attributable risk factors and potential solutions.  The main gap in the research 
is the implementation and analysis of effective interventions. 
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1.2.3.2 Sleep as a Resource 
Similar to most health research, sleep science and sleep medicine have focussed on what can go 
wrong with sleep.  While this approach has been important in advancing our understanding of 
the role of sleep in the development of ill health and disease, there is growing acknowledgement 
that healthy sleep is more than just an absence of sleep problems or a sleep disorder.  A 
sufficient amount of good quality sleep is being acknowledged as one of the fundamental 
components of good health, along with diet and physical activity.   
Consistent with the health as a resource model described above, several researchers have begun 
to suggest that sleep may be a valuable resource for dealing with challenging and stressful 
situations (Zohar, Tzischinsky, Epstein, & Lavie, 2005).  So too, the Australian Sleep Health 
Foundation asserts this notion, stating: “Sleep in many respects is a built in biological source of 
resilience and the ability to bounce back” (Australian Sleep Health Foundation, 2019b).  Optimal 
sleep is necessary for not only the prevention of chronic illness (N. F. Watson et al., 2015), but 
has the potential to positively improve distal outcomes of health.  Health care strategies that 
promote good health and wellbeing, should therefore incorporate a focus on sleep health.  This 
could provide crucial downstream health benefits in individuals, families and communities, 
engagement in social and work opportunities, while limiting the demands on treatment focused 





1.2.4 Conceptual model of sleep health 
To date, only one conceptual model of sleep health has been proposed, by Buysse (2014) who 
offers the following definition: 
“Sleep Health is a multidimensional pattern of sleep-wakefulness, adapted to 
individual, social and environmental demands, that promotes physical and 
mental well-being. Good sleep health is characterised by subjective satisfaction, 
appropriate timing, adequate duration, high efficiency and sustained alertness 
during waking hours.” 
This definition is important in three ways. Firstly, sleep health is expressed as a positive 
component of health and a key resource to health improvement, through intermediary 
processes at the genetic, molecular, cellular and system level (figure 1.4).  The concept of 
positive health view is highly appropriate in the context of pregnancy, because for many women 





Figure 1.4   Sleep dimensions and intermediary processes (Buysse, 2014). 
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Secondly, in Buysse’s model sleep health is a multidimensional construct.  While a majority of 
sleep research has concentrated on either sleep quality or sleep quantity, Buysse argues for five 
dimensions of sleep health; sleep duration, sleep quality, sleep timing, sleep continuity, and 
daytime sleepiness.  These dimensions are all associated with differing health outcomes, can be 
measured both quantitatively and qualitatively (although difficulties remain for defining and 
quantifying sleep quality – see below) and can all be readily understood by healthcare 
professionals and the individual.   
Thirdly, Buysse’s definition of sleep health recognises that good sleep health may not be 
identical for every individual or in every situation and therefore allows for flexibility around 
social/environmental contexts and intrinsic/extrinsic influences.  Buysse’s framework is a 
relatively new concept and is untested in the fields of pregnancy and depression.  Previous 
research has usually examined one or two aspects of sleep in association with mood at different 
stages of pregnancy.   
To the researcher’s knowledge, the studies in this research are the first to examine all five 
aspects of sleep health in this context.  The following sections will explore these sleep aspects 
in more detail and briefly describe their association with pregnancy, however a more thorough 
description of trimester changes to sleep throughout pregnancy will be discussed in section 
1.4.2. 
1.2.4.1 Duration 
Sleep duration is the total amount of sleep an individual gets either in a nighttime period or in a 
24-hour period.  The National Sleep Foundation recommends that adults should sleep seven or 
more hours per night on a regular basis (Hirshkowitz et al., 2015) although it is also 
acknowledged that sleep duration is a highly individual requirement.  
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In recent years, research has consistently indicated that habitual short sleep among adults is an 
independent predictor of poor mood, negative motor and cognitive performance, obesity, 
cardiovascular disease, diabetes, hypertension, respiratory diseases, learning difficulties, 
increased mortality risk and an increased risk of accidents (Cappuccio, D'Elia, Strazzullo, & Miller, 
2010; Ferrara & De Gennaro, 2001; Gangwisch et al., 2006; Krueger & Friedman, 2009; Magee, 
Caputi, & Iverson, 2011; Stranges et al., 2008).  Habitual long sleep is also associated with many 
of the same negative health outcomes (Cappuccio et al., 2010; Steptoe, Peacey, & Wardle, 
2006).  A systematic review and meta-analysis of prospective studies showed consistent 
patterns of both short (less than seven hours) and long sleep duration (more than eight to nine 
hours, depending on the study) being associated with a 12% and 30% increased risk of all-cause 
mortality respectively (Cappuccio et al., 2010).  Long and short sleepers may be at higher risk for 
a range of medical comorbidities, which would contribute to these associations (National 
Institutes of Health, 2011; Stranges et al., 2008).  It is important to note that regularly sleeping 
more than nine hours may be appropriate for young adults or those recovering from illness (N. 
F. Watson et al., 2015).  Even so, it remains that short and long habitual sleepers represent 
higher risk population groups. 
There is increasing evidence that short sleep is highly prevalent in modern Western culture. 
Approximately one in five New Zealand adults have insufficient sleep (Paine & Gander, 2016) 
and similarly in Australia, two large studies investigating sleep quantity found comparable 
prevalence of short sleep durations.  Bartlett et al. (2008) analysed 3300 responses from adults 
between the ages of 18 to 64 living in New South Wales and found that 18.4% were sleeping less 
than six and a half hours per night, while in the 2010 Australian Sleep Foundation poll that 
surveyed 1512 Australian adolescents and adults, 23.7% of respondents were reporting 
insufficient sleep (less than seven and a half hours), mostly women and younger to middle-aged 
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men (Hillman & Lack, 2013).  While demographics, data collection, analysis and definitions of 
short sleep vary between these studies, collectively, they indicate that a percentage of the 
population are potentially significantly sleep deprived. 
In a study comparing 1075 third trimester pregnant women to 958 women in the general 
population, Signal et al. (2014) found that pregnant women averaged 30 minutes less sleep than 
women in the general population, but were also three times more likely to be either short 
sleepers (less than six hours) and nearly twice as likely to be long sleepers (longer than nine 
hours).  Evidence suggests that long and short sleep durations may affect pregnancy outcomes.  
Lee & Gay (2004) found that pregnant women with sleep durations under six hours had 
significantly higher rates of caesarean section compared to those with sleep durations over 
seven hours, though no additional studies have replicated these findings.  In a cohort of 1,272 
pregnant women, Williams et al. (2010), found that short sleep (less than six hours) and long 
sleep duration (more than nine hours), were associated with pregnancy-induced hypertension 
and pre-eclampsia, while Facco et al. (2017) reported that a short sleep duration (less than seven 
hours) was associated with an increased risk of gestational diabetes but not hypertensive 
disorders.  A recent meta-analysis reviewing the relationship between pregnancy sleep and poor 
fetal outcomes concluded that short sleep duration, and in some cases long sleep duration, was 
associated with preterm birth and stillbirth (Warland, Dorrian, Morrison, & O'Brien, 2018).  This 
finding is particularly important as preterm delivery accounts for 75% of perinatal mortality and 
more than half of long-term morbidity (Goldenberg, Culhane, Iams, & Romero, 2008). 
1.2.4.2 Sleep Quality 
Though sleep quality is a widely accepted construct of sleep, it is a “complex phenomenon that 
is difficult to define and measure objectively” (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989).  
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Researchers and clinicians have suggested a number of quantitative metrics for sleep quality to 
allow for the assessment, evaluation and comparison of sleep complaints and disorders.  These 
include sleep duration (total sleep time (TST)), how long it takes to fall asleep (sleep onset 
latency (SOL)), the level of sleep fragmentation or sleep disturbance during the sleep period 
(wake after sleep onset (WASO)) or sleep efficiency (TST divided by time in bed (TIB), expressed 
as a percentage).  However, sleep quality also includes less quantifiable aspects of sleep 
satisfaction.  Subjective indices, such as; ‘depth of sleep’, ‘how rested one feels after awakening’ 
and ‘satisfaction with sleep’ (Pilcher, Ginter, & Sadowsky, 1997) are crucial considerations.  
Differences between individuals also complicate the definition of sleep quality.  One person may 
find a specific number or duration of awakenings or length of time to fall asleep to be 
problematic, while someone else with the same objective sleep structure, may not.  Indeed, it 
has been noted that individuals with insomnia cannot be differentiated from normal sleepers 
based on these objectively measured aspects of sleep (Krystal & Edinger, 2008). 
There is substantial evidence linking the subjective perception of unrefreshing sleep, poor or 
inadequate sleep to adverse health outcomes, such as inflammation, metabolic syndrome, 
insulin resistance and Type 2 diabetes (Okun et al., 2012).  Poor quality sleep is also associated 
with accident, error and poor mood (Okun et al., 2012; Volkovich, Tikotzky, & Manber, 2016; 
Weaver, Stutzman, Supnet, & Olson, 2016), and is a commonly reported in pregnancy.  This is 
evidenced by Yang et al. (2017) who examined the self-reported sleep quality of 500 pregnant 
women in all trimesters and found that poor sleep quality was experienced by 82%, 87% and 
87% of women in trimesters one, two and three respectively.   
Importantly, previous research has shown that the feedback an individual receives about their 
sleep is a key influence on their mood and daytime functioning.  Semler & Harvey (2005) 
discovered that when individuals with insomnia were provided with negative comments about 
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their sleep quality, they were more likely to report daytime sleepiness, negative thoughts, 
monitoring for sleep-related threat, and daytime safety behaviours, compared to those who 
received positive feedback about their sleep quality. 
1.2.4.3 Sleep Timing 
The timing of sleep is an important sleep health factor that has received much less attention 
than sleep duration and sleep quality.  Emerging research suggests chronic disruptions to sleep 
timing contribute to diabetes and obesity as well as immune, cardiovascular and endocrine 
disorders (Scheer, Hilton, Mantzoros, Shea, & Takahashi, 2009; Zee & Turek, 2013).  Sleep timing 
is related to an individual’s chronotype, but also highly dependent on environmental factors and 
lifestyle choices.  Social, work and family demands increasingly dominate over our genetic 
predisposition to sleep at certain times, highlighted by the fact that a growing number of adults 
use substances to help them fall asleep and stimulants (such as caffeine) during the day (Foster 
et al., 2013) and over 80% use an alarm clock to wake on workdays (Roenneberg, Allebrandt, 
Merrow, & Vetter, 2012). 
‘Social Jetlag’ describes the discrepancy between an individual’s circadian and social clocks 
(Roenneberg et al., 2012), as measured by the difference in the amount and timing of sleep on 
scheduled days versus free days (Wittmann et al., 2006).  A global on-line survey using the 
Munich Chronotype Questionnaire (MCTQ) questionnaire (approximately 150,000 entries) has 
found that 69% of participants experience at least a one-hour social jetlag shift, and 33% 
experience a shift of two hours or more (Foster et al., 2013). 
Social jetlag can cause chronic sleep restriction and circadian disruption (Foster et al., 2013) and 
is strongly associated with chronotype, with evening types more greatly affected than morning 
types (Takahashi et al., 2018).  Importantly, ‘eveningness’ has been associated with greater risk 
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of depression symptoms (Hidalgo et al., 2009).  Greater social jetlag is also independently 
associated with increased risk of metabolic disorders, diabetes and elevated BMI (Foster et al., 
2013; Roenneberg et al., 2012).  Of particular significance is the relationship between social 
jetlag and depression.  In a study of 4051 rural Brazilians, Levandovski et al. (2011) found that 
two or more hours of social jetlag was associated with significantly higher depression scores on 
the Becks Depression Inventory (BDI), especially in 31-40 year-olds. 
Data on sleep timing and social jetlag in pregnant women are very limited.  Tsai et al. (2011) 
found that pregnant women had significantly different wakeup times on weekdays compared to 
weekends, while also having longer sleep durations on weekends.  A recent study by Martin-
Fairey et al. (2019) reported that women in their first and second trimesters have significantly 
earlier sleep onset times compared to pre-pregnancy, in conjunction with decreased levels of 
activity.   
1.2.4.4 Sleep Continuity 
Sleep continuity refers to the amount and distribution of sleep versus wakefulness in a given 
sleep period and includes both sleep initiation and sleep maintenance (Mezick, 2013).  Poor 
sleep continuity is typical in individuals with insomnia and commonly reported in those with 
mood disorders or medical conditions, such as sleep apnea, chronic pain, asthma and respiratory 
conditions, chronic renal disease, infectious diseases, and cancer (Mezick, 2013). 
Frequent nocturnal awakenings and symptoms of insomnia are common pregnancy sleep 
complaints (Facco, Kramer, Ho, Zee, & Grobman, 2010).  Okun (2019) suggests that sleep 
architecture may not be dissimilar between pregnant and non-pregnant states, but arousals and 
awakenings more frequent.  Emphasising the magnitude of sleep disturbance some women 
experience during this time, Kohn & Murray (2008) state, “Sleep fragmentation and disruption 
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during the normal physiological changes of pregnancy are as significant as some medical 
diseases”.   
Findings from cross-sectional studies of postnatal women suggest sleep disturbances and 
daytime dysfunction are associated with depression after delivery, (Dørheim, Bondevik, 
Eberhard-Gran, & Bjorvatn, 2009; Huang, Carter, & Guo, 2004).  This is consistent with the 
results from Park et al. (2013), who found that both self-reported (and actigraphic measures to 
a lesser extent) of sleep maintenance were significantly associated with postnatal depressive 
symptoms.   
1.2.4.5 Daytime Sleepiness 
Excessive daytime sleepiness is characterised by difficulty staying awake and alert during 
daytime hours.  It has been associated with a range of cardiovascular, metabolic, neurological 
and mental health disorders and can have significant social, economic (Jaussent, Dauvilliers, 
Morin, & Ivers, 2017), safety and quality of life (Young, 2004) implications.   
Approximately one in five adults experience daytime sleepiness (Young, 2004), however, there 
are limited studies investigating the relationship between daytime sleepiness and mood in 
perinatal women.  Tsai et al. (2016) investigated maternal characteristics associated with 
daytime sleepiness in all three trimesters and found that 15% of women had persistent daytime 
sleepiness across all three trimesters and a further 15% developed new-onset daytime 
sleepiness with advancing gestation, which was associated with being nulliparous (first time 
mothers), working long hours, snoring and having elevated depressive symptoms.  Bei et al. 
(2010) examined sleep and mood in 44 healthy women from the third trimester to one week 
postnatal and found that poorer subjective nighttime sleep, greater daytime dysfunction, and 
more daytime napping were significantly associated with poor mood in the third trimester and 
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one week postnatal, however actigraphic sleep quality or duration were not strongly associated 
with mood at either time point.  Increased awareness of sleep’s impact on waking hours is 
important in understanding mood disturbances (Bei et al., 2010) and since daytime sleepiness 
can be a symptom of depression, it is not surprising that the two are correlated (Bais et al., 
2019). 
1.3 Measuring Sleep 
1.3.1 Polysomnography 
The gold standard for objectively measuring sleep is polysomnography (PSG), as it is the only 
method that provides detailed information on the structure of sleep and physiological events 
that occur during sleep.  PSG requires the placement of surface electrodes on the head and body 
to measure cortical activity, eye movements and muscle activity and in some instances also 
heart physiology and respiratory function.  In addition to providing comprehensive information 
to definitively quantify sleep and wake it is also used to diagnose many types of sleep disorders.   
PSG normally takes place in a laboratory making it time-consuming, resource-intensive and 
costly. It requires specialist personnel to apply, monitor, and score.  This renders PSG impractical 
in many situations, including large research cohorts or when long term measurement is needed.  
Ambulatory PSG can be performed in an individual’s own home, and does allow a familiar 
sleeping environment, but this method still requires specialist equipment, application and 
scoring.  Another downside of PSG is the ‘first-night effect’ (Agnew, Webb, & Williams, 1966).  
Because of the unfamiliar environment of the sleep laboratory and the equipment used, sleep 
can be significantly disturbed on the first night of PSG recording, thus more than one night of 
PSG recording is typically needed to get a more accurate representation of normal sleep.  PSG 
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also cannot generate information about perceived sleep quality, daytime sleepiness, and it is 
limited in assessing sleep patterns over time. 
1.3.2 Actigraphy 
Actigraphy involves wearing a compact wrist-worn, battery operated device (similar to a wrist-
watch) that utilises a motion sensor, known as an accelerometer, to measure the occurrence 
and degree of movement.  Because immobility is a key characteristic of sleep (relative to 
wakefulness), actigraphy is a widely used objective sleep measurement tool.  Data are stored in 
the device’s memory for the length of the recording and then downloaded for analysis.  
Actigraphy can be used in the study of larger research populations as it does not require 
technicians to set up, is relatively inexpensive and unobtrusive.  A key benefit of actigraphy is 
continuous and long-term (up to a month at a time) monitoring in a familiar environment, which 
provides important information on night-to-night/weekday-weekend variability and sleep 
patterns over time.  Compared to PSG, actigraphy estimates sleep based solely on movement so 
cannot detect sleep stages or sleep disorders, such as apneas, snoring or parasomnias.  
Furthermore, actigraphy can overestimate sleep and underestimate wake since still wakefulness 
can be misinterpreted as sleep (Ancoli-Israel et al., 2003).  Nonetheless, actigraphic sleep 
parameters have been validated against PSG (de Souza et al., 2003; Kosmadopoulos, Sargent, 
Darwent, Zhou, & Roach, 2014; Kushida et al., 2001; Marino et al., 2013).  Current best practice 
recommends that actigraphy is used concurrently with a sleep diary to properly identify and 
confirm periods of sleep and inactive wake (Littner et al., 2003), such as reading or watching 
television, or indeed off-wrist periods.   
Comparisons have been made between PSG and actigraphy in women of child-bearing age  
(Ancoli-Israel et al., 2003) and actigraphy has often been used as a non-invasive measure of sleep 
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in pregnant and postnatal women (Bei et al., 2010; K. A. Lee & Gay, 2004; Montgomery-Downs, 
Insana, Clegg-Kraynok, & Mancini, 2010; Reid et al., 2017; Tsai et al., 2011).  In pregnancy 
research, actigraphy allows considerable data to be collected from many women over an 
extended period of time (Okun, 2019), and may be a valid and reliable way to help inform clinical 
decisions and improve sleep hygiene (Ferraro, Chaput, Gruslin, & Adamo, 2014).  Actigraphy has 
been validated against PSG in healthy adults (Marino et al., 2013), adolescents and children 
(Meltzer, Hiruma, Avis, Montgomery-Downs, & Valentin, 2015), but has not been validated 
against PSG in pregnant and postpartum women.   
In a critical review of sleep in pregnancy, Ross et al. (2005) identified significant gaps in objective 
sleep measures.  Many pregnancy studies have assessed sleep through self-reported measures 
at either one or two time points, typically in the second and third trimester.  In a systematic 
review and meta-analysis of non-pharmacological interventions for improving postnatal sleep 
only three of the 11 studies employed objective measures of sleep (Owais, Chow, Furtado, Frey, 
& Van Lieshout, 2018).  Researchers have suggested that a valuable contribution to sleep and 
pregnancy literature would be more prevalent use of objective measures to assess sleep (Howe 
et al., 2015; K. A. Lee & Gay, 2004) with repeated measures across different stages of pregnancy 
(Howe et al., 2015; Yang et al., 2017), while other researchers have recommended comparing 
both objective and subjective measures and multidimensional sleep-aspects (Felder et al., 
2018). 
1.3.3 Subjective sleep measures 
Subjective or self-report measures of sleep are most often acquired from sleep diaries, 
questionnaires and structured sleep scales.  Self-report measures are easy to administer, are 
minimally intrusive, low-cost and provide a good reflection of an individual’s overall perception 
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of sleep (Bei, Coo, & Trinder, 2015).  It is also an effective way of collecting long-term data or 
acquiring pilot data to inform further enquiry (Okun, 2019).  Self-report measures have also been 
used extensively in assessing sleep patterns of pregnant women.  
There are several self-report measures with adequate reliability and criterion validity for adults 
and numerous sleep scales have been developed to obtain personal accounts of habitual sleep.  
Because subjective measures typically rely on a retrospective account of sleep and a reliance on 
memory, they can introduce recall bias and therefore undermine the accuracy of the data.  
Wilson et al. (2013) compared self-reports to PSG and found that while women in the third 
trimester were equally likely to slightly over or under estimate their sleep duration, women in 
the first trimester and non-pregnant women underestimated sleep duration by almost one hour 
on average.  This is similar to Herring et al. (2013) who noted that women in the second trimester 
underestimated self-reported sleep time by nearly 30 minutes when compared to actigraphy, 
and McIntyre et al. (2016) who found that women in the third trimester underestimated self-
reported sleep time by nearly 60 minutes when compared to video recording.  McIntyre et al. 
(2016) also found there was poor agreement between self-reports and video for sleep latency, 
however caution needs to be applied when interpreting the results of this study, as sleep onset 
was defined as the participant lying still for more than three minutes.  This is much less than the 
10 minutes of inactivity required for actigraphically measured sleep onset. 
Many studies have found that subjectively measured sleep disruption, but not objective sleep 
measures, are more strongly associated with depressive symptoms (Bei et al., 2010; Okun et al., 
2013; Park et al., 2013; Volkovich et al., 2016) thus, the perception of sleep quality may be an 





A society that places a low value on its mothers and the process of birth will 
suffer an array of negative repercussions for doing so.  Good beginnings make 
a positive difference in the world, so it is worth our while to provide the best 
possible care for mothers and babies throughout this extraordinarily 
influential part of life. 
Ina May GASKIN, A Midwife’s Manifesto,  
Seven Stories Press, New York, 2011 
The future of a child is shaped the moment he or she enters the world, as pregnancy and birth 
are typical entry points into a country’s healthcare system (World Health Organization, 2005a).  
This provides a unique opportunity to survey the wellbeing of the family, and monitoring of 
maternal and fetal/newborn health should form an integral part of monitoring the health of the 
overall population (New Zealand Ministry of Health, 2019b). 
A typical pregnancy gestation lasts around 40 weeks from the first day of a woman's last 
menstrual period.  It is generally divided into trimesters, each lasting about 12–13 weeks (or 
about 3 months), though specific days throughout pregnancy are also recorded.  A pregnancy 
that is “36 and 3/7 weeks” means 36 weeks and 3 days of pregnancy.  The American College of 
Obstetricians and Gynecologists (ACOG) (Spong, 2013) define trimesters accordingly to the 
following timeframes: 
• First trimester: 0 weeks to 13 and 6/7 weeks (1–3 months) 
• Second trimester: 14 and 0/7 weeks to 27 and 6/7 weeks (4 –7 months) 
• Third trimester: 28 and 0/7 weeks to 40 and 6/7 weeks (7–9 months) 
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In this thesis, the term antenatal is used synonymously with pregnancy, and postnatal used 
interchangeably with postpartum. 
Current research advocates for the fundamental importance of a child’s first 1000 days, 
specifically, from conception to the child’s second birthday.  Cusick & Georgieff (2019) describe 
this time frame as the ‘brain’s window of opportunity’, a unique period of rapid developmental 
plasticity and programming in a child’s brain, but also the foundation for optimal health and 
growth across the lifespan.  This rapid physiological development shows a level of connectivity 
throughout the developing brain that far exceeds that of adults (Innocenti & Price, 2005) and 
while both gene expression and environmental input are vital for normal brain development, 
the disruption of either can fundamentally alter neural outcomes (Stiles & Jernigan, 2010).  
Hence, health, relationships and behaviour such as nutrition, attachment and sensory 
encounters, all affect brain development and lay the foundation for the rest of the child’s life 
(Moore, Arefadib, Deery, & West, 2017).  Misra (2007), states: ‘The first 38 weeks of life spent in 
the allegedly protected environment of the amniotic sac are medically more eventful and more 
fraught with danger and accident than the next 38 years in the life span of most human 
individuals.’  This highlights just how critical the mother’s physical and mental state are in 
shaping a healthy fetus, infant and young child.  It ‘predicts’ the world they will be born into, 
and how they adapt to relationships and environments, either beneficially or detrimentally 
(Moore et al., 2017). 
It is prudent to note that even in a normal physically healthy pregnancy, a women’s level of 
worry or fear of childbirth may be high.  A large qualitative study of 202 Australian pregnant 
women found that nearly a quarter of pregnant women used the words “terrifying” and 
“petrifying” to describe their approaching birth (Fenwick, Hauck, Downie, & Butt, 2005).  Fear of 
childbirth has been bidirectionally linked to both depression during pregnancy and postnatally 
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(Räisänen et al., 2013; Soderquist, Wijma, Thorbert, & Wijma, 2009), such that depression can 
reinforce the fear, or the fear may be a symptom of the depression (Storksen, Eberhard-Gran, 
Garthus-Niegel, & Eskild, 2012). 
1.4.1 Maternity care in New Zealand 
Birth rates in New Zealand and average age of women giving birth have increased between 2008 
and 2017.  The vast majority of women gave birth at a maternity facility (approximately 87% at 
a secondary or tertiary facility, 10% at a primary maternity facility and 3% at home).  Over 90% 
of New Zealand mothers have a midwife as their lead maternity carer (LMC) (New Zealand 
Ministry of Health, 2019b), with most LMC’s being registered midwives.  This midwife-led 
continuity of care is defined as one in which “the midwife is the lead professional in the planning, 
organisation and delivery of care given to a woman from initial booking to the postnatal period” 
(Sandall, Soltani, Gates, Shennan, & Devane, 2016).  A recent co-designed survey by the New 
Zealand Ministry of Health and New Zealand College of Midwives (New Zealand Ministry of 
Health and New Zealand College of Midwives, 2017) showed that a registered midwife spends 
an average time per woman of up to 53hrs, which included a booking visit, antenatal visits, 
labour, birth and immediate postnatal care, postnatal visits, travel and other non-contact 
requirements.  These services are free to all New Zealand citizens and permanent residents.  If 
the mother requires care outside the LMC’s scope of practice, it is the LMC’s responsibility to 
refer the woman to an appropriate clinician, either a state-funded obstetrician or doctor, but 
private obstetric care can be an option at a greater financial cost. After six weeks post birth, 
health care for mother and baby reverts to the family doctor or general practitioner and Well 
Child Tamariki Ora provides free health and development monitoring for all New Zealand 
children up to the age of five years. 
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The New Zealand Perinatal and Maternal Mortality Review Committee (PMMRC) guidelines 
recommend that all women should register with maternity care before 10 weeks gestation 
(Perinatal and Maternal Mortality Review Committee, 2012) which is similar to other developed 
countries recommendations (National Collaborating Centre for Mental Health, 2014).  This 
offers the opportunity to screen for sexually transmitted infections, family violence, mental 
health issues and congenital abnormalities.  In 2017, over two thirds of New Zealand women 
register with a LMC as soon as the pregnancy is confirmed, an increase from 2008 when only 
half registered within the first trimester (New Zealand Ministry of Health, 2019b). 
In addition to health care, New Zealand women also receive 10 days unpaid special leave 
during pregnancy to attend medical appointments, antenatal classes etc. and are also eligible 
for 22 weeks of government funded paid parental leave, plus an additional 22 weeks un-paid 
leave, to care for the child after birth (based on 12 months service with the same employer for 
more than 10 hours a week) (leave entitlements increase to 26 weeks from July 2020).  
Spouses or partners are also eligible for up to two weeks leave or have maternal entitlements 
transferred if the partner is the primary care giver (Employment New Zealand, 2018).   
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1.4.2 Sleep during pregnancy 
Investigating sleep during pregnancy is a relatively new field of research, but one that is gaining 
rapid traction.  A ‘Discover’ search using the term “sleep” and “pregnan*” revealed an 
exponential growth in the number of publications found in the last 60 years (see figure 1.5). 
It is important to note from the outset that sleep in pregnancy is highly variable among women, 
with some experiencing little change, while for others the profound physiological, psychological 
and hormonal change occurring in pregnancy makes sleep a significant challenge (Howe et al., 
2015; Mellor, Chua, & Boyce, 2014).  Though the reason for the differences is unclear, it appears 
the factors that intensify sleep changes and fatigue during pregnancy are gestational-age 
dependent (Bialobok & Monga, 2000; J. J. Chang, Pien, Duntley, & Macones, 2010).  The 








































1.4.2.1 First Trimester 
Significantly high levels of sleep disruption and fatigue are often felt early in pregnancy (K. A. 
Lee & Zaffke, 1999) and may well be the first symptom of pregnancy (Pien & Schwab, 2004).  
Total sleep time increases compared to pre-pregnancy levels (Hedman, Pohjasvaara, Tolonen, 
Suhonen-Malm, & Myllylä, 2002), suggesting that sleep need may increase in early pregnancy 
(J. J. Chang et al., 2010).  Other studies investigating first trimester sleep have found that women 
have difficulty in initiating and maintaining sleep (Haney, Buysse, Okun, Rosario, & Chen, 2014), 
experience reduced sleep continuity, less SWS (K. A. Lee, Zaffke, & McEnany, 2000) and higher 
levels of daytime sleepiness and fatigue (Bai et al., 2016; J. J. Chang et al., 2010; K. A. Lee, Zaffke, 
et al., 2000; Tsai, Lee, Lin, & Lee, 2016b).  Martin-Fairey et al. (2019) reported that women in 
their first and second trimesters have a significantly earlier sleep onset time compared to pre-
pregnancy while they also have significantly decreased levels of waking activity, further 
endorsing the suggestion that women in early pregnancy experience more fatigue or sleepiness 
during the day.  Okun et al. (2009), have suggested that significant consequences of poor sleep 
are most likely to be established within the first 20 weeks of pregnancy, but there is a dearth of 
objective and subjective information from this period.   
Up to 70% of women report nausea and vomiting in the first trimester (commonly known as 
‘morning sickness’), which is likely to be a side-effect of rapidly increasing hormones or stress 
(Bai et al., 2016).  Though symptoms are generally limited to the first trimester, a small majority 
of women will experience this for the entirety of pregnancy.  Because first trimester nausea is 
often present throughout the day and night, restricted sleep duration, poor continuity, daytime 
sleepiness and fatigue are a common experience (Pien & Schwab, 2004).  A recent paper by 
Yıldırım & Demir (2019) found that 61% of pregnant women experiencing severe nausea and 
vomiting in pregnancy (referred to as hyperemesis gravidarum (HG)) in the first trimester had 
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poor sleep as compared to 8% who did not have HG and furthermore, for women with HG, there 
was also a positive correlation between depressive symptoms and poor sleep.  Similar 
associations have been found between nausea, vomiting, insomnia and depression (Swallow, 
Lindow, Masson, & Hay, 2004), and nausea, vomiting, fatigue and depression (Bai et al., 2016; 
Chou, Lin, Cooney, Walker, & Riggs, 2003).  While nausea and vomiting are not likely to be the 
result of a psychological disorder, it is well understood that affected women have psychological 
symptoms that become entwined with, and possibly intensify, their physical symptoms (N. M. 
Lee & Saha, 2011).  
Short or long sleep durations and subjective poor sleep continuity in early pregnancy have also 
been associated with cardiometabolic risk factors (Haney et al., 2014; Qiu, Frederick, Sorensen, 
Enquobahrie, & Williams, 2014; Williams et al., 2010), an increased risk of gestational diabetes 
(Zhong et al., 2018), premature labour (Klebanoff, Shiono, & Rhoads, 1990) and short infant birth 
length (W. Wang et al., 2017).  Poor sleep continuity and quality during the first trimester can 
also be a result of increased need for urination (Baratte-Beebe & Lee, 1999), nasal congestion 
(Caparroz, Gregorio, Bongiovanni, Izu, & Kosugi, 2016; Ellegård & Karlsson, 2006), hot flashes 
during sleep (Thurston, Luther, Wisniewski, Eng, & Wisner, 2013), back pain (Ray-Griffith, 
Wendel, Stowe, & Magann, 2018; Sabino & Grauer, 2008), indigestion or heartburn (Vazquez, 
2015) and breast pain (Nazik & Eryilmaz, 2014). 
The first trimester of pregnancy is accompanied by a dramatic rise in hormones throughout the 
body and while these are vital for creating and sustaining a healthy fetal environment, they can 
have an adverse effect on sleep and circadian rhythms (Pien & Schwab, 2004).   
Progesterone is a key hormone in pregnancy.  Dramatic increases in progesterone are secreted 
by the placenta and are vital for maintaining a pregnancy.  Progesterone is also  soporific (K. A. 
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Lee, 1998) and thermogenic, increasing the core body temperature (Wolfson & Lee, 2005).  This, 
along with the body’s lack of thermoregulation during REM, may cause overheating, leading to 
sleep fragmentation.  Elevated progesterone levels having an inhibitory effect on the smooth 
muscle in the urinary tract (Wolfson & Lee, 2005) and may be why women experience frequent 
urination in early pregnancy.  Increased progesterone also increases minute ventilation and 
ventilatory drive (Jensen, Webb, & O’Donnellz, 2007).   
Estrogen levels also rise significantly in the first trimester and while this is necessary to improve 
vascularisation in the placenta and uterus, the rapid increase in estrogen levels can cause 
nausea.  Increases in estrogen alter the vascular tissue in the nasal passages, increasing mucosa, 
and hence leading to hypersecretion and nasal congestion.  This predisposes pregnant women 
to increased upper airway obstruction and snoring, both of which are independent risk factors 
for OSA in the general population, and a common effect of increased estrogen levels in 
pregnancy (Wolfson & Lee, 2005).  There is some evidence that increased estrogen levels 
contribute to Restless Leg Syndrome (RLS), however evidence is inconsistent (Manconi et al., 
2012).  Dzaja et al. (2009), found that pregnancy-related RLS was associated with increased 
estradiol levels, but no other hormone, which supports evidence of a higher incidence of RLS in 
the third trimester when estrogen levels are maximal, however, this result has yet to be 
replicated.  In animal studies, estrogen has been shown to suppress REM sleep (Pien & Schwab, 
2004).  
Human chorionic gonadotrophin (hCG) is an indispensable pregnancy hormone that stimulates 
progesterone production in the corpus luteum in early pregnancy (Rahman & Rao, 2009).  It is 
one of the first proteins synthesised after conception (Rull & Laan, 2005) and as such, is the 
hormone with the highest sensitivity and specificity for detecting a pregnancy (Buyalos et al., 
1992), being detected as early as six days after conception (Braunstein, Rasor, Danzer, Adler, & 
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Wade, 1976).  Research has shown that hCG reaches its maximum levels at the end of the first 
trimester between days 56-68 and dramatically reduces after this time (Braunstein et al., 1976).  
Recent findings suggest that although levels are low in trimesters two and three, hCG may also 
contribute to myometrial quiescence (active relaxation of the uterine smooth muscle) during 
these trimesters (Rahman & Rao, 2009). 
Interestingly, hCG is only found in humans, primates and equines, and this may be why there is 
minimal research on the effects of hCG on sleep behaviour.  While the soporific hormone, 
progesterone, is considered to be associated with sleep changes during pregnancy (and indeed 
hCG promotes progesterone production), Toth et al. (1994), suggests that the levels of 
progesterone do not correlate with the sleep changes throughout the trimesters (i.e. sleepiness 
is lower in the second trimester, but progesterone levels are higher), however hCG correlates 
better with sleep changes.  This is also supported by findings that found hCG receptors are 
present in the brain centres that control sleep (Toth et al., 1994).  However, the effects of hCG 
on human sleep are not yet well understood (Bourjeily, 2009). 
1.4.2.2 Second Trimester 
Compared to the first three months, the second trimester sees a significant increase in NREM3 
sleep but may also be accompanied by increased restlessness (Pien & Schwab, 2004).  Although 
the mechanisms are not fully understood, both subjective and objective reports of sleep are 
improved during the second trimester compared to the first (Okun et al., 2012), and many 
women find they have higher levels of daytime energy (Wolfson & Lee, 2005).  Once again, it 
must be emphasised that this is highly variable from woman to woman.   
Conversely, there is a marked increase in the prevalence of snoring in the second trimester 
compared to pre-pregnancy levels.  Wolfson & Lee (2005) state that 30% of women report the 
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onset of snoring that did not exist prior to pregnancy, while Franklin et al. (2000) found that 23% 
of pregnant women reported snoring every night and 25% occasionally snoring, compared with 
only 4% prior to pregnancy.  Snoring is also an indicator for pre-eclampsia and hypertension in 
the mother, as well as growth retardation and lower APGAR (appearance, pulse, grimace, 
activity, and respiration) scores in the infant (Franklin et al., 2000; Wolfson & Lee, 2005).  
As discussed earlier, melatonin plays an important role in sleep physiology, but also has a crucial 
part in normal fetal development (Carlomagno, Tilotta, Minini, & Unfer, 2018) and is a highly 
effective antioxidant in the ovaries, placenta and fetus (Reiter, Tan, Korkmaz, & Rosales-Corral, 
2014).  Night-time concentrations of melatonin begin to increase after 24 weeks gestation, with 
significantly higher levels after 32 weeks (Voiculescu, Zygouropoulos, Zahiu, & Zagrean, 2014).  
Melatonin crosses through the placenta without modification, providing photoperiodic 
information to the fetus thereby influencing circadian rhythms (i.e. sleep/wake cycles) of the 
offspring (Carlomagno et al., 2018; Voiculescu et al., 2014).  These rhythms have been shown to 
be interrupted if mothers are kept in continuous light environments (Carlomagno et al., 2018).  
Circadian disruption due to shift work changes melatonin production and is associated with 
adverse obstetric conditions such as pre-eclampsia and growth restriction, prematurity and 
spontaneous abortion (Nakamura et al., 2001; Reiter et al., 2014; Voiculescu et al., 2014), as well 
as neurological disability in the fetus (Carlomagno et al., 2018).     
Relaxin levels increase in the first trimester and reach a stable elevated state in the second 
trimester.  Because relaxin serves as a muscle and blood vessel relaxant, it may also increase 
upper airway softening during sleep.  This can increase the likelihood of snoring or breathing 
problems, especially later in pregnancy.  The relaxant properties of relaxin on the back muscles 
and ligaments are also believed to be one reason why women experience increased back pain 
during this trimester. 
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Cortisol levels increase around the 25th week of pregnancy and by the end of pregnancy levels 
are about two to three times higher than pre-pregnancy.  Cortisol has a circadian rhythm, 
typically with a nadir close to midnight.  Levels begin to increase two to three hours after sleep 
onset and continue to rise into the early morning hours.  Cortisol peaks approximately 30 
minutes after waking and then continues a steady decline until the nadir (Bleker, Roseboom, 
Vrijkotte, Reynolds, & de Rooij, 2017).  The cortisol awakening response is attenuated as 
pregnancy progresses, however a less pronounced attenuation or higher cortisol levels have 
been associated with adverse birth outcomes, such as lower birth weight and a shorter gestation 
period (Bublitz, Bourjeily, D’Angelo, & Stroud, 2018).  Elevated cortisol levels are associated with 
poor sleep and sleep disturbances (Bublitz et al., 2018).  There is evidence that elevated cortisol 
is associated with being nulliparous (Bleker et al., 2017), preterm delivery (Sandman et al., 2006) 
and depression in pregnant women (Peer, Levitan, Soares, Steiner, & Streiner, 2013), though 
depression findings are mixed, with some authors finding associations in the early third 
trimester (Voegtline et al., 2013) but not in the first trimester (Bleker et al., 2017).  A small study 
by Suzuki et al. (1993) found a significant relationship between sleep and women’s 
cortisol/melatonin ratio in late pregnancy, where poor sleep was associated with lower ratios 
and good sleep associated with higher ratios.   
Restless legs syndrome (RLS) or Willis-Ekbom disease is a neurological disorder characterised by 
an urge to move the legs due to unpleasant sensations.  Women with pre-existing RLS often find 
pregnancy exacerbates symptoms (Manconi et al., 2004), which are most commonly felt at night 
when lying at rest, typically when trying to fall asleep.  It is therefore unsurprising that RLS in 
pregnancy has been found to be associated with poor sleep quality, daytime sleepiness (Dunietz 
et al., 2017) and shorter sleep duration (Manconi et al., 2004).  The onset appears to be most 
common in the third trimester, though some authors have noted increased rates in the second 
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trimester (Srivanitchapoom, Pandey, & Hallett, 2014).  A review of RLS in pregnancy noted a 
prevalence of up to 32%, approximately two to three times higher than in non-pregnant women.  
Fortunately most pregnancy-related RLS cases fully resolve within a month after birth 
(Srivanitchapoom et al., 2014).  Leg cramps are involuntary muscle contractions which also often 
occur at night and are commonly felt by women in their second and third trimesters (K. Zhou, 
West, Zhang, Xu, & Li, 2015).  Prevalence of leg cramps in pregnancy and subsequent adverse 
sleep issues are similar to those of RLS (Hensley, 2009). 
1.4.2.3  Third Trimester 
Sleep in the third trimester is characterised by decreased SWS, REM sleep (Brunner, Münch, 
Biedermann, & Huch, 1994) and total sleep time (J. J. Chang et al., 2010).  For some women, the 
third trimester is also distinguished by high levels of sleep fragmentation which continues to 
increase through to the last week of pregnancy (M. L. Evans, Dick, & Clark, 1995). 
The growth of the fetus, placenta, uterus, breast tissue, blood volume, amniotic fluid and 
nutrient storage equate to a weight gain of approximately 11.5-16 kilograms for a woman with 
a healthy BMI range (Rasmussen et al., 2010).  This places a large energy demand on the body 
to supply oxygen and nutrients to the fetus, placenta and uterus and places a significant load on 
the cardiac system (Yosefy et al., 2012).  For a healthy woman with a normal-sized fetus, blood 
plasma volume increases during pregnancy by almost 50%, in turn increasing cardiac output 
(Hytten, 1985).  Increased demand on heart and lung capacity requires an increase in 
metabolism, which can have a fatiguing effect on the body (K. A. Lee & Zaffke, 1999).  The 
enlarged abdominal girth causes upward pressure on the diaphragm, resulting in increased 
effort to breath, increased minute ventilation and a decrease in functional residual capacity 
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(Butkov & Lee-Chiong, 2007).  Additionally, the recumbent position reduces the mechanical 
efficiency of breathing, increasing dyspnea and precipitating sleep fragmentation. 
Many other factors contribute to poor sleep quality in the last trimester, such as uterine 
contractions, abdominal pain, frequent urination, cramps, feeling uncomfortable, feeling hot, 
having bad dreams and gastroesophageal reflux (Ursavas, 2009; Wolfson & Lee, 2005).  
Increased uterine size and fetal movements can make finding a comfortable sleep position 
difficult later in pregnancy.  Joint and muscle pain, fluid retention and breast tenderness can be 
painful enough to prevent sleep onset or cause frequent arousals from sleep (Baratte-Beebe & 
Lee, 1999).  Nocturia and reflux can cause awakenings as the uterus compresses the bladder, 
reducing its capacity (resulting in frequent nocturia) and as the uterus squashes the diaphragm, 
the intestines and oesophageal sphincter are displaced (causing reflux).  Iron deficiency 
anaemia, of which tiredness is a symptom, can also result from the increased blood volume (K. 
A. Lee & Zaffke, 1999).   
Poor sleep in pregnancy has been linked to increased pain sensitivity, inflammation, discomfort 
during labor, and preterm labor (Beebe & Lee, 2007; Blair, Porter, Leblebicioglu, & Christian, 
2015; K. A. Lee & Gay, 2004).  Bourjeily et al. (2010) found sleep disordered breathing is 
associated with adverse pregnancy, delivery and fetal outcomes, specifically, gestational 
diabetes (even after controlling for body mass index), unplanned caesareans and low one-
minute APGAR scores but not five-minute APGAR scores.  Similarly, short sleep duration in 
pregnancy is associated with significantly longer labour, higher rates of caesarean births (K. A. 
Lee & Gay, 2004), more pain and discomfort in labour, higher rates of preterm labour (J. J. Chang 
et al., 2010), excessive weight gain (Althuizen, van Poppel, Seidell, & van Mechelen, 2009) and 
psychiatric disorders (Qiu, Gelaye, Fida, & Williams, 2012).  Interestingly, long sleep durations in 
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pregnancy have also been associated with psychiatric disorders (Qiu et al., 2012) and 
hypertension (Williams et al., 2010).   
Sleep position appears to have a considerable effect on pregnancy outcomes.  Recent studies 
have investigated the associations between third trimester sleep practices and late stillbirth.  In 
a meta-analysis of six case-controlled studies, Cronin et al. (2019) identified that supine going-
to-sleep position after 28 weeks gestation was associated with increased odds of stillbirth, while 
going-to-sleep position on the left or right side appeared equally safe.  While stillbirth is most 
commonly associated with supine sleep position, O‘Brien et al. (2019) found that long nighttime 
sleep durations (greater than nine hours), having long periods of undisturbed sleep and waking 
on the right side in the last pregnancy month, to be associated with late stillbirth (>=28 weeks 
gestation).  This is similar to two other studies (Heazell et al., 2018; Stacey et al., 2011) that 
found that both long and short sleep durations, one or fewer awakenings to use the bathroom 
and frequent daytime napping were also more common in women experiencing stillbirths, 
though two additional studies have found no associations between frequent daytime napping 
and stillbirth (McCowan et al., 2017; O'Brien et al., 2019).  The mixed results from these studies, 
highlight the need for more research in this area. 
Studies investigating sleep and parity in the perinatal period are limited.  Both Signal et al. 
(2007), and Lee (2000) found that multiparous (experienced) mothers have more disrupted 
sleep in pregnancy compared to nulliparous mothers, although the latter study did not find any 
difference by parity for sleep duration.  Similarly, Coo Calcagni et al. (2012) found that found 
nulliparas napped more often and experienced worse sleep in the third trimester and one week 
postnatally compared to multipara.  A recent study by Christian et al. (2019) found that 
nulliparas experienced declining sleep quality from the first to the third trimester while 
multiparas had poorer overall sleep quality compared to nulliparas during the first and second 
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trimesters but no significant change over the course of pregnancy or in early postnatal period.  
These authors suggest that multipara have poorer sleep quality in early pregnancy due to care-
giving for additional children, but the fewer parity-related differences in sleep quality in later 
pregnancy and the early postnatal period may be due to both groups of women experiencing 
greater sleep disruption from pregnancy related symptoms and the demands of having a 
newborn child.   
1.4.3 Lack of first trimester data 
There is a small body of literature that supports the importance of investigating sleep in early 
pregnancy (Haney et al., 2014).  As described previously, there are clear changes in sleep during 
the first trimester, however there is an under-representation of first trimester data, with 
common summaries of maternal sleep trajectories stemming from data primarily focussed on 
the second and third trimesters.  This absence has fuelled common statements such as “sleep 
declines with advancing gestation” (Ferraro et al., 2014) or study design justifications such as 
“participants were recruited in the second trimester, since sleep is more affected by pregnancy 
in the third trimester” (Bais et al., 2019).  Conclusions such as “Our study confirmed previous 
findings that general sleep quality declines as pregnancy proceeds” when data collection only 
commenced in week 18-20 does not provide an accurate representation of the current research 
(Polo-Kantola, Aukia, Karlsson, Karlsson, & Paavonen, 2016). 
 In a meta-analysis by Sedov et al. (2018) examining the sleep quality of over 11,000 women 
throughout pregnancy, the authors acknowledged there was a low representation of first 
trimester data, stating that the low sample numbers made it impossible to accurately summarise 
the changes in sleep quality from trimester one to trimester two.  In a systematic analysis by 
Pamidi et al. (2014) looking at maternal sleep disordered breathing and adverse pregnancy 
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outcomes, only three of the 31 articles examined first trimester participants, however closer 
assessment identified that two of these had small sample sizes (n=9 & 15), while the third had a 
larger sample (n=202) but gestations ranged from six to 20 weeks, which encroaches well into 
the second trimester.  Another recent meta-analysis by Xu et al. (2018) investigating the 
association between sleep duration and gestational diabetes stated that all seven studies in the 
analysis included ‘early’ pregnancy data, however importantly only three of these seven studies 
were conducted in the first trimester.  This highlights the complexities and importance, of 
defining pregnancy timeframes in research studies. 
It is not only sleep research that is lacking in the first trimester.  Other pregnancy reviews that 
focus on other aspects of gestational risk are underrepresented at this time point.  Only one 
study could be located that has examined the links between sleep quality and suicidal ideation 
in the first trimester (Gelaye et al., 2017), and similarly in a meta-analysis investigating maternal 
smoking and fetal measurements of over 70,000 women only 5.2% of the cohort were studied 
in the first trimester.   
A systematic review with over 1500 citations by Bennett et al. (Bennett, Einarson, Taddio, Koren, 
& Einarson, 2004), examined 21 articles (n=19,284 patients) to estimate depression prevalence 
in pregnancy and found rates of 7.4%, 12.8% and 12.0% in the first, second and third trimesters 
respectively.  However, calculations revealed that only 1.3% of the review’s data were collected 
within the first trimester.  The authors did acknowledge that rates must be interpreted with 
caution because few studies were available with small samples and the small cohort precluded 
the assessment of publication bias.  However, on closer investigation of the five studies included 
in the first trimester assessment, only two studies identified women prior to 14 weeks gestation, 
with the remaining three studies reporting gestations of <20 weeks (Pajulo, Savonlahti, 
Sourander, Helenius, & Piha, 2001), “early pregnancy” (Areias, Kumar, Barros, & Figueiredo, 
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1996) and <16 weeks (Birndorf, Madden, Portera, & Leon, 2001).  Interestingly, this latter study 
found a major depression prevalence of 24.6% for women at less than 16 weeks gestation.  The 
two studies with representative data from the first trimester also found relatively different 
outcomes from the main finding.  One study found that 16% of their sample experienced an 
affective disorder throughout the entirety of pregnancy, but importantly, 68% of these women 
experienced it prior to 12 weeks gestation (Kitamura, Shima, Sugawara, & Toda, 1993).  The 
other study that clearly reported first trimester data (<14 weeks), also found that total 
prevalence of depression was reasonably low (5%), but trimester one and trimester three 
prevalence were the same, with lower prevalence in trimester two (Affonso, Lovett, Paul, & 
Sheptak, 1990).  This study also used a non-standard questionnaire, instead modifying the 
‘Schedule for Affective Disorder and Schizophrenia’ (SADS) assessment by deleting items that 
‘had nothing to do with depression’ and furthermore, scoring guidelines were modified for 
somatic items as well as loss of interest, social withdrawal, anger, irritability and psychomotor 
retardation.  Clearly, this review is not representative of first trimester depression rates, 
however the conclusions from this paper have been used extensively, including being used in 
other systematic reviews (Dennis, Ross, & Grigoriadis, 2007).   
This is not a unique finding.  In another systematic review examining the prevalence of 
depression among over 30,000 pregnant women, only 528 women were studied in the first 
trimester, totalling only 1.7% of the cohort (Gavin et al., 2005).  These statements and 
conclusions perpetuate the myth that women in the first trimester are relatively immune to, or 
less effected by, pregnancy related issues.  While difficulties in recruiting are present and data 
are scarce, care still need needs to be taken in using broad statements about the trajectories of 
sleep and mood in pregnancy until sufficient research focussing on the first trimester is available 
and conclusions can be justified. 
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Difficulty recruiting women in the first trimester is understandable, given the small window 
between when mothers have a pregnancy confirmed and the beginning of the second trimester.  
A range of reasons may lead to delayed announcement of pregnancy, including previous 
miscarriage or termination, family or friends struggling with infertility, discussions about 
whether to terminate the pregnancy, couples wishing to keep the first trimester as a special time 
between themselves, fear of employment discrimination against pregnant women, and women 
not recognising they are pregnant until later in pregnancy.  
Studies with narrow eligibility criteria or complex protocols face additional recruitment 
obstacles.  Recruiting nulliparous women could be seen as more challenging, as they and their 
partners are experiencing an unfamiliar, and quite possibly overwhelming life event, though 
multiparous women may decide research studies create a further burden in an already 
challenging environment of looking after multiple children.  Furthermore, women with a history 
of depression may be hesitant to reveal their psychiatric history.  By no means an extensive list, 
these illustrate important considerations when recruiting pregnant women in the first trimester. 
1.4.4 Sleep from pregnancy to the postnatal period 
Typically, sleep is disrupted through the early postpartum period.  This is highly variable, with 
sleep returning to pre-pregnancy levels within three months postpartum for some women 
(Hedman et al., 2002), while for others sleep continues to be a challenge (Richter, Krämer, Tang, 
Lemola, & Montgomery-Downs, 2019).  One early study by Lee et al. (2000), assessed 29 women 
with home-based (ambulatory) PSG for two nights during pre-pregnancy, once per trimester, 
and during the first and third months postpartum.  The authors found no significant variation in 
sleep duration throughout pregnancy (though a declining trend), but there was a significant 
decrease at one month postnatal and improvement by the third month back to pre-pregnancy 
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values.  A similar significant pattern was seen in sleep efficiency, though improvements did not 
return to pre-pregnancy levels. 
Coo et al. (2014) examined 29 pregnant women late in the third trimester, 15 days postpartum, 
and 10 to 12 weeks postpartum.  Objectively measured sleep duration (via actigraphy) declined 
significantly in the immediate postpartum but recovered by three months postpartum to late 
pregnancy levels, while subjective reports (as measured by the Pittsburgh Sleep Quality Index 
(PSQI)) also declined but did not improve to late pregnancy levels.  They found a greater impact 
on sleep efficiency and though there was some improvement by three months postnatal, sleep 
did not return to pregnancy levels.  This is similar to Montgomery-Downs et al. (2010), who also 
found that sleep efficiency improved from the first month to fourth month postpartum, however 











For women of childbearing age, mental illness (specifically depression) is the leading cause of 
disease burden globally (World Health Organization, 2009) and women are twice as likely to 
become depressed than men (Buist et al., 2002).  Importantly, depression is a highly recurrent 
disorder, with more than 75% of depressed patients having more than one depressive episode, 
usually within two years of recovery (Gotlib & Joormann, 2010).  
Depression is a condition that primarily involves a disturbance of mood, characterised by being 
sad, hopeless, discouraged, or simply depressed (American Psychiatric Association, 2010).  
According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (American 
Psychiatric Association, 2013), major depressive disorder (MDD) requires five or more symptoms 
to be present within a two-week period.  One of the symptoms should at least be either a 
depressed mood or anhedonia (loss of interest or pleasure).  The secondary symptoms of MDD 
are appetite or weight changes, sleep difficulties (insomnia or hypersomnia), psychomotor 
agitation or retardation, fatigue or loss of energy, diminished ability to think or concentrate, 
feelings of worthlessness or excessive guilt, and suicidality.  
Among all age groups in New Zealand, depressive and anxiety disorders are the second leading 
cause of health loss behind heart disease, but of greater prevalence than obesity.  For 
childbearing aged women (aged between 15-44 years) mental health disorders are the leading 
cause of health loss, accounting for over 25% overall and nearly three times the rate of cancer 
or injury (New Zealand Ministry of Health, 2016).  Based on 2013 Organisation for Economic Co-
operation and Development (OECD) figures, New Zealand women aged 15-24 had the highest 
suicide rates from the 34 countries (New Zealand Ministry of Health, 2017a). 
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1.5.1 Sleep and depression 
A ruffled mind makes a restless pillow. 
Charlotte BRONTË, The Professor, (1857), 1st Ed., Smith Elder & Co., London, England 
One of the most consistent symptoms or risk factors for depression is poor sleep (Murphy & 
Peterson, 2015).  In all types of sleep disorders, 25-58% of patients exhibit some form of 
depression (Vandeputte & de Weerd, 2003).  Conversely, it is well established that those 
diagnosed with psychological disorders typically have disturbed sleep (Benca et al., 1997).  Up 
to 90% of depressed patients reporting poor sleep quality (Drago, 2008) and approximately 40% 
suffering from insomnia related complaints, such as difficulties with sleep onset, sleep 
maintenance and early morning awakenings (Murphy & Peterson, 2015; Perlis, Giles, 
Mendelson, Bootzin, & Wyatt, 1997), daytime sleepiness and fatigue (Franzen & Buysse, 2008), 
subjective sleep disturbances and poor sleep quality (Nutt, Wilson, & Paterson, 2008; Thase, 
2006).  Multiple disturbances in sleep are evident in about 45% of depressed outpatients and 
80% of more severely depressed inpatients (Tsuno, Besset, & Ritchie, 2005).  Furthermore 
depressive disorders are often associated with hypersomnia or long sleep durations (van Mill, 
Hoogendijk, Vogelzangs, van Dyck, & Penninx, 2010) and changes to sleep architecture, such as 
decreased latency to REM, increased REM and decreased SWS (Finan, Quartana, & Smith, 2015).  
The association between psychological disorders and sleep is so strong that the DSM-5 classified 
mental health disorders, such as depression and anxiety, list sleep disruption as a diagnostic 
criteria (R. Cooper, 2014). 
On reflection, it is not surprising that suboptimal waking function is associated with disrupted 
sleep and vice versa, since these are interdependent states of the same brain.  Sleep disturbance 
can pre-date the onset of depression (Meerlo, Havekes, & Steiger, 2015) and depression is 
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associated with sleep disruption (Kempler, Sharpe, & Bartlett, 2012).  Evidence also suggests 
that sleep strongly influences not only the development of depression but also the trajectory of 
depression; that is, episode frequency, severity and duration (Franzen & Buysse, 2008).  
Moreover, people with persistent sleep problems have elevated risk of developing major 
depression within one year (Breslau, Roth, Rosenthal, & Andreski, 1996; Eaton, Badawi, & 
Melton, 1995; Paunio et al., 2015), more than for any other depression symptom (Franzen & 
Buysse, 2008).  Conversely, improving sleep in those suffering depression has been found to 
improve health-related quality of life in non-pregnant samples (Franzen & Buysse, 2008; McCall 
et al., 2010).  However, because the relationship between sleep and depression is bidirectional 
and complex, it remains poorly understood.  
1.5.2 Pregnancy and depression 
All I could think about were the weeks stretching out in front of me.  Sixteen of them, 
and nothing I could do to speed them up.  It reminded me of the feeling I had on 
flights, which had also become a source of deep anxiety for me.  I was stuck in the 
mid-air of pregnancy, and I couldn't force the plane to land...  My mind played on a 
loop, fixating on the days and weeks that I had left.  The kicks and flips that I had 
treasured not long before became taunting reminders of the mental distress I was 
in.  I couldn't eat or sleep.  I walked everywhere, in an attempt to distract myself from 
the monotonous loop of thoughts playing repeatedly in my head.  At night, I lay in the 
bath and had frightening thoughts of suicide.  I didn't want to die but I couldn't bear 
the low hum of terror that had become my unwelcome companion. 
Clementine Ford, “I steeled myself for postnatal depression, but it struck earlier",  
Sydney Morning Herald, Sydney Australia, 18th Nov 2016 
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The majority of maternal mental health research has concentrated on the postnatal period, 
leaving depression in pregnancy relatively neglected.  ‘Postnatal depression’ was first presented 
as a field of research in the early 19th century, however the psychiatric community did not 
officially recognise this disorder until 1994 (American Psychiatric Association, 1994).  Moreover, 
it has only been since 2013 that the American Psychiatric Association (APA) have broadened the 
time period to include pregnancy, demonstrated by changes in terminology (perinatal instead 
of postnatal) and based on insufficient evidence to distinguish between pregnancy and postnatal 
depressive episodes (Alhusen & Alvarez, 2016).  It is only in the last decade that it has been more 
intensively investigated.  This may be in part due to the long-held belief that pregnancy had a 
protective effect on mental health (Oates, 2003). 
Mental health disorders disproportionately affect women (Yonkers, Vigod, & Ross, 2011), and 
women of childbearing years’ (25-34 years) experience higher rates of depression than at any 
other time (J. Evans, Heron, Francomb, Oke, & Golding, 2001) with some suggesting that peak 
risk is in pregnancy (O'Keane & Marsh, 2007).  Perinatal depression prevalence rates vary 
greatly.  Mellor (2014) recently summarised worldwide rates of depressive symptomology in 
pregnancy as varying from 5% to 39%, with lower rates in economically developed countries and 
higher rates in poorer countries, though the opposite was seen in a review of postnatal 
depression, where prevalence ranged from 4% to 64% but was higher in high-income countries 
(Arifin, Cheyne, & Maxwell, 2018; Parsons, Young, Rochat, Kringelbach, & Stein, 2012).  The 
American College of Obstetricians and Gynaecologists state that major and minor depression in 
pregnancy or postnatal affect one in seven women (Gavin et al., 2005), though a report from the 
same organisation four years later concluded that one in five women will experience pregnancy 
depression (Yonkers, Wisner, et al., 2009).  An Australian study, reviewing antenatal depression 
rates of over 17,000 women in two localised areas in New South Wales, found a lower 
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prevalence in its cohort of 6.2%, however the authors posit this may be due to the occurrence 
of well-received, government funded, in-patient and community-based interventions that aim 
to identify and support mothers with probable depressive episodes quickly (Ogbo et al., 2018).  
Though recent meta-analyses have been published in various countries and regions, such as 
Bangalore (Nath et al., 2019), Ethiopia (Ayano, Tesfaw, & Shumet, 2019), and South Asia 
(Mahendran, Puthussery, & Amalan, 2019), prevalence figures are often outdated.  Even a 2019 
systematic review investigating perinatal depression interventions from the United States of 
America (USA) Preventive Services Task Force, used prevalence data from 2012 (O’Connor, 
Senger, Henninger, Coppola, & Gaynes, 2019).  A current systematic review and/or meta-
analysis focusing on depression prevalence in pregnancy is warranted because perinatal 
depression is thought to be under-recognised (Highet, Gemmill, & Milgrom, 2011), under-
diagnosed and suboptimally treated (Biaggi, Conroy, Pawlby, & Pariante, 2016). 
Studies in New Zealand investigating the prevalence of antenatal depressive symptomology, 
confirm rates between 11.9% and 15% (Signal et al., 2016; Waldie et al., 2015), with rates for 
Māori women higher at 22% (Signal et al., 2016).  According to Statistics New Zealand, with  just 
over 61,000 births in New Zealand in 2015, approximately 10,000 New Zealand women are likely 
to have their health compromised each year by antenatal depression.  By comparison, 
prevalence rates for postnatal depression range from 9% to 20% (Coverdale, McCullough, 
Chervenak, & Bayer, 1996) and though less well documented, antenatal depression appears to 
be at least as common as postnatal depression (J. Evans et al., 2001). 
Gestational age appears to be a significant factor.  A systematic review by Bennett et al., (2004) 
which utilised data from 21 studies and over 19,284 pregnancies, found that depression in 
pregnancy had a prevalence rate of 7%, 14% and 12% for the first, second and third trimesters 
respectively.  This is similar to the findings by Evans et. al (2001), who found rates to be 11.8% 
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and 13.5% at 18 weeks and 32 weeks gestation respectively.  However, it must be emphasised 
again that reviews on gestational prevalence may not be accurate.   “There is a painful lack” of 
first trimester, and indeed longitudinal data across pregnancy (Kozinszky & Dudas, 2015) and 
the perinatal period (Gaynes et al., 2005).  This is despite researchers nearly 25 years ago 
appealing for more studies to collect and evaluate first trimester data (Coverdale et al., 1996). 
The limited literature available in early pregnancy suggests that the incidence of antenatal 
depression appears to increase in the first trimester (Coverdale et al., 1996; Fan et al., 2009; 
Maschi et al., 2008).  Yu et al. (2017) analysed data from women in trimester one, two and three 
(n=3645, n=2320 and n=2109 respectively) and found that the prevalence of depression was 
highest in trimester one (36%), compared to trimester two (24%) and three (26%).  Similarly, 
Truijens et al. (2017) found that, of the number of women presenting with persistent depression 
throughout pregnancy, 83% could be detected in the first trimester.  These findings suggest that 
this period may be a time of high vulnerability to depression, though further studies are greatly 
needed.   
1.5.2.1 Risk Factors for Depression in Pregnancy 
A systematic review by Lancaster (2010) identified the following key risk factors for depression 
in pregnancy: A history of depression; life stress and/or negative life events and belonging to an 
ethnic minority as well as other psychosocial factors such as low socioeconomic status, lack of 
social or partner support, intention to get pregnant, pregnancy anxiety, domestic violence and 





Previous History of Depression 
One of the primary risk factors for developing depression in pregnancy is having a previous 
history of depression (Marcus, Flynn, Blow, & Barry, 2003).  In a systematic literature review of 
111 articles, Rich et al. (2013), identified that women with previous personal or family mental 
health problems were significantly more likely to experience pregnancy-related depression.  
Similarly, a review by Lancaster et al. (2010), found a significant relationship between a personal 
history of depression and depressive symptoms in pregnancy.  Consistent with these review 
findings, studies by Jeong et al. (2013), Deitz et al., (2007) and O’Keane (2007) all found that 
having both a history and familial history of depression presented a two-fold increase in risk for 
antenatal depression.  Forty et al. (2006), has shown that 42% of women with a family history 
of postnatal depression experienced postnatal depression themselves, compared to only 15% 
of women who had no family history. 
Antenatal depression is also a strong predictor of postnatal depression (Leigh & Milgrom, 2008; 
Robertson, Grace, Wallington, & Stewart, 2004), and also increases the risk of developing 
depression later in life (McMahon, Trapolinia, & Barnett, 2008).  A large Swedish cohort study 
of over 700,000 women from 1997 to 2008 found that the risk of postnatal depression was 20 
times higher for women with a history of depression.  A Brazilian study of 831 pregnant women, 
found that women who experienced antenatal depressive symptoms were 2.4 times more likely 
to present with postnatal depressive symptoms than women who had no pregnancy depressive 
symptoms (Faisal-Cury & Menezes, 2012).  A similar finding was reported by Deitz et al. (2007) 
in a study of 4,398 pregnancies.  Of the women that experienced postnatal depressive 
symptoms, 54% had a depression diagnosis either during or preceding pregnancy.  Choi et al. 
(2014) also found 59% of women with antenatal depression experienced postnatal depression. 
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While these findings underscore the recurring nature of depression, what is unclear is whether 
the high levels of depression in pregnancy are due to a high relapse rate or an overall increased 
incidence of depression (O'Keane & Marsh, 2007).  While there is a consensus that pregnancy 
depressive symptoms are generally associated with postnatal depressive symptoms, there is 
some suggestion that each may have their own, or multifactorial, aetiology and set of risk factors 
(Kettunen, Koistinen, & Hintikka, 2014; Putnam et al., 2015; Wikman et al., 2019). 
To further explore this, recent studies have examined the trajectories in the occurrence of 
depression over these timeframes.  English et al. (2018) found that while pregnancy and 
postnatal depression are correlated, different factors predicted depression at each time point. 
Pregnancy depression was better explained by socioeconomic and lifestyle factors, such as 
worry, lack of support, younger age, and adverse lifestyle habits (such as sleep).  Postnatal 
depression, however, was mostly associated with a personal or family history of depression and 
less reliably predicted by all other available covariates in the analysis.  These findings are similar 
to those of Kinser et al. (2014), who suggest that environmental factors are related to depression 
in pregnancy, but biologic-genetic components are associated with the occurrence of postnatal 
depression.  This has important implications for the development, timing and content of 
interventions aimed at minimising perinatal depression. 
Ethnicity 
Women that identify as coming from an ethnic minority group have considerably higher rates of 
pregnancy and postnatal depression, with studies demonstrating prevalence rates of up to 50% 
in studies focusing on Hispanic, African-American populations (W.-H. Kuo et al., 2004; Zayas, 
Cunningham, McKee, & Jankowski, 2002).  In New Zealand, the most recent reports from the 
Ministry of Health reveal Māori are approximately one and a half times more likely to experience 
CHAPTER 1 
53 
depressive disorders than non-Māori (New Zealand Ministry of Health, 2018b).  Moreover, 
Māori women have a higher prevalence of perinatal depression, higher mortality (Perinatal and 
Maternal Mortality Review Committee, 2018) greater severity of depressive symptoms and 
often experience onset of mental health conditions at an earlier age and (New Zealand Ministry 
of Health, 2008).  Māori suicide rates are significantly higher than other New Zealand ethnic 
groups (Durie, 2017).   
The Māori mental health strategy for the period 2002–2007 “Te Puawaitanga Māori Mental 
Health National Strategic Framework”, indicates significant disparities between the mental 
health of Māori and non-Māori, including differences in access to care and inequities in health 
services (greater deprivation, social isolation and discrimination).  This results in Māori women 
being less likely to be detected or treated for depression by maternal care providers.  Māori 
women are also more likely to have simultaneous risk factors, such as younger age, lower 
socioeconomic status, poorer access to services and less partner support (New Zealand Ministry 
of Health, 2012).  Furthermore, at least two in five Māori report feeling socially isolated or lonely 
which significantly exacerbates the mental distress they are experiencing as well as feeling 
significantly higher levels of psychological distress related to their depressive symptoms (Russell, 
2018). 
Psychosocial Risk Factors  
Major meta-analyses and systematic review studies have stressful life events, social and partner 
support, low self-esteem, low income and education and other measures of low socioeconomic 
status are additional key predictors of perinatal depression (Dennis et al., 2007; Lancaster et al., 
2010; O'Hara & Swain, 1996; Smorti, Ponti, & Pancetti, 2019).  Unintended pregnancy, history 
of domestic violence and marital status have also been found to have a strong association with 
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depressive symptoms (Dennis & Dowswell, 2013; Lancaster et al., 2010).  Inconsistent findings 
have been found for smoking, alcohol and drug use, parity and employment status (Dennis & 
Dowswell, 2013).  Moreover, a systematic review and meta-analysis of 15 studies demonstrated 
that immigrant women have a two-fold risk of developing postnatal depression as compared to 
non-immigrant women (Falah-Hassani, Shiri, Vigod, & Dennis, 2015).  A review by Biaggi et al. 
(2016) noted mixed findings about the role of parity as a risk factor for antenatal depression 
with five studies finding that multiparous mothers had more risk than nulliparous, three studies 
finding the reverse and 10 studies finding no difference.  Gravidity was also examined and found 
to be just as inconclusive.  
1.5.3 Consequences of depression in pregnancy 
While pregnancy depression prevalence is not dissimilar to the general population (English et 
al., 2018), it is the consequences of depression in pregnancy that can lead to considerable 
problems for both mother and baby.  In extreme cases, suicide is the most devastating 
consequence.  Sadly, maternal suicide is the leading cause of death in the year after birth (Oates, 
2003) and has higher rates than haemorrhage as a cause of mortality (American College of 
Obstetricians and Gynecologists., 2015).  Estimates reveal that 56% of all women committing 
suicide have a known mental health disorder with a mood disorder being the most common 
(Koslow, Ruiz, & Nemeroff, 2014).   Furthermore, a study of 1298 women in the third trimester 
found that depressed women with poor sleep quality had 13.56-fold increased risk of suicidal 
ideation (Gelaye et al., 2017).  This author also reported on a separate cohort of 641 women in 
the first trimester and similarly, depressed women with poor sleep quality had 3.48-fold 
increased odds of suicidal ideation (Gelaye et al., 2015).  Sadly, on a national basis, New Zealand 
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has maternal suicide rates seven times higher than those in the United Kingdom (Perinatal and 
Maternal Mortality Review Committee, 2012).   
Depressed women may have a diminished ability to make good health decisions, so are more 
likely to have a poor diet, smoke, misuse illicit substances (Buist et al., 2002) or overuse 
prescription drugs (Newport et al., 2012).  They may also be less compliant with prenatal care 
(Leigh & Milgrom, 2008) and feel less invested in the care of the fetus (Marcus & Heringhausen, 
2009).  Depression in pregnancy has been shown to be associated with adverse gestation and 
birth outcomes, such as small-for-gestational age, maternal preeclampsia, low birth weight, 
smaller head circumferences, increased risk of premature delivery, increased surgical delivery 
interventions, lower APGAR scores, and more admissions to the neonatal intensive care unit 
(Marcus & Heringhausen, 2009), as well as increased risk of infant mortality (Goedhart et al., 
2010). 
Nicholson et al., (2006) found that in a group of 175 women in the first trimester, those with 
elevated depressive symptoms had significantly poorer health-related quality of life compared 
to those with minimal depressive symptoms, even after controlling for sociodemographic 
factors.  This is similar to the work by Da Costa et al. (2010) who found that experiencing sleep 
problems in the third trimester was linked with poorer health-related quality of life which was 
also then independently associated with elevated depression scores.  Moreover, Setse et al. 
(2009) found that quality of life scores improved in consecutive trimesters if depression scores 
improved compared to those who remained depressed. 
A strong correlation between maternal and paternal depression is evident, with up to 50% of 
fathers developing paternal depression if their partner is depressed (Goodman, 2004).  Critically, 
infant outcomes and developmental milestones are more greatly impaired when both parents 
CHAPTER 1 
56 
are depressed (Kerstis et al., 2016).  Marital conflict and dissatisfaction are also associated with 
maternal depression (Dennis & Ross, 2006). 
Depression during pregnancy can also have detrimental effects on infant development (Barker, 
Kirkham, Ng, & Jensen, 2013; Meijer et al., 2011).  A study of nearly 800 women in their early 
first trimester (approximately 10 weeks gestation) found that over 40% of the sample had 
significant depressive symptoms, with this group having a 60% increased risk of preterm delivery 
(Li, Liu, & Odouli, 2009).  Maternal depression is associated with disruptions in mother-infant 
bonding (Hairston, Solnik-Menilo, Deviri, & Handelzalts, 2016), with evidence demonstrating 
that depressed mothers are less engaged, less responsive and more inconsistent to their infant 
needs and are less likely to interact through reading, singing, and playing games (Campbell et 
al., 2004).  Depressed mothers also exhibit other compromised parenting behaviours such as 
less compliance with infant safety practices, such as using car seats and childproof latches on 
cupboards (Field, 2010).  Infants of mothers who had depression during pregnancy are more 
likely to cry regularly, are more difficult to console, have more irregular sleep patterns (Marcus 
& Heringhausen, 2009; Zuckerman, Bauchner, Parker, & Cabral, 1990), more sleep problems 
(Armitage et al., 2009; Field et al., 2007), have reduced social interaction and poor fear 
regulation (Feldman et al., 2009).  Maternal depression decreases the likelihood of 
breastfeeding initiation (Grigoriadis et al., 2013) and can lead to the cessation of breastfeeding 
(Cato, Sylvén, Lindbäck, Skalkidou, & Rubertsson, 2017; Nishioka et al., 2011).     
Toddlers of depressed mothers have delayed developmental milestones (Tuovinen et al., 2018), 
while pre-school and school-aged children often have deficits in social, behavioural, 
neurophysiological and cognitive areas (Burke, 2003; Kingston, McDonald, Tough, & Austin, 
2015; O'Connor, Monk, & Fitelson, 2014).  Long-term parental depression has been found to be 
associated with a substantial increase in the child presenting at emergency departments and 
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using secondary healthcare services (Dreyer, Williamson, Hargreaves, Rosen, & Deeny, 2018; 
Sills, Shetterly, Xu, Magid, & Kempe, 2007).  Longitudinal studies have found that children of 
depressed parents and / or mothers have a higher risk of substance abuse (Weissman et al., 
2006) and a five-fold increase of experiencing depression themselves into adolescence and 
middle age (Murray et al., 2011; Weissman et al., 2006).  Furthermore, the trans-generational 
effect of depression is becoming more apparent, with depressed mothers having a 50% higher 
chance of having a grandchild with psychopathology (Weissman et al., 2005).  Whether this is 
via behavioural or mental programming or genetics, is not yet understood.  Because depression 
impacts are extensive, severe and enduring, maternal depression is now considered the most 
common non-obstetric complication related to childbirth (English et al., 2018).  Pregnancy 
represents a crucial time where “there is no health without mental health” (Sattler et al., 2017), 
and therefore needs urgent attention. 
Beyond Blue (an independent Australian federal government mental health initiative), 
contracted Price Waterhouse Cooper in 2012 to analyse the cost of untreated perinatal 
depression and anxiety to the Australian community (PricewaterhouseCoopers Australia, 2012).  
They found the societal cost to be $728 million over a 20-year period, a figure that considered 
adverse birth outcomes, the cost of medical care and lost productivity to mothers, fathers and 
the child.  Because of the recognised long-term cost, this figure included reduced educational 
attainment, long term health impacts and reduced earning potential of the child.  Beyond Blue 
recommended early intervention for perinatal depression and has estimated that reducing 
perinatal depression by just 5%, total costs could be reduced by $136 million/$178 million/$203 
million over two years/10 years/20 years respectively.  The productivity loss effect is more 
pronounced for antenatal depression than postnatal depression due to greater workforce 
participation during pregnancy than the immediate year following childbirth. 
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1.5.4 Screening and treatment for depression in pregnancy 
There are few psychiatric events as predictable as depression in pregnancy and understanding 
women’s past and current mental situation should be as essential as asking questions about 
diabetes and epilepsy (Oates, 2003).  The Royal Australian and New Zealand College of 
Obstetricians and Gynaecologists (RANZCOG) recommends that all perinatal care providers are 
aware of the risks of perinatal depression and screen their patients at least once during the 
perinatal period using a standardised, validated screening tool and refer for early intervention 
as required (Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 
2018). 
The under-recognition of antenatal depression is concerning.  In a small study of 76 women by 
Whitton et al. (1996), 55% of the women thought their symptoms were bad enough to amount 
to depression, but 89% of this group had not reported their symptoms to any health care 
provider.  Similarly Yazici et al. (2015) found that in a sample of 73 women in the first trimester 
experiencing depressive symptoms, only 29% sought treatment.  In a New Zealand sample, 
Signal et al. (Signal et al., 2016), found that less than 50% of pregnant women sought help after 
experiencing two weeks of poor mood.  Relatedly, Mellor et al. (2014) found that of the pregnant 
women that screened positive for probable depression, 48% did not consider themselves 
depressed.  These findings suggest that 1) prevalence rates may be higher than previously 
evidenced, and/or 2) women themselves are unable, or perhaps apprehensive, to recognise 
symptoms.  However, a number of studies have shown that healthcare professionals are also 
not recognising depressive symptomology in pregnant women.  For example, Marcus et al. 
(2003) found that, of the 20% of pregnant women who screened positive for likely depression 
by a healthcare professional, 86% were not receiving any formal treatment.  
CHAPTER 1 
59 
1.5.5 Postnatal depression 
Postnatal depression refers to the development of a depressive illness following childbirth 
(Musters, McDonald, & Jones, 2008).  Although the DSM-5 does not recognise postnatal 
depression as a separate condition in its current classification system, it can be specified as being 
perinatal-onset if the onset of a depressive episode is within four weeks of childbirth (American 
Psychiatric Association, 2013). 
“Postnatal blues” typically occurs for a short period of few hours up to seven days following 
delivery and includes symptoms such as irritability, restlessness, despondency, mild confusion 
and/or hypochondriasis (Pitt, 1973).  Postnatal depression is a more prolonged and serious 
condition, with many authors suggesting that the DSM-5 specifier of within four weeks of 
childbirth is too conservative, since prevalence appears to peak two to six months after birth 
(Gavin et al., 2005) and propose that depressive episodes occurring up to 12 months post birth 
may be a considered a more accurate timeframe (O'Hara & McCabe, 2013; Sit & Wisner, 2009).  
Women who experience postnatal depression have more than twice the risk of experiencing 
future episodes of depression (Llewellyn, Stowe, & Nemeroff, 1997), which is consistent with a 
review of 23 longitudinal studies by Vliegen et al. (2014).  They established that 50% of mothers 
from clinical samples remained depressed at one-year post birth, while 30% of mothers from 
community samples were still experiencing depression up to three years post birth. 
A review by Arifin et al. (2018) of 124 studies with data from more than 50 countries, found that 
global postnatal depression prevalence ranged from 4% to 64%, with Japan recording the lowest 
rates and America reporting the highest.  These findings are similar to another review by 
Halbreich which analysed 143 studies from 40 countries and found a prevalence of between 0% 
and 60%.  Both studies stated that study design, sampling methods, measurement tools and cut-
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offs, point prevalence and cultural and socio-demographic diversity are broad, hence it was 
meaningless to generate a mean prevalence. 
Evidence shows that the consequences of postnatal depression are similar to that of pregnancy 
depression in terms of the adverse impact on the mother, baby, partner and extended family, 
though depression that occurs in the baby’s first year of life would be considered to have a 
greater impact on the child’s development (González et al., 2017).  This is congruent with the 













1.6 Sleep, pregnancy and depression 
Changes in sleep across all perinatal time points appears to coincide with the occurrence of 
mood disturbances and likely share a reciprocal causal relationship (Baiardi et al., 2016), though 
directionality is unclear (Bei, Coo, Baker, & Trinder, 2015), with both cross sectional and 
longitudinal studies showing that insufficient and poor sleep quality are associated with 
depressive symptoms at the same time point (Bais et al., 2019; Jomeen & Martin, 2007; Sattler 
et al., 2017; Yang et al., 2017), and additionally, poor sleep predicts worsening depressive 
symptoms in later pregnancy (M.-W. Chang, Brown, Nitzke, Smith, & Eghtedary, 2015; Eichler, 
Schmidt, Hiemisch, Kiess, & Hilbert, 2019; Skouteris, Wertheim, Germano, Paxton, & Milgrom, 
2009).  To illustrate, Mellor et al. (2014) found that among women with low mood in pregnancy, 
87.5% of women who attributed this to sleep-related causes and did in fact have poor sleep 
quality according to the PSQI.  In addition, studies have found associations between poor sleep 
in late pregnancy and an increased risk of postnatal depression (Lawson, Murphy, Sloan, Uleryk, 
& Dalfen, 2015; H. Zhou, Li, & Ren, 2018).   
Studies examining multiple sleep aspects have found a relationship with depression.  
Pietikäinen et al. (2018) found that poor sleep quality, daytime sleepiness, short sleep duration, 
difficulty getting to sleep in late pregnancy and postnatally were all associated with postnatal 
depressive symptoms, even after adjusting for demographic characteristics and prenatal 
depression.  Severity of poor mood has been found to be associated with the severity of sleep 
disturbance (Khazaie, Ghadami, Knight, Emamian, & Tahmasian, 2013).  Poor sleep quality, even 
in the absence of pregnancy depression, places women at increased risk of suicide ideation in 




Although reviews examining sleep in the perinatal period suggest a relationship between the 
severity and frequency of sleep disturbances and associated psychological conditions (Lawson 
et al., 2015; Ross et al., 2005), there are studies that have not found such associations.  Coo 
Calcagni et al. (2012) did not find a relationship between self-reported sleep in pregnancy and 
postnatal depressive symptomatology.  Similarly, in a larger study of 217 nulliparous women, 
Stremler et al. (2019) collected retrospective self-reported sleep data on pregnancy sleep and 
additional actigraphic and self-reported sleep measures and depression score were repeated at 
six and 12 weeks postnatal.  While no relationship was found with the pregnancy sleep 
parameters and depressive symptoms, a strong association was demonstrated with self-
reported sleep at six weeks postnatal and postnatal depressive symptoms at six or 12 weeks 
(there were not enough participants with an EPDS score greater than nine to allow for an 
examination of these time points separately).  This association was particularly prominent with 
women who reported having a “big problem” with their sleep.  No significant findings were 
found between actigraphic sleep and depressive symptoms, which is similar with other studies 
that have found associations with self-reported sleep but not objectively measured sleep (Bei et 
al., 2010; Okun et al., 2013; Park et al., 2013; Volkovich et al., 2016). 
Krawczak et al. (2016) found that circadian rhythm disruption, rather than sleep quality, 
predicted worsening of postnatal depressive symptoms, both in women with or without 
previous history of depression.  This was similar to the findings of Sharkey (2013) who found 
that most women experienced circadian phase delays from late pregnancy to six weeks 
postnatal, which were associated with greater depressive symptom severity.  Additionally, 
Wolfson et al. (2003) found that mothers who experienced worse depressive symptoms at two 
to four weeks postnatal had significantly different sleep schedules (later rise times, longer naps, 
and more total sleep) in late pregnancy compared to mothers with minimal depressive 
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symptoms.  This is intriguing, given that both groups of women reported similar sleep patterns 
postnatally.  Kamysheva et al. (2010) found that in a healthy sample of 257 pregnant women, 
second trimester physical discomfort predicted third trimester depressive symptoms, mediated 
by poor sleep.  
Poor sleep in the postnatal period has been shown to be associated with depression (Aksu, Varol, 
& Sahin, 2017), worse maternal/infant attachment, premature weaning, impatience, less ability 
to concentrate, fatigue, reduced daytime functioning and impaired infant development (Coo, 
Milgrom, Kuppens, Cox, & Trinder, 2014; Doering, Morin, & Stetzer, 2009; Goyal, Gay, & Lee, 
2009; Kennedy, Gardiner, Gay, & Lee, 2007; Tikotzky, 2016).  Indeed, in a study by Aksu et al. 
(2017) of 400 women at six weeks postnatal, found that of women (77%) reporting fatigue, 96% 
had elevated depressive symptoms.  This is similar to the work of Brown and Lumley (2000), who 
reported that 74% of women between six and seven months postnatal with elevated depressive 
symptoms reported higher levels of fatigue.  Postnatal maternal daytime sleepiness is associated 
with increased psychiatric problems, Attention Deficit Hyperactivity Disorder (ADHD) symptoms 
and poorer executive function (attention, working memory and inhibitory control) in pre-school 
children (Lahti-Pulkkinen et al., 2018), though this finding was attenuated when controlling for 
pregnancy depression and anxiety. 
Examining a different but pertinent angle, Finnbogadóttir & Persson examined 532 expectant 
fathers whose partner was in their first trimester.  They found that nearly 10% of fathers had a 
high risk of depression, but importantly fathers with sleeping difficulties were 5.7 times more 
likely to have elevated EPDS scores.  While having high stress was strongly associated with 
experiencing depressive symptoms, sleep was also significantly associated and had a stronger 
effect than hazardous alcohol consumption, sexual dissatisfaction and having an unfavourable 
lifestyle or socioeconomic position.  While expectant fathers were not included in this thesis, 
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interventions aimed at both mother and partner could provide additional information and 
should be considered in any further research in this area (Da Costa et al., 2017; Finnbogadóttir, 
Svalenius, & Persson, 2003). 
Some researchers have recognised the importance of early identification of both poor sleep and 
depression in pregnancy (Buist et al., 2002; Jeong et al., 2013; Jomeen & Martin, 2007; Sharp & 
Lipsky, 2002).  But despite strong evidence of links between sleep and depression, and 
indications that early pregnancy is a critical time for depression and sleep problems to emerge, 
few studies have explored depression and sleep longitudinally beginning early in pregnancy.  
Indeed, the International Federation of Gynecology and Obstetrics (FIGO) have recently stated 
that the first trimester is a window of opportunity to predict and prevent many pregnancy 
complications (Poon, McIntyre, Hyett, da Fonseca, & Hod, 2018).  Early detection and effective 
treatment of antenatal depression could result in fewer, less severe symptoms and faster 
recovery.  Thus, there is an urgent need to better understand the causal links between 







1.7 Sleep and depression interventions in pregnancy 
1.7.1 Pharmacological treatments 
With increasing awareness of the importance of treating perinatal depression and the gamut of 
risks a mother faces with untreated depression, the rates of pharmacological treatment has 
more than doubled in recent years (W. O. Cooper, Willy, Pont, & Ray, 2007).  One Danish study, 
representing a cohort of nearly one million women, reported a 16-fold increase in 
antidepressant use from 1997 to 2010 (Jimenez-Solem et al., 2013).  However, decisions around 
the use of pharmacology treatments throughout pregnancy and postnatal is problematic for 
mothers and clinicians due to conflicting evidence about the safety of antidepressant use during 
pregnancy and breastfeeding (Scime, 2016).  It requires a careful weighing of the risk of 
medication exposure to both mothers and their unborn babies.  While antidepressant 
medication appears to decrease the risk of depression relapse (Cohen et al., 2006), many women 
report that antidepressants would be an unacceptable treatment option in pregnancy (Battle, 
Salisbury, Schofield, & Ortiz-Hernandez, 2013).  In a study investigating women’s depression 
treatment preferences, only 7% of women stated that pharmaceuticals would be their first 
choice of intervention (Goodman, 2009).  Mothers who use antidepressant medications report 
anxious and regretful feelings (Bonari et al., 2005) or have poor adherence (Boath, Bradley, & 
Henshaw, 2004).  Over two thirds of women will have a depression relapse if they discontinue 
antidepressant therapy during pregnancy (Armstrong, 2008).  So while women may be 
concerned about their mental health, their desire to protect their unborn baby, even at the 
expense of their own needs may be greater (Condon & Corkindale, 1997).   
It appears only one pharmacological study has been completed with the joint aim of improving 
pregnancy sleep and postnatal depression symptoms (Khazaie et al., 2013).  In this randomised 
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controlled trial, 54 women in the third trimester with insomnia, were assigned trazodone or 
diphenhydramine or placebo.  Actigraphic sleep efficiency (the ratio of total sleep time to the 
amount of time spent in bed) and sleep duration were improved for the two treatment groups, 
compared to the placebo groups, at six weeks postpartum.  Similarly, depression symptoms as 
measured by the EPDS also significantly improved in the two treatment groups, compared to 
placebo, at two and six weeks postpartum.  Even with promising results, ACOG  have classified 
trazodone as a ‘C’ class medication, meaning that the risk of adverse effects cannot be ruled out 
(Armstrong, 2008). 
These improvements are not consistent with results of the next two studies.  Okun et al. (2011) 
found that at 20, 30 and 36 weeks gestation, depressed women using a Selective Serotonin 
Reuptake Inhibitor (SSRI) antidepressant medication spent more time awake at night, more time 
napping and had poorer sleep efficiency than depressed women not taking SSRI’s.  Stone et al. 
(2017) examined the longitudinal course of antidepressant use with sleep quality and depression 
severity, in 215 women at trimester two, as well as one and six months postnatal.  The results 
showed disturbed sleep from pregnant women with a depressive disorder and using 
antidepressants had greater depressive symptom severity throughout the study period and 
women with remitted depression who continued using antidepressants had elevated levels of 
sleep disturbance.  This could suggest that sleep disturbance as a symptom of depression is not 
adequately addressed by antidepressant use or equally that the sleep disturbance they are 
experiencing is not related to depression. 
While non-pharmacological treatments are becoming increasingly sought, there are minimal 
options for women that are safe, cost-effective, readily accessible and non-intrusive.  Indeed, 
the New Zealand Guidelines Group (NZGG) have stated that non-pharmacological interventions 
should be considered before antidepressant treatment especially if symptoms are mild or if the 
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mother is in early pregnancy (NZGG 2008).  This is consistent with a recent review study on 
antidepressant use in pregnancy, which recommended that antidepressant medications should 
only be prescribed after trying other proven non-pharmacological treatments and alternative 
depression interventions should be more actively pursued (Campagne, 2018).  
1.7.2 Behavioural interventions 
Similar numbers of pregnant women are using natural/complementary/non-invasive therapies 
compared to antidepressant medication to treat depressive symptoms (Dennis & Dowswell, 
2013), and because the demand for non-pharmacological treatment is growing in pregnant 
populations, behavioural interventions are increasingly being sought. 
In a review of the potential cost benefit of 24 early interventions that prevent or reduce perinatal 
depression (defined as being conducted during pregnancy and up to one year postpartum) 
(Bauer et al., 2016), interventions were categorised into five groups: universal interventions; 
selective preventive interventions (targeted high-risk groups); interventions addressing mild or 
sub-threshold symptoms; interventions addressing moderate to major symptoms; and 
interventions addressing major symptoms only.  Interventions included yoga, exercise, cognitive 
behavioural therapy, healthy lifestyle, parenting and peer support.  Overall, interventions were 
shown to be effective in helping prevent or recover from mood disorders and led to positive net 
benefits from a societal perspective.  Women in the universal or selective preventative 
intervention categories also saw health benefits.  Groups that targeted women with mild or sub-
threshold symptoms achieved health care benefits only if initiated in pregnancy or long term 
throughout pregnancy and the postnatal period.  Interventions addressing only moderate and 
major symptoms required significant investment but appeared to have a substantial positive 
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impact on both mother and child.  Specifically, the review suggests that parent education and 
infant sleep interventions are likely to provide good value for money. 
Alternative therapies, such as psychotherapy and cognitive behavioral therapy (CBT) are 
promising (Sockol, Epperson, & Barber, 2011) but are generally associated with high cost, 
logistical hurdles, attitudinal barriers and waitlist times (Kim, Hantsoo, Thase, Sammel, & 
Epperson, 2014).  Bright light therapy, acupuncture and herbal remedies are also being 
increasingly researched, but are far from mainstream or easily available.  A study investigating 
mindfulness training (Felder et al., 2018) found that women who slept poorly at baseline 
suffered from increasing depression regardless of intervention group  and similarly mindful yoga 
was found to improve the sleep of pregnant women if they started in their second trimester, but 
not in their third (Beddoe, Lee, Weiss, Kennedy, & Yang, 2010).  Both studies suggest that early 
intervention would be highly valuable.   
1.7.3 Availability of pregnancy sleep information 
Women are hungry for pregnancy-related health information.  In a Canadian study by Hall et al. 
(2012), 39 women in the third trimester were equally keen to receive information about what 
interfered with sleep in pregnancy (73%) as understanding concerns, fears, and anxieties 
regarding pregnancy and labor (73%).  Interestingly, the authors indicated that sleep may be an 
area where women lacked knowledge, either because it has not received adequate research 
attention, or the transfer of knowledge from existing evidence was not available to pregnant 
women, and that mothers were looking for reassurance that their sleep experiences were 
shared by other pregnant women.  Similarly, a study by Da Costa et al. (2017) explored the web-
based search behaviour of 174 men, whose partners were pregnant or had recently given birth.  
Ninety-eight percent of the men had spent approximately six hours per month searching for 
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information on pregnancy and the top three information topics within the psychosocial domains 
were emotional adjustment (60%), managing sleep problems (58%) and stress-management 
tools (56%). 
Over 90% of pregnant women use the internet as an information source (Huberty, Dinkel, Beets, 
& Coleman, 2013).  A systematic review on the internet use of pregnant women also found that 
women search for pregnancy information most often during the early stages of pregnancy and 
not unexpectedly, nulliparous women search more than multiparous (Sayakhot & Carolan-Olah, 
2016).   A further review on 27 Australian Government and leading industry websites reported 
that only two websites included information on sleep during pregnancy but neither 
communicated evidenced based guidelines (Cannon, Lastella, Vincze, Vandelanotte, & Hayman, 
In press).  There is mixed evidence about women’s trust in the accuracy or reliability of 
pregnancy information, with some studies saying that a majority of women perceive the health 
information they read on the internet to be trustworthy, reliable and useful (Lagan, Sinclair, & 
Kernohan, 2010; Sayakhot & Carolan-Olah, 2016), while also feeling concerned that information 
could be wrong or misleading (Lagan et al., 2010).  Pregnant women, who can often find 
themselves confused and worried about how their actions might affect their baby, may have 
difficulty ascertaining the accuracy and trustworthiness of websites and whether they are 
current and regulated. 
A simple perusal through best-selling pregnancy books and pregnancy guidance material on 
government and similar websites shows a huge lack of sleep information.  Searches on the 
Australian Sleep Health Foundation website resulted in limited information as to how or why 
sleep changes from trimester to trimester and a list of five bullet points for improving sleep 
(Australian Sleep Health Foundation, 2019a).  The Australian Government supported parenting 
website “raisingchildren.net.au” has a separate section for pregnancy information, and though 
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it covers diverse topics (such as exercise, nutrition, alcohol use, mental health), the only 
information relating to sleep is a statement on sleep position (Raising Children Network, 2019).  
The New Zealand Ministry of Health website provides another illustration of the scarcity of 
pregnancy sleep information.  Pregnancy-related health information covering nutrition, 
smoking, dietary supplements and alcohol consumption is presented but information on sleep 
is absent, with the exception of a brief statement on sleep position (New Zealand Ministry of 
Health, 2019a).  The New Zealand Health Navigator provides a simple one page fact sheet on 
sleep in pregnancy with brief information on avoiding fluids at bedtime, snacking options, 
sleeping comfortably on either side, relaxation routines at bedtime, getting regular exercise and 
asking for help if tired (Health Navigator, 2019). 
1.7.4 Sleep education 
Sleep education involves learning about healthy sleep and strategies to improve sleep.  In a 
recent systematic review and meta-analysis comparing sleep education to cognitive behavioural 
therapy for insomnia (CBTi), Chung et al. (2018) found that sleep education was an efficacious 
insomnia treatment option, produced significant small to medium effects, although CBTi 
treatments were more effective, showing medium to large effects.  The authors also state that 
sleep education intervention studies suffer from methodological and implementation issues, 
such as the level of practitioner training and coverage of material (basic leaflet vs comprehensive 
program).  Nevertheless, they recommend that sleep education may be a sound first-option 
treatment, especially if CBTi is unavailable or too expensive, though implementation should 
encompass broad and complete sleep education material. 
A study by Tsai et al. (2016) investigating the relationship between sleep hygiene knowledge and 
sleep quality found that pregnant women with poor sleep quality engaged in poor sleep hygiene 
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practices, and suggested that poor sleep hygiene can either exacerbate or perpetuate existing 
sleep problems.  The authors also specifically noted a relationship between arousal related 
behaviours and sleep quality, such as watching television before bed, sleep stress, vigorous 
exercise and not relaxing before bed and suggested that education to reduce these behaviours 
before bedtime could be a target for a sleep education intervention. 
While the overall efficacy of sleep education appears promising, some specific findings and 
critical gaps were noted in the Irish et al. (2015) review which evaluated the empirical evidence 
for several common sleep hygiene recommendations.  These authors rightly emphasise that 
direct extrapolation and evaluation of specific sleep hygiene recommendations are mostly 
limited to sleep disruption studies and not sleep improvement studies.  Furthermore, there is 
mixed evidence on the timing, mode and dose of many recommendations.  For example, “limit 
caffeine intake before sleep”.  Does that mean that abstaining from caffeine improves sleep?  
What dose of caffeine is required to impair sleep?  What if caffeine has a beneficial impact for 
specific behaviours (increasing alertness to drive home safely after a night shift)?  What 
recommendations apply to individuals consuming large amounts of caffeine during the day, but 
not at bedtime (is there a cumulative affect)?  What is the negative impact of withdrawal and 
does withdrawal need to be staged?  Simply providing brief sleep hygiene statements with 
minimal guidance on implementation is not always advisable or effective.  Depending on 
knowledge, resources and the situation, this may prove challenging and result in abandoning 
efforts to change.  Irish et al. (2015, p. 32) further state, “sleep hygiene education has the 
potential to be a key strategy for improving sleep in the general population, and future research 
has the potential to extend its utility”, especially when applied at an personalised level while 
investigating other behavioural and environmental factors  involved. 
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1.7.4.1 Pregnancy sleep education interventions  
Sleep is one of only a handful of modifiable risk factors for numerous health problems, so 
contains a unique utility for behavioural change interventions. Sleep education interventions in 
pregnancy are limited and only a handful of reviews examining non-pharmacological 
interventions for improving pregnancy-related sleep have been published.  Hollenbach et al. 
(2013) completed a systematic review of seven non-pharmacological pregnancy interventions 
(acupuncture, physical activity, mindfulness/yoga and massage) with sleep as an outcome 
measure.  Findings supported trends for improving sleep, however, the authors concluded that 
studies were generally low quality, and none focused on sleep hygiene or sleep education.  No 
direct sleep education interventions were identified in a review by Carroll et al. (2019), even 
though the authors were assessing maternal sleep interventions in pregnancy and the postnatal 
period.  The authors discussed limited intervention options, such as CBTi, mindfulness, yoga/tai 
chi and nutrition and family focused strategies.  Though sleep hygiene/education was addressed 
within the CBTi intervention, the review only provided a description of the intervention and no 
appraisal of the studies or effect.  
An additional handful of recent sleep-based interventions were discovered in the literature post 
these reviews.  An Iranian study by Sanaati et al. (2017), provided sleep hygiene information as 
part of a broader lifestyle education intervention to pregnant women and their partners in their 
second trimester.  Of the 189 women in the study, 126 generally healthy women (including 
having no history of depression) were allocated to two intervention groups, one group had 
husbands/partners attending and the other were women on their own.  The remaining 63 
women were in a routine care group.  EPDS scores were not statistically significant different 
between groups at baseline, but both groups receiving the lifestyle (and sleep) intervention had 
significantly lower EPDS scores at the conclusion of the eight-week intervention. 
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In another Iranian study by Rezaei et al., (2015), specifically examined a sleep health education 
intervention with 96 women in the second trimester with poor sleep (≥5 on the PSQI).  A group 
of 48 intervention participants received sleep hygiene training between 22- and 25-weeks 
gestation in four, one-hourly fortnightly sessions.  Sessions included general sleep concepts, 
changes to sleep in pregnancy, providing strategies for disturbed sleep, sleep hygiene habits and 
diet, exercise, alcohol and tobacco use.  Consistent with the findings of Sanaati et al. (2017), 
there were no significant differences at baseline (16-20 weeks gestation), but significantly lower 
BDI scores four and eight weeks post intervention (29 and 33 weeks gestation respectively), 
compared to the control group, who received no sleep education. 
Tomfohr-Madsen et al. (2016) used CBTi to treat 15 women in the third trimester suffering 
insomnia.  Treatment consisted of 90-minute group sessions (three to four participants in each 
group) over five weeks. Included in the psychoeducation were; review of sleep diaries, stimulus 
control, strategies to examine attitudes about sleep, and infant sleep information.  Post-
intervention measurement showed that women in the intervention group had significant 
improvement in EPDS scores, insomnia symptoms, total sleep time and sleep efficiency, sleep 
latency, all while having a decreased time in bed, compared to controls.  Women also reported 
positive experiences about their participation in the intervention, including enjoyment from 
learning about sleep and knowing they were not alone in their sleep experiences.  Psychological 
treatments, such as CBTi, have been researched and validated for use in non-pregnant 
populations (Parikh et al., 2009) and hold promise for pregnant women, but lengthy waitlists 
and high costs make this a restrictive option outside the research context.   
Sleep hygiene training was also trialled on 128 women in the third trimester suffering from RLS 
(Sönmez & Aksoy Derya, 2018).  Women in the intervention group (n=64) received a one-off 
sleep session guided by booklet information (pregnancy sleep, benefits of sleep, factors 
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affecting sleep and sleep hygiene principles) and were followed up two weeks later to revisit the 
material if problems were arising or material misunderstood.  Delivery information (length or 
format) was not provided by the authors.  Pre-intervention PSQI scores were not significantly 
different between intervention and control groups, however post-intervention PSQI scores were 
significantly lower compared to pre-test scores for the intervention group, indicating that sleep 
education had benefit in this population. 
A recent study by Lee et al. (2017) found that 25 women who were hospitalised for a high-risk 
pregnancy in the third trimester and participated in a hospital-based behavioral intervention 
(including elements of sleep hygiene and CBTi) had significantly lower sleep disturbance than 
controls.  Importantly, the authors have suggested that promoting healthy sleep hygiene 
behaviours would be beneficial in early pregnancy during routine prenatal visits. 
Another study by the same lead author, Lee et al. (2016) evaluated the feasibility and efficacy of 
a four-week CBT based sleep enhancement program for women in late pregnancy and one to 
two months postnatally.  The intervention program included auditory and reading relaxation 
programs, sleep diaries and dietary recommendations, while the control group only received 
dietary information.  Though adherence to the program was variable, the intervention group 
reported positive feedback about their experience, and they also had significantly longer sleep 
duration and better sleep continuity than two comparison groups, particularly at the postnatal 
assessment.  A specific recommendation from this study was initiating sleep interventions 
earlier in pregnancy so women have greater opportunity to practice skills prior to the onset of 
sleep problems. 
It appears that sleep education in pregnancy is rapidly becoming a popular choice of 
intervention.  Hawkins et al. (2019), has published an randomised controlled trial (RCT) study 
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protocol examining the use of a 12 week sleep education program including the use of a personal 
health monitor to achieve sleep goals, starting in the mid to late second trimester.  The study 
aimed to increase sleep hygiene knowledge, however there was no mention of providing 
trimester specific information.  Results from the study have not yet been published.  Kempler et 
al. (2012) also focused on the third trimester to implement a psychoeducational sleep 
intervention in an effort to improve mothers sleep and mood in the early postnatal period, but 
did not look at improving sleep throughout pregnancy.  Again, results for this study are not yet 
published. 
1.7.4.2 Postnatal sleep education interventions 
Postnatal sleep interventions have been studied more, with some placing a greater emphasis on 
the mother-infant dyad and/or managing infant sleep rather than trying to improve maternal 
sleep.  A systematic review by Douglas et al. (2013) showed that educational sleep interventions 
focusing on infant sleep had limited success, though studies looking at maternal sleep as an 
outcome had more positive results (Hiscock, Bayer, Hampton, Ukoumunne, & Wake, 2008; J. 
Phillips, Sharpe, & Nemeth, 2010; Smart & Hiscock, 2007).  A recent review assessing the current 
status of non-pharmaceutical management of perinatal depression, including novel 
interventions under investigation, did not discuss any studies examining sleep education 
intervention in pregnancy (Johansen, Robakis, Williams, & Rasgon, 2019).   
A systematic review and meta-analysis of 15 non-pharmacological sleep-focused interventions 
found that, collectively, non-pharmacological interventions exerted moderate effect on 
improving postnatal maternal sleep, with massage and exercise having the largest effect on 
maternal subjective sleep quality (Owais et al., 2018), though there are not enough studies to 
compare relative effectiveness.  The review also concluded that sleep interventions were most 
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likely to see significant improvements in the first three weeks after birth but not with 
interventions administered from four to 12 weeks postnatal, concluding that because the 
immediate postnatal period is characterised by the most disturbed sleep, it makes sense that 
this time may produce the largest effect sizes.  Five of the 15 studies reviewed in the meta-
analysis, examined the impact of sleep interventions on maternal mood, including drinking 
chamomile and lavender tea and implementing CBTi, both of which showed significant 
improvements in mood compared to controls.   
Similarly, the American Academy of Sleep Medicine (AASM) completed a comprehensive review 
of 52 scientific articles examining behavioural treatment interventions for parents to manage 
sleep problems of infants and young children.  The review found that 94% of the studies 
reported clinically significant improvements in infant and child sleep and concluded that sleep 
training and education not only improves infant and child sleep, but also improves parental 
sleep, parental mood and parent-child bonding in the short to medium term (Hiscock et al. 2008; 
Price et al. 2012; Symon et al., 2005)  
Lastly, a systematic review and meta-analysis evaluated the results of nine psychosocial sleep 
intervention studies in the postnatal period (Kempler, Sharpe, Miller, & Bartlett, 2016).  
Although primarily focussed on infant sleep outcomes, it also examined the interventions’ effect 
on maternal mood and found small but significant improvements following sleep-based 
interventions, although only a small number of studies were assessed.  Notably, this review 
recommended that future research would benefit from investigating interventions in groups at 
high risk of depression (which concurs with recommendations by Mihelic (2018) and further 
understanding when the most effective time period is in terms of intervention administration 
(pregnancy versus postnatal). 
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1.7.4.3 Considerations for sleep interventions in pregnancy 
Felder et al. (2018) explains that while decreases in sleep quality during pregnancy may be 
inevitable due to normal physiological changes, how women respond to those changes may 
provide the protective effect for depression.  Zhou et al. (2018) further promotes this idea, by 
stating that sleep interventions that normalise sleep changes in pregnancy and help women to 
develop effective coping strategies to prevent depressive symptoms from occurring would be a 
valuable contribution to the field. 
Another aspect to consider in a pregnancy sleep intervention is timing.  In a systematic review 
of pregnancy and parenthood preparation by Entsieh & Hallstrom (2016), participants reported 
wanting early and realistic information about parenting skills, and to have the opportunity to 
seek support and help from health professionals when need arose.  This idea was discussed in 
two pregnancy interventions described above by Lee et al. (2017; 2016) who promoted early, 
rather than late gestational intervention.   
This last recommendation is important due to the results of a pilot study and subsequent 
randomised controlled trial by Stremler et al. (2013; 2006) who implemented a behavioural-
educational sleep intervention that incorporated information on sleep hygiene, strategies for 
improving sleep, relaxation techniques and infant sleep.  Interestingly, the authors found a 
positive effect on maternal and infant sleep in the pilot study but not in the full RCT.  The authors 
theorised the non-effectiveness may be due to less support women received (or ‘dose’) in the 
RCT compared with the pilot or that the immediate postnatal period may be one of too much 
change and adjustment to implement a sleep education intervention and suggested waiting until 
several months into the postpartum.   
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This was consistent with findings reported by Verbiest et al. (2018) that a majority of pregnant 
women wanted tailored education appropriate for their particular stage so that it could provide 
relevant, timely guidance, but not so far in advance that it was overwhelming.  A particular note 
by these authors was the need for more evidence-based information to expand knowledge 
around sleep, specifically around napping, sleep duration and sleep hygiene principles.  Similarly, 
Pinquart & Teubert’s (2010), meta-analysis concluded that preventive parenting education 
programs with expectant and new parents should ideally start before problems develop. 
This notion of intervention timing is illustrated well in a study by Beddoe et al. (2010).  The 
authors demonstrated that sleep improvements in second trimester pregnant women were 
possible after participating in mindful yoga.  However, the same improvements were not seen 
for women who completed the same program in the third trimester.  This similar notion of “early 
is better” is noted by Hickie et al. (2013) who stated that early identification and care for those 
at risk of developing mood disorders, or those with lower severity of illness, has to be prioritised, 
due to the risk of negative affect and the large amount of resources needed if depression lingers.  
Therefore, there is a strong case that preventative sleep and depression programs that begin in 
early pregnancy would have a higher chance of success. 
There is a growing list of researchers advocating the benefits of treating sleep problems or 
investing in sleep education in pregnancy, as a way of improving perinatal depression and health 
outcomes (J. J. Chang et al., 2010; Christian, Carroll, Teti, & Hall, 2019; Felder et al., 2018; Hickie 
et al., 2013; Mindell, Cook, & Nikolovski, 2015; Stone et al., 2017; Stremler et al., 2019; Toffol et 
al., 2018; Tsai, Lin, et al., 2016; G. Wang et al., 2018; Yang et al., 2017; H. Zhou et al., 2018; 
Zsamboky, 2017) with emphasis on implementing these programs in early pregnancy (Da Costa 
et al., 2010; Haney et al., 2014; K. A. Lee & Gay, 2017; K. A. Lee et al., 2016; Qiu et al., 2014; 
Ryan, Milis, & Misri, 2005; Williams et al., 2010; Zhong et al., 2018).   
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Tsai et al. (Tsai, Lee, Wu, et al., 2016) suggests that evaluating maternal sleep hygiene knowledge 
and identifying poor sleep practices would befit a sleep intervention in pregnant women.  The 
same lead author in a subsequent publication states, “improving sleep would likely be associated 
with a reduction in depression symptom severity and an attenuation of the prevalence of 
depression in pregnant women” (Tsai, Lin, et al., 2016).  In a review article titled “The Potential 
Value of Sleep Hygiene for a Healthy Pregnancy: A Brief Review”, by Ferraro et al. (2014, p.4), 
the authors specifically state: 
“The high prevalence of pregnancy-related sleep complaints and the limited number 
of efficacious pharmacological treatments indicate that behavioural management 
of sleep hygiene is essential in early gestation when sleep quality is optimal. Thus, 
encouraging sleep early in pregnancy and/or behaviours which facilitate improved 
sleep (e.g., regular physical activity participation) may help attenuate pregnancy-
associated deterioration in sleep hygiene and improve maternal-fetal outcomes… It 
is theorized that a consequence of better sleep may be greater engagement in 
healthy lifestyles” 
Such implementation is possible in both primary and secondary health care settings and 
importantly, may identify low threshold depression issues in women early in gestation (Sattler 
et al., 2017).  Similarly, it is acknowledged that recognition of early pregnancy depression is 
required to reduce later pregnancy depressive symptoms (Nicholson et al., 2006) and prevent 
the harmful health consequences to both mother and baby (Sattler et al., 2017). 
Crucially though, there is limited understanding about maternal sleep hygiene (Verbiest et al., 
2018) and longitudinal studies are required (J. J. Chang et al., 2010; Sattler et al., 2017).  Though 
interest and intent are high, no one has yet developed an early implementation, longitudinal 
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intervention that promotes sleep among pregnant women.  A sleep intervention also has the 
potential to be easily and cost-effectively disseminated in community or clinical settings. 
Interventions can make a difference.  Ross et al., (2005, p. 255), concludes their critical review 
on sleep and perinatal mood disorders by stating: 
“Reduction of sleep deprivation during the perinatal period may offer a cost-
effective method for the prevention, and potentially treatment, of postpartum 
depression and psychosis. Studies that measure both sleep and mood during the 
perinatal period, particularly those that employ objective measurement tools 
such as polysomnography or actigraphy, will provide important information 
about the causes, prevention and treatment of perinatal mood disorders.” 
Pregnancy is often a time when women have greater access to health services and is thus an 
ideal time for a sleep health intervention, especially as women are motivated to improve their 
health for the benefit of their child.  Despite it being opportune, women are frequently given 
little or no advice or instruction on managing their sleep and they are seldom afforded the time 
to explore their sleep habits and patterns.  
Simple and early behavioural interventions may ameliorate the negative effects of depression 
(Okun et al., 2012).  Providing education and emotional support also has the potential to reduce 
birth interventions, such as caesarean deliveries (Toohill et al., 2014).  While some may argue 
that screening and intervening with depressed women may be financially unviable, the benefits 
to both the individual and community far outweigh to costs associated with it (Buist et al., 2002). 
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1.8 Reasons for the current research 
From the background information presented in this chapter, critical gaps in knowledge are clear: 
• There is little understanding of normal sleep characteristics throughout pregnancy; 
• Early and longitudinal sleep and depression data are needed throughout pregnancy, 
especially those that incorporate objective and subjective measures; 
• Longitudinal depression data from pregnancy to postnatal are needed, especially in a 
New Zealand context; 
• Evidenced based pregnancy sleep information is needed for women and healthcare 
providers; 
• Interventions that normalise and optimise sleep in pregnancy are greatly needed, 
especially those commencing in early pregnancy and those attempting to prevent or 
minimise depression; 
• Given the increased risk for women with a history of depression, more information 







1.8.1 Research questions 
This program of research aimed to investigate the relationship between sleep and depressive 
symptoms throughout an extended perinatal period, namely early pregnancy to three years post 
birth, and was prompted by three key questions. 
1.  What does sleep health look like for healthy women in each trimester of pregnancy? 
2a.   What are the patterns of depressive symptoms from late pregnancy through to three 
years post birth? 
2b.  What is the relationship between these patterns of depressive symptoms and sleep 
health during this timeframe?  
3a.  Is an early and longitudinal sleep education intervention feasible and acceptable to 
pregnant women?  
3b.  Is an early and longitudinal sleep education intervention effective in optimising sleep 
and minimising depressive symptoms for nulliparous pregnant women with a history of 
depression? 
3c.  How do sleep and depressive symptoms change over a nine-month period, from 12 
weeks gestation to 12 weeks postnatal? 
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1.8.2 Thesis components 
To answer these key research questions, this thesis was constructed around three separate 
studies, as illustrated in figure 1.6, each respective to the questions above.  Study 1 is a scoped 
review to explore what normal sleep looks like for a healthy pregnant woman (Chapter 3).  Study 
2 examines the trajectories of maternal depressive symptoms from late pregnancy to three-year 
post birth and investigates sleep dimensions related to those trajectories (Chapter 4), and Study 
3 develops and implements a sleep education intervention and assesses the feasibility, 
acceptability (Study 3a, Chapter 5) and efficacy (Study 3b, Chapter 6) of an early and longitudinal 
intervention aimed minimising depression symptoms throughout pregnancy. 
  









This chapter provides a more thorough description of the study aims, study design, and 
methodology used in this doctoral research than is possible within the scope of the journal 
manuscripts due largely to prescribed word limits.  In particular this chapter outlines why each 
study was conducted, the methodological approaches and explanations of measurement tools 
and more detailed description of the Sleep HAPi intervention. 
The first section of this chapter describes the E Moe, Māmā study which was used in Studies 2 
(Chapter 4) and 3 (Chapter 6), while the second section describes the Sleep HAPi study which 
was used in Study 3 (Chapters 5 and 6). 
2.2 E Moe, Māmā and Moe Kura Research Studies 
From October 2009 to October 2012, the Sleep/Wake Research Centre at Massey University 
conducted a large community based, Health Research Council (HRC) funded project entitled E 
Moe, Māmā: Maternal Sleep and Health in Aotearoa/New Zealand, with a cohort of 1144 
women: 406 Māori and 738 non-Māori women.  Kaupapa Māori epidemiological principles 
informed the study design, which situates Māori at the centre of the research and allows for 
Māori participation and control at all stage of the research (including processes relating to 
recruitment and retention), appropriately classifies different ethnic groups to identify and 
monitor health disparities and allows for equal explanatory and analytical power (Paine & 
Gander, 2013).  Leadership was shared through Māori and non-Māori co-principal investigators 
and expertise from senior Māori health researchers was provided by an expert advisory panel. 
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E Moe, Māmā was a questionnaire-based project designed to investigate relationships between 
sleep and mood changes across the perinatal period. Comprehensive questionnaires were 
administered at 35-37 weeks gestation and at 12 weeks postnatal.  A brief phone interview was 
completed between four and six weeks postnatal, but the number of measures collected was 
limited and not used in this research. 
Between December 2012 and April 2015, a second phase of the study, entitled Moe Kura: 
Mother and Child, Sleep and Wellbeing in Aotearoa/New Zealand (hereafter referred to as Moe 
Kura), was conducted.  Women from the original E Moe, Māmā study were invited to participate 
in a follow up data collection round when the E Moe, Māmā child was three years of age.  The 
follow-up questionnaire investigated the sleep and mood of the same mother-infant dyads using 
near identical measures as E Moe, Māmā.  Participants also completed a ‘Child Sleep and Health’ 
questionnaire at this time point, but data from that questionnaire are not used in this thesis.  
The Moe Kura cohort included 912 women (281 Māori and 629 non-Māori).   
Data from three time points are used in this research; 36 weeks gestation, 12 weeks postnatal 
and three years post birth. 
2.2.1 The E Moe, Māmā and Moe Kura Names  
In Te Reo Māori the E Moe, Māmā study name translates to “sleep mother, go to sleep mother”.  
Dr Te Huirangi Waikerepuru (Taranaki) from Te Matahiapo gifted the name “Moe Kura” to the 
study in 2013 “Moe Kura is based in the concept of te au Moe Kura i te ao mārama: the peaceful 
treasured sleep as of the child into the world of ancient wisdom, wonderment and light”.  Dr 
Waikerepuru also named the Open Lab creative design (see figure 2.1) Te Aioiotanga: kia aioio 
te moe, e au te moe (restful, peaceful sleep).  The name and design signify the importance of the 





2.2.2 Study teams 
The E Moe, Māmā & Moe Kura studies were led by a team of researchers from the Massey 
University’s Sleep/Wake Research Centre, in collaboration with researchers from New Zealand 
and international institutions and a panel of Māori  and non-Māori  advisors.  The advisory team 
had expertise in child and maternal sleep, indigenous health, mental health, and epidemiology, 
the advisory panel and collaborators provided advice on study development and 
implementation. 
2.2.3 Researcher role 
At the time of my commencement at the Sleep/Wake Research Centre in February 2016, all E 
Moe, Māmā data from the late pregnancy, six weeks and 12 weeks postnatal time points had 
been entered (using Epi Info, version 3.5.1), double entered, cleaned and variables had been 
created.  Moe Kura data from the three-year time point had been entered, then double entered, 
into a database (using LimeSurvey open source software) but had not been cleaned or had 
variables generated.  
It is at this point that my involvement with these studies began.  I checked and cleaned the Moe 
Kura data in accordance with data entry rules and discussions with the study team.  I further 
created and reviewed descriptive statistics, checked data anomalies and identified outliers in 
collaboration with colleagues at the Sleep/Wake Research Centre, Dr Lora Wu and Dr Diane 
Figure 2.1   Moe Kura Logo 
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Muller.  Upon finalisation of the three-year post birth dataset, Dr Edgar Santos Fernández 
provided statistical support to create a number of variables, based on the same variable creation 
rules used in the E Moe, Māmā datasets.   
After a number of variables were created, I merged the E Moe, Māmā and Moe Kura datasets 
to obtain one consolidated dataset with each time point; late pregnancy, 12 weeks postnatal 
and three years post birth.  A final dataset was then created with participants that had responses 
at each of those time points (total n=856; Māori n=262 and non-Māori n=594).  I then created 
further variables required for the longitudinal analysis and completed descriptive analyses using 
this dataset.  Dr Mona Jefferies provided statistical support to complete the latent class analysis.  
A subset of the E Moe, Māmā sample was identified and used in the comparison analyses, which 
I completed and are presented in Chapter 6.   
2.2.4 Ethical procedure 
The New Zealand Central Health and Disability Ethics Committee (HDEC) granted ethical 
approval to the original E Moe, Māmā study in October 2009 (CEN/09/09/070) (Appendix 1).  
The ethics approval for Moe Kura was granted as an amendation in November 2012 
(CEN/09/09/070/AM02) (Appendix 2). 
2.2.4.1 High scorer protocol 
A protocol was in place for participants showing elevated depressive symptoms or self-harm 
ideation which included women providing consent for the researchers to contact their doctor or 
maternity health care provider (Lead Maternity Carer or Obstetrician).  This protocol was used 
in the E Moe, Māmā study and was additionally used in Sleep HAPi study (described below), with 
updated contact information (the Sleep HAPi version is outlined in Appendix 6). 
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2.2.4.2 Miscarriage and stillbirth protocol 
An additional protocol was also available in the event a participant had a miscarriage or stillbirth.  
The protocol involved acknowledging the gravity of loss and recognising how difficult the 
situation is for women. This protocol was used in the E Moe, Māmā study and was additionally 
used in Sleep HAPi study (described below), with updated contact information (the Sleep HAPi 
version is outlined in Appendix 6). 
2.2.5 Recruitment 
In the initial E Moe, Māmā study, women were recruited from the lower North Island of New 
Zealand, however recruitment was subsequently expanded nationwide, in the hope of achieving 
equal explanatory and analytical power for Māori.  Recruitment of non-Māori participants was 
also closed in the later stages of recruitment as a secondary method of attaining sufficient Māori   
participants (Paine & Gander, 2013).  The Moe Kura study participants were given the 
opportunity to opt out of the age three follow-up.  A flow diagram of study participants, 
including the merging of studies, is detailed in figure 2.2. 
Figure 2.2   Flow diagram of E Moe, Māmā and Moe Kura participants. 
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2.2.6 Inclusion criteria 
Minimal inclusion and exclusion criteria were established in an effort to obtain the most 
representative sample of self-selected, community-based women.  To participate, women 
needed to be 16 years of age or older, carrying a single fetus and able to answer questions in 
English. 
2.2.7 Late pregnancy questionnaire 
The Sleep and Health during Pregnancy questionnaire was developed and pre-tested in 2009 
with careful attention to question selection and language, as it was understood that the 
questionnaire would be completed by women of varying literacy abilities, including having 
English as a second language.  The final version was a 58 item, 12-page questionnaire (Appendix 
3) which women were asked to complete between 35-37 weeks gestation.  It included questions 
on demographics, sleep, general health, mental health and obstetric history and also included 
limited retrospective questions on sleep and mental health.   The demographic information 
collected included information on maternal age, parity, gestational weeks, ethnicity, 
socioeconomic position, partner support, stressful life events and employment details. 
2.2.8 12-week postnatal questionnaire 
Women were asked to complete the Postnatal Sleep and Health Questionnaire between 11-13 
weeks postnatal.  The final version was a 91-item, 27-page questionnaire (Appendix 4) and 
included repeated questions from the pregnancy questionnaire on demographics, sleep, general 
health and mental health.  Items relating to the birth experience and the infant were also 
collected, however given the focus of the current program of research on maternal sleep and 
mood relationships, only infant age was included from these items 
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2.2.9 Three-years post birth questionnaire 
Moe Kura data collection commenced on 21 December 2012 and finished on the 30 April 2015.  
The women from the E Moe Māmā study were contacted no earlier than five weeks before their 
child’s third birthday.  While the questions varied slightly from those used in the E Moe Māmā 
study, the same demographic, sleep and mental health questions from the late pregnancy and 
12 weeks postnatal questionnaire were used at the three-year post birth time point (Appendix 
5). 
2.2.10 Measures 
2.2.10.1 Demographic information 
Maternal Age was calculated by subtracting the mother’s date of birth from the completion date 
of the questionnaire. 
Parity was assessed by asking the total number of times a woman had given birth to an infant, 
alive or not, after 20 weeks gestation. 
Gestational weeks was calculated using mother’s self-reported estimated due date subtracted 
by the questionnaire completion date.  
Ethnicity was reported using the New Zealand Census 2006 question (Statistics New Zealand, 
2006).  Women were classified as of Māori ethnicity if they selected Māori as a single choice or 
as part of multiple responses.  Women that selected any ethnicity except Māori were defined as 
non-Māori.   
Socioeconomic position was defined using a neighbourhood-level index of relative deprivation 
(NZDep 2006 and NZDep 2013) based on small geographical units called ‘meshblocks’.  The 
CHAPTER 2 
92 
NZDep indices incorporate dimensions of social and material deprivation, including; home 
ownership, support (non-means tested benefits or benefits not necessarily associated with 
economic deprivation such as student allowances), communication (access to a telephone), 
income, employment status, educational qualifications, living space (bedroom occupancy) and 
access to transport (access to a car).  An index is derived from these variables and a ten point 
ordinal scale is created from one to ten, where decile one is represents the 10% of areas that 
are least deprived and decile ten represents 10% of areas that are most deprived (Atkinson, 
Salmond, & Crampton, 2014).  In analyses, NZDep was utilised as quintiles (i.e. five levels, each 
representing 20% of small areas). 
Relationship happiness was used as a proxy for the broader construct of social support. Women 
reported on a 0-7 likert scale item, “If you have a partner, how is your relationship with them at 
the moment?”, where 0 signifies being perfectly happy and 7 signifies being extremely unhappy.  
Women also had the option of selecting “not applicable”.  A dichotomous variable was created, 
where less than three signifies greater satisfaction, and greater to or equal to three signifies less 
satisfaction or not applicable. 
Stressful life events were measured using the 13-item Pregnancy Risk Monitoring System 
(PRAMS) phase 5, 2004-2008, questionnaire which was developed by the Centers for Disease 
Control and Prevention in the USA (Centers for Disease Control and Prevention, 2018).  Women 
were asked if they had experienced any of the following over the past 12 months: Arguing with 
partner more than usual; partner did not want pregnancy; or separation from partner; being 
homeless; partner went to jail; someone close had alcohol/drug problems; they or their partner 
lost a job, could not pay bills; moved to a new address; was in a physical fight; a close family 
member was very sick and had to be admitted to hospital; or experiencing the death of a close 
family member.  Low stress was considered less than two stressors, and high stress considered 
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greater than or equal to two stressors) (Mukherjee, Fennie, Madhivanan, Trepka, & Coxe, 2017).  
Da Costa et al. (2009) found that greater stressful life events experienced in the previous year 
was a predictor of poorer mental health scores. 
Employment details items included questions asking participants if they currently work for pay, 
profit or income, and if answered yes, they were asked for the average number of hours per 
week they worked and how often they worked between midnight and 5am.  If women were not 
currently working, they were asked about their plans to return to paid work in the future. 
2.2.10.2 Sleep measures 
Sleep quality was measured by the three-item General Sleep Disturbance Scale (GSDS) Quality 
Subscale; “How often in the last week did you feel rested upon awakening at the end of a sleep 
period?”, “How often in the last week did you feel satisfied with the quality of your sleep?” and 
“How often in the last week did you sleep poorly?”  The first and last items are reversed scored.  
Each item is rated on a 0 (never) to 7 (every day) numeric rating scale and the mean of the three 
items is calculated (K. A. Lee, 1992; K. A. Lee & Gay, 2004). 
Sleep duration was measured by self-reported nighttime total sleep time (TST), as well as 
sleep in a 24-hour period (including naps) in the last week.   
Sleep continuity was measured by the GSDS Maintenance Insomnia Subscale.  The two items 
that form this subscale are, “How often in the last week did you wake up during your sleep 
period?” and “How often in the last week did you wake up too early at the end of your sleep 
period?”  Each item is rated on a 0 (never) to 7 (every day) numeric rating scale and the mean 
of the two items is calculated (K. A. Lee, 1992; K. A. Lee & Gay, 2004). 
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Sleep Onset Insomnia was measured by the GSDS Onset Insomnia Subscale.  The item that forms 
this subscale is, “How often in the last week did you have difficulty getting to sleep?” This item 
is rated on a 0 (never) to 7 (every day) numeric rating scale (K. A. Lee, 1992; K. A. Lee & Gay, 
2004). 
Daytime Sleepiness was measured by the ESS.  The ESS assess daytime sleepiness in eight 
everyday situations using the question “How likely are you to doze off in the following situations, 
in contrast to feeling just tired…?”  The ESS has been deemed reliable and valid for use in 
pregnant populations (Baumgartel, Terhorst, Conley, & Roberts, 2013) and excessive daytime 
sleepiness is typically defined as a total score greater to or equal to ten (Johns, 1991). 
2.2.10.3 Depressive symptoms measures 
Because of the serious and long-term effects of perinatal depression, screening and 
identification of the disorder are increasing.  Though there are both concerns about non-
identification and mis-identification, it is important to acknowledge that that screening 
techniques are not designed to diagnose depressive disorders, but to identify women that 
require further clinical assessment (Kerr & Kerr, 2001). 
The EPDS is a well-validated and widely used assessment tool for depression screening in 
pregnancy and the postnatal period.  As there has been no assessment tool specifically 
developed for assessing depression in pregnancy, the EPDS has been used by many research 
studies by default in screening and identifying depression (Ji et al., 2011) and has been validated 
for use in pregnancy (Gibson, McKenzie-McHarg, Shakespeare, Price, & Gray, 2009).  It excludes 
somatic symptoms of depression, such as sleeping issues, that are prevalent in antenatal and 
postnatal periods (American College of Obstetricians and Gynecologists., 2015).   
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The EPDS is a ten-item questionnaire rated on a four-point scale that is sensitive to changes in 
the severity of depression over time (Cox, Holden, & Sagovsky, 1987).  Higher scores usually 
reflect a higher level of symptom severity and scores at or above 13 are considered clinically 
significant (Cox et al., 1987; National Collaborating Centre for Mental Health, 2014).  Studies 
that have used a score of greater than or equal to 13 to identify major depression have reported 
good sensitivity (68-95%) and specificity (78-96%) (Cox, Chapman, Murray, & Jones, 1996; 
Dennis, 2004; Murray & Carothers, 1990).  While a decision was made to use the author’s 
recommendation of scores at or above 13 as the cutoff, it should be noted that some studies 
have demonstrated that a lower cutoff score can be used to detect major depression (Eberhard‐
Gran, Eskild, Tambs, Opjordsmoen, & Ove Samuelsen, 2001; Smith-Nielsen, Matthey, Lange, & 
Væver, 2018; Stuart, Couser, Schilder, O'Hara, & Gorman, 1998) and clinical cut-offs for the EPDS 
in Māori populations have not been established. 
2.2.11 Statistical analyses 
Descriptive statistics (means, medians, standard deviations, range, and proportions) and 
univariate analyses were generated and conducted in SPSS, which included histograms, 
probability plots and boxplots to check their distribution and identify any outliers.  All further 





2.3 Sleep HAPi pilot study 
The Sleep HAPi pilot study was a prospective community-based sleep education intervention, 
developed for nulliparous women with a history of depression.   The aim of the study was to 
implement and assess the feasibility, acceptability of trimester specific sleep education 
intervention aimed at optimising sleep and minimising depression symptoms throughout 
pregnancy.  The findings of this study are described in Chapter 5. 
While the Sleep HAPi participants completed a greater number of measures during the 
intervention arm of the study, all participants completed the same late pregnancy written 
questionnaire as the E Moe, Māmā participants.  To measure the Sleep HAPi intervention 
efficacy, a matched subset of women from E Moe, Māmā was used as a comparison group.  They 
were matched on parity, a prior history of depression and ethnicity (all were non-Māori) (n=76). 
The findings of this study are described in Chapter 6. 
2.3.1 The Sleep HAPi name 
Sleep HAPi is an acronym for “Sleep Health and Pregnancy Information”.  The title and logo were 
developed by the researcher (figure 2.3). 
Figure 2.3   Sleep HAPi logo. 
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2.3.2 Study team 
Sleep HAPi was led by the researcher, in conjunction with the supervisory team, Associate Prof 
T. Leigh Signal, Prof Philippa Gander, Dr Bronwyn Sweeney and Dr Mark Huthwaite, all of whom 
have extensive experience in conducting research protocols on sleep and/or mental health 
issues across the perinatal period.  Dr Sweeney, a clinical Psychologist and Dr Huthwaite, a 
consultant maternal mental health psychiatrist, provided guidance and clinical support when 
addressing mental health aspects of the study design, protocols and referrals of women to their 
health care provider.    
2.3.3 Researcher role 
As Sleep HAPi was a key focus of my thesis, my role in this research component was 
comprehensive.  With guidance and input from my supervisory team, my contribution was; 
concept formulation, study design and development, design and creation of recruitment and 
intervention material, participant recruitment and liaison, and education session 
implementation.  I also entered, cleaned the data, developed the statistical analysis plan, coded 
and analysed the data which involved substantial self-directed learning.  All statistical 
procedures were guided and reviewed by supervisor Dr Leigh Signal, fellow Sleep/Wake 
Research Centre colleague Dr Margo van den Berg and biostatistician Dr Mathangi 
Shanthakumar, of the Centre for Public Health Research, Massey University, Wellington.   
Two manuscripts on the Sleep HAPi intervention which are detailed in Chapters 3 and 4 were 




Recruitment for Sleep HAPi occurred over a 12-month period, from February 2017 to February 
2018. A study poster and flier were designed (Appendix 8) and distributed to medical centres, 
midwifery clinics, mental health clinics, hospitals, parent and community centres, book and toy 
libraries, primary schools and colleges, crèches/kindergartens, supermarkets and community 
fairs.  Massey University communications department assisted in the development of media 
releases and other material to promote the study through social and traditional media channels.  
The researcher conducted a national radio interview with Radio New Zealand discussing 
pregnancy sleep and depression while also promoting study recruitment.  Presentations were 
also given to hospital staff at the Wellington Hospital, the New Zealand College of Midwives, 
WellSleep continuing medical education (CME) workshop, Fertility Associates (assisted 
reproduction / fertility clinic) and various community midwifery groups to encourage medical 
professionals to pass fliers on to patients and/or clients.  Additional ethical submissions (to those 
described in 1.3.6) were completed for Fertility Associates, the Capital and Coast District Health 
Board (CCDHB) and the Hutt Valley District Health Board (HVDB) to allow medical professionals 
from these organisations to endorse the study.  Endorsement and promotion were also afforded 
by community and non-government agency websites, such as Perinatal Anxiety and Depression 
Aotearoa (PADA), Neonatal Trust, The Parents Centre and Family Planning New Zealand.   
Initially women were recruited from the Greater Wellington Region (Wellington, Porirua, Hutt 
Valley, Kapiti areas) due to the ease of meeting women in a 50km proximity of the Sleep/Wake 
Research Centre.  After six months of recruitment, advisements were extended to Palmerston 
North (140km proximity) in an effort to increase numbers, however this only resulted in one 
further woman completing the study. 
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The posters and fliers provided a brief outline of the study; what study involvement required, 
the key eligibility criteria, and the koha (a Māori term which means ‘gift of appreciation’) 
provided on completion.  Advertisements provided contact details in the form of a free “0800” 
phone number, a free text messaging service and a designated email address.  The text 
messaging service generated an automated reply and texts were followed up with a phone call 
to discuss the study.  Emailing was the most popular method of contacting the research team, 
with 32 women using this option. Text messaging was used by 12 women and phone calls by 
seven women. 
Once a potential participant contacted the research team, the researcher would phone the 
woman, complete a screening questionnaire (Appendix 9), discuss details of study involvement, 
including explanation of the study timeline, equipment and questionnaires and go through any 
questions or concerns the women may have.  If women were eligible to participate and 
expressed interest in the study, the researcher organised to meet the woman at an initial study 
visit (further described in 2.3.7). 
2.3.5 Participant eligibility 
Prior to commencing the study, women were screened to ensure they met the eligibility criteria. 
Women needed to have a history of diagnosed depression, to focus the study on a group that 
are understudied and at high-risk of depression relapse in the perinatal period.  They were 
required to be symptom- and medication-free for at least three months prior to study 
enrolment, to ensure sleep was not being confounded by current depressive 
symptoms.  Women also needed to be at or less than 14 weeks pregnant (first trimester), 
carrying a singleton pregnancy, at least 16 years of age, proficient in English, have a primary 
health care provider (a Lead Maternity Carer (LMC) or General Practitioner (GP) that they could 
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be referred back to) and living in the Greater Wellington area or Palmerston North.  Lastly, 
women needed to be nulliparous and have no children under three years of age living in the 
home.  This was considered important as it ensured women’s sleep was not being affected by 
additional childcare responsibilities. Women were excluded if they had diagnosed sleep 
disorders, uncontrolled medical conditions or a severe mental health disorder (other than 
depression) known to contribute or be associated with sleep abnormalities. 
Fifty-one women responded to study advertisements and 47 completed an initial screening 
questionnaire.  Of the 22 women were eligible to enrol, all commenced the study.   Table 2.1 
details reasons why initial respondents did not take part in the study.  Of the 29 women that 
responded but did not enrol in the study, 23 did not meet the eligibility criteria.  Of the other 
six, four women did not return future contact attempts and two women thought the study 
burden would be too great.  
Table 2.1   Reasons for ineligibility in the Sleep HAPi study (Note: two respondents had dual 
reasons for ineligibility). 
n Reason for ineligibility 
8 Multiparous 
7 Currently experiencing depressive symptoms 
4 No response to follow up 
4 Advanced gestational age 
3 No history of depression 
2 Participant burden too great 
2 Lived outside of Greater Wellington region or Palmerston North 
1 Medical condition that affected sleep 




Table 2.2 illustrates the location where the 22 women enrolled in the study saw study 
advertisements.  Over half of the women found out via clinician channels (midwives, antenatal 
groups, hospitals or medical centres).  The remaining women found out through media and 
social media platforms or from friends. 
Table 2.2  How enrolled participants found out about the study. 
n Recruitment channel 
6 Poster in medical centre/hospital/midwife clinic 
3 Antenatal Group at Wellington Hospital 
4 Directly from Community Midwife 
4 Word of mouth 
1 Radio Interview 
1 Poster in library 
1 Twitter post 
1 Eventfinder 
1 CME Presentation 
22 Total 
 
Figure 2.4 shows the flow diagram of study recruitment and retention.  Six women dropped out 
of the study.  Notably, three of these women dropped out for reasons outside their control (two 
women miscarried prior to their first week of actigraphy recording, and one women had an 
extreme pre-term birth at 22 weeks gestation).  Three women chose to discontinue their 
involvement in the study.  One was non-contactable at the beginning of the second trimester 
despite numerous attempts.  The remaining two women dropped out after the first trimester 
and second sleep education sessions, stating that burden was too great when combined with 
employment commitments and other activities occurring for them at the time.  
CHAPTER 2 
102 
An additional participant was excluded from analyses as she had a multiple and moderate 
preterm birth.   Therefore, complete data sets were analysed for 15 women during pregnancy 
(68% retention rate) and 14 in the postnatal period (64% retention rate).  All questionnaires, 
education sessions and actigraphy were completed except for one woman who did not complete 
her trimester two sleep education session due to work travel (99.7% completion rate). 
 
2.3.6 Ethical procedure 
A Health and Disability Ethics Committee (HDEC) ethics application was submitted.  HDEC Central 
Region reviewed the application and deemed that HDEC approval was not necessary due to the 
study involving no more than minimal risk (“that is, potential participants could reasonably be 
expected to regard the probability and magnitude of possible harms resulting from their 
participation in the study to be greater than those encountered in those aspects of their 
Figure 2.4   Flow diagram of Sleep HAPi recruitment and retention. 
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everyday life that relate to the study”).  An out-of-scope letter was issued and HDEC 
recommended institutional review (Appendix 10).  Full ethical review was then undertaken and 
approved by the Massey University Human Ethics Committee:  Southern A Committee (SOA 
16/29).  The study was also reviewed and registered with the Australian and New Zealand Clinical 
Trials Registry (ACTRN12617000055303) (Appendix 11). 
Supporting pregnant women and being sensitive to their needs was considered in the ethics 
process and study design.  Measures included: 
• Face-to-face and one-on-one contact. 
• Allowing time in meetings to discuss patient confidentiality, data security and 
anonymity. 
• Meeting women for education sessions at times and places that were convenient, safe 
and private for the participant.  This meant that extra time was often needed to allow 
meetings to be schedule on weekends or weeknights.  Extensive travel was sometimes 
required and protocols were put in place to ensure researcher safety.   
• Sensitivity when calling and meeting participants, especially at workplaces and in 
public meeting areas, such as text messaging a participant and asking them to call back 
at a time that is convenient and private so as not to create awkwardness or intrude on 
privacy.  This was especially critical at study enrolment as women had not often told 
work colleagues they were pregnant. 
• Approaching the material with respect and non-judgement, which is especially needed 
when women are discovering their own notions of mothering and parenthood. 




Women were given two koha; one at the completion of the pregnancy intervention ($50 value) 
and another at the completion of both postnatal questionnaires ($20 value).  Women were 
either posted or hand delivered a gift card of their choice (either fuel, supermarket, book or 
department store voucher). 
2.3.6.1 Participant consent 
Written consent was obtained prior to study commencement and ongoing consent was 
completed at each time point.  (Initial Consent form – Appendix 12; Consent and Checklist forms 
for trimester two and three are identical as are postnatal six and 12 weeks.  Examples of each 
are provided in Appendix 13 and 14 respectively). 
2.3.6.2 High scorer protocol & miscarriage and stillbirth protocol 
The same high scorer protocol and miscarriage or stillbirth protocol described for E Moe, Māmā 
above, were used for Sleep HAPi participants (Appendix 6 and 7). 
2.3.6.3 Cultural considerations 
During study development, members of the research team met with Dr Kara Mihaere 
(Rangitāne, Ngāti Kahungunu ki Wairoa, Ngāti Rakaipaaka, Rangitāne ki Tamaki-nui-ā-Rua) a 
Clinical Psychologist with Te Whare Marie ki Puketiro (Specialist Māori Mental Health Services), 
at the CCDHB.  Dr Mihaere completed her doctorate in Sleep Science at the Sleep/Wake 
Research Centre so has significant knowledge of both sleep and mental health.   
Dr Mihaere provided feedback on the proposed research methodology, including identifying 
important issues in recruiting and retaining Māori women, and offered valuable advice on the 
support networks and services available to Māori women with mental health concerns.  Dr 
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Mihaere confirmed the CCDHB Te Haika (Mental Health Contact Centre) is the one point of 
contact for all mental health services within the Greater Wellington Area whether Māori or 
otherwise.  This service is available 24 hours a day, seven days a week (including public holidays) 
for any general mental health questions, referrals/appointments to mental health services 
based (including specific Māori and Pacifica services) at CCDHB and mental health emergency 
phone calls.  This contact was included in the High Scorers Protocol and contact details for 
women experiencing mental health issues including dedicated support for Māori women. 
2.3.7 Study design 
The study covers six time points: Pre-pregnancy (PP), pregnancy (first trimester (T1), second 
trimester (T2) and third trimester (T3)) and postnatal (six weeks postnatal (P1) and 12 weeks 
postnatal (P2)) (see figure 2.5).   
Questionnaires were used to collect sleep (all time points) and subjective mental health data 
(T1, T2, T3, P1 and P2).  Actigraphy was used to obtain objective sleep data (T1, T2 and T3).  Sleep 
education sessions were completed in between actigraphy weeks in each trimester.   
Figure 2.5   Sleep HAPi study design. 
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Women commenced the study between 11- and 14-weeks gestation (T1).  After an initial phone 
call to complete the screening questionnaire, women were met by the researcher and given the 
following paperwork to read, discuss and fill out: 
• An information sheet (Appendix 15) 
• An initial consent form (Appendix 12) 
• An instruction sheet detailing the use of the actiwatch and sleep diary (Appendix 16) 
• A sleep diary (Appendix 17) 
• A sheet detailing the dates of the first and subsequent education sessions, drop-offs 
and pick-ups of actigraphy watches and diaries  
• A checklist of study documentation and equipment provided 
• A retrospective pre-pregnancy sleep questionnaire (Appendix 18) 
• Trimester one questionnaire (taken home to fill out during the week) (Appendix 19) 
The researcher read through the information sheet with the participant and any questions about 
the study were answered.  Informed consent was obtained.  At the conclusion of this meeting, 
women were asked to commence wearing the actigraphy watch and filling out the diary.  After 
seven days of recording, the researcher organised collection of the watch, diary and 
questionnaire.  Data was analysed and printouts of actigraphy recordings were produced and 
then presented at the sleep education session.  Immediately after the education session, the 
participant commenced another actigraphy week for that trimester.    
The process for T2 and T3 were identical (questionnaires for T2 and T3 are detailed in Appendix 
20 and 21 respectively).  P1 and P2 consisted only of sleep and mental health questionnaires 
(detailed in Appendix 22 and 23 respectively).  The first education session at T1 was 60-90 
minutes in length and sessions at T2 and T3 lasted 45-60 minutes. 
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When women finished the pregnancy component of the study, they were asked to fill out a 
feedback questionnaire (Appendix 24), which asked for information on their sleep knowledge, 
the structure, content and helpfulness of the intervention and views on their participation.  To 
gauge women’s level of sleep knowledge prior to enrolling in the study, women were asked how 
much they knew about sleep in general, trimester specific changes to sleep, sleep strategies to 
employ in pregnancy and what their own sleep was like. They were also asked how helpful the 
information on those topics was.  At the completion of the study, participants were provided 
with a summary of the study findings (Appendix 27). 
2.3.8 Sleep education intervention 
To the best of the researcher’s knowledge, a sleep intervention developed for early pregnancy 
and continued throughout pregnancy has not yet been developed or implemented, so the sleep 
education intervention was not based on other studies, but instead on a review of the existing 
literature. 
2.3.9 Sleep education sessions 
Sleep HAPi is a multidimensional evidence-based sleep education package developed by the 
study researchers.  A four-section sleep education booklet was developed to provide evidence-
based information on sleep in pregnancy.  The first section of the booklet explained sleep and 
circadian principles, while the remaining three sections provided specific sleep information 
respective to the three gestational trimesters.  Participants were guided in one-on-one, face-to-
face sessions through the material in three separate sessions, once per trimester, reflecting the 




• Increase women’s knowledge of sleep and circadian principles;  
• Increase women’s understanding of the benefits and consequences of good and poor 
sleep;  
• Provide information to ‘normalise’ the considerable sleep changes possibly 
experienced in each specific trimester;  
• Provide ideas and advice for improving sleep health in each specific trimester.  
See figure 2.6 for detail on layout and content.   
In addition to the booklet and to make the interventions personalised, a summary of each 
woman’s subjective and objective (actigraphic) sleep data from the pre-intervention week were 
presented and discussed.  It was anticipated this would provide greater self-awareness of sleep 
behaviour and patterns, with further exploration of pertinent healthy sleep principles on an 
individual basis.  The women retained their booklet and were encouraged to reference it in 
future and share the contents with their family/social supports.  
Based on the available literature and the potential challenges of recruiting in early gestation, a 
unique sample from a relatively small population area, and trialling un-tested intervention 
material and strategies, this intervention was designed as a pilot study.  This was to allow 
exploration of the feasibility and acceptability as well as efficacy.  A control group was not 
recruited because of the feasibility focus of the study.   
Verbal information was concurrently presented via hardcopy booklet in an insertable folder so 
that subsequent trimester information could be added, as well as their actigraphy printouts, to 


































































education session, women were encouraged to refer to the information and/or share with their 
family/social supports.   
The intent was to increase women’s understanding of the benefits of good sleep and 
consequences of poor sleep, practices and factors that either promote or hinder sleep, 
‘normalise’ the sleep changes experienced in pregnancy and to improve overall sleep health.  
Stremler et al. (2019) discusses the concept of normalising sleep in interventions during the 
perinatal period to allow women to have reasonable expectations of what “normal” sleep is 
during this period.  There was no expectation that all of the information and advice would be 
used by all women, rather that they would have a ‘tool kit’ of knowledge to use when necessary. 
It should be noted that while efforts were made to ‘normalise’ the sleep changes (i.e. confirming 
that sleep changes are common), the symptoms were by no means trivialised.  That is, their 
impact was acknowledged.  Pregnant women may often hear, “you think your sleep’s bad now, 
wait until after the baby is born”, or “it’s just your body’s way of getting you ready for having a 
baby”.  Evidence suggests that this type of public discourse and stigma is often experienced in 
relation to a number of pregnancy related changes, not just sleep (Da Costa et al., 2010) but 
with nausea (Chou et al., 2003), and depression (Manber, Blasey, & Allen, 2008).  Women often 
believe that unless there is a genuine medical concern, the enormous changes in pregnancy are 
to be ‘put up with’ or dismissed as a side effect, or a mere complaint of pregnancy (Han, 
2013).   This may cause mothers not raise the subject again, misread symptoms or stop them 
seeking help for symptoms, which is of utmost importance when experiencing pregnancy 
complications (Kavanaugh & Hershberger, 2005).  This is also highly pertinent because many of 
the discomforts of pregnancy are similar to depressive symptoms (Gaynes et al., 2005). 
CHAPTER 2 
111 
In the Sleep HAPi study, all meetings and communication were scheduled at a time and place 
convenient to the women (homes, café, community library, university meeting spaces), and 
were one-on-one, face-to-face to ensure confidentiality and personalisation.  The researcher 
delivering the education program was careful to approach the information in a sensitive way, 
mindful of the volume of advice and information that pregnant women receive.  To maintain 
consistency and personalisation of the intervention, and confidentiality of the participant, all 
education sessions and communication were performed by the same researcher.  
2.3.10 Measures 
As the demographic, subjective sleep and mental health questions reported for this study were 
identical to those in the E Moe Māmā study described above, they will not be repeated here, 
however additional measures are described below. 
2.3.10.1 Sleep measures 
Objective sleep measures were obtained from the Ambulatory Monitoring Inc. (AMI) wrist-worn 
actigraph.  This model of actigraph has a functional time display (making it easier for the wearer 
to record bedtimes and rise times in the sleep diary), event marker button for the wearer to 
push to denote start and end of sleep periods and a light sensor for recording light exposure.  
This actigraph also has the ability to detect if the watch is being worn against skin which provides 
additional information for scoring.  Prior to issue, each actigraph was cleaned, a new battery 
inserted, and the device was initialised. Participants were instructed to wear the actigraph 
continuously (except during water-based activities) for seven nights on the non-dominant wrist, 
recording movement in one-minute epochs to quantify their sleep and wake patterns across 
both weekends and weekdays.  Current best practice recommends actigraphy is used 
concurrently with a sleep diary to properly identify and confirm periods of sleep and inactive 
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wake (Littner et al., 2003).  Thus, participants completed a sleep diary developed during previous 
Sleep/Wake Research Centre studies with a modified version of the Core Consensus Sleep Diary 
(CSD) added (Carney et al., 2012). Participants were asked to record bedtimes (‘lights off’), rise 
times and at the same time, press an event marker button on the device.   Participants also 
noted the times when the actiwatch was removed.  Full actigraph and diary instructions are 
detailed in Appendix 16 and 17.   
The data were visually inspected for any discrepancies between the sleep diary, event markers, 
and physical activity data.  The data was scored with reference to a scoring protocol (Appendix 
25) then analysed with Action-W (Version 2.7; Ambulatory Monitoring, Inc) software using the 
Cole Kripke algorithm.  Actigraphic sleep onset was defined as 10 minutes of immobility, with 
no more than one epoch containing activity, a setting with the greatest agreement and least 
bias in comparison with PSG for sleep measurements in a pregnant population (Tsai et al., 2011; 
Zhu et al., 2018).  
Guided by Buysse’s Sleep Health model, the following measures were calculated: 
Sleep duration was calculated from the actigraphy data. 
Sleep timing was calculated using the sleep midpoints from actigraphic sleep periods, while 
subjective social jetlag scores were calculated using questions on bedtime and wake time from 
the Munich Chronotype Questionnaire (Roenneberg, Pilz, Zerbini, & Winnebeck, 2019).  Using 
these data, weekday and weekend midpoints were computed, and weekday midpoint was 
subtracted from weekend midpoint to calculate an absolute social jetlag, as a continuous and 
categorical variable (0-60mins, 61-120mins, and 120+ mins) (Wittmann et al., 2006). 
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Sleep quality was assessed using two further measures in addition to the General Sleep 
Disturbance (GSDS) quality subscale described in the E Moe, Māmā study above.  The Pittsburgh 
Sleep Quality Index (PSQI) is a 19-item measure of sleep quality over the past month, yielding a 
total score ranging from 0 to 21 with the higher total score indicating worse sleep quality.  In 
distinguishing good and poor sleepers, a global PSQI score of greater than five yields a sensitivity 
of 89.6% and a specificity of 86.5% (Buysse et al., 1989), a cutoff that has been validated in a 
pregnant population investigating associations between sleep and mood (Qiu et al., 2016) and 
has good internal consistency, convergent, and divergent validity in early pregnancy (Jomeen & 
Martin, 2007).  The second sleep quality measure was a single question asking, “In the last week, 
how often did you get a good night’s sleep?”  This was then dichotomised into good (greater 
than three nights a week) or poor (less than or equal to three nights a week) in line with the 
GSDS quality subscale. 
2.3.10.2 Other sleep aspects 
Insomnia symptoms were measured by the Insomnia Severity Index (ISI), a seven-item 
questionnaire validated against sleep diaries and polysomnography, with excellent internal 
consistency in both population-based and clinical samples (Morin, Belleville, Bélanger, & Ivers, 
2011).  A cut off score of ten has been identified to classify insomnia cases in a population-based 
sample (Morin et al., 2011).   
An additional measure of sleep disturbance was assessed by the total GSDS score.  The GSDS 
asks about frequency of various poor sleep experiences in the previous week on a numerical 
scale of 0 (never) to 7 (every day).  It has shown good internal consistency in pregnant women 
(Cronbach = .81) (K. A. Lee & Gay, 2004) and concurrent validity has been demonstrated using 
sleep logs and wrist actigraphy (S.-Y. Lee, 2007). 
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Other sleep items assessed in the Sleep HAPi study were: Reasons for awakenings; getting a 
comfortable sleep position (nights per week); frequency of napping (days per week); frequent 
snoring (greater than or equal to three nights per week); frequent breathing pauses (greater 
than or equal to three nights per week); frequent leg twitching (greater than or equal to three 
nights per week).   Restless Legs Syndrome (RLS) was also identified if all four of the following 
criteria were met: 1) the urge to move the extremities usually accompanied by unpleasant 
sensations; 2) worse symptoms at night; 3) more noticeable at rest; and 4) relieved by 
movement (Allen, Picchietti, Hening, Trenkwalder, Walters & Montplaisir, 2003)1. 
2.3.10.3 Depressive symptom measures 
As well as the EPDS total score described above (section 1.2.10.3), the Sleep HAPi study also 
used two EDPS subscales; a three-item anxiety subscale (EPDS-3A; 3A items 3, 4 & 5) and a 
seven-item depression subscale (EPDS-7D; items 1, 2, 6, 7, 8, 9 & 10).  Phillips et al. (2009) 
identified a two-factor model of the EPDS to be a superior fit of data compared with a uni-
dimensional model in a postnatal sample.  For detecting major depression, the depression 
subscale with a cut-off of 8 has the same sensitivity and specificity as the cut-off of 13 on the 
total score indicating that the subscale alone would be acceptable to screen for depression.  The 
depression subscale was also found to have a high correlation with the Becks Depression 
Inventory II (BDI-II) (r=.68).   
 
 
1 The 2003 International Restless Legs Syndrome Study Group (IRLSSG) diagnostic criteria was the relevant 
diagnostic criteria at the time of E Moe Māmā study development.  These criteria were used in the Sleep 
HAPi study to ensure comparisons could be made between the two data sets. 
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The BDI-II was also utilised in the Sleep HAPi study2.  The BDI-II is a revision of the original BDI 
designed to have better correlation with the DSM criteria for depressive disorders.  The 
questionnaire has 21 multiple choice questions scoring from 0 to 3, with total scores ranging 
from 0 to 63.  The BDI-II is also a well validated measure used in previous studies to assess the 
relationship between sleep and depression (Isaac & Greenwood, 2011; Swanson, Flynn, Wilburn, 
Marcus, & Armitage, 2010).  Chaudron et al. (2010) found the EPDS and BDI-II were equally 
accurate in identifying depression in low-income, black mothers during the first postnatal year. 
The BDI II (Beck, Steer, Ball, & Ranieri, 1996) is widely used in depression screening in perinatal 
settings.  A complication of using the BDI-II in pregnancy and the postnatal period is its heavy 
reliance on somatic symptoms.  As pregnancy symptoms can mimic some somatic items in the 
BDI II, some researchers have suggested it could present false positives in detecting depression 
(Gaynes et al., 2005), however others have argued that higher somatic symptoms during 
pregnancy provides important insights to a woman’s mental state (Kelly, Russo, & Katon, 2001; 
Nylen, Williamson, O'Hara, Watson, & Engeldinger, 2013).  Indeed, women with depression 
present with greater somatic complaints, (Apter et al., 2013; Nylen et al., 2013) suggesting that 
they might be valid markers of the disorder. 
As such, depressive symptoms were measured by both the BDI-II and the EPDS.  Ji et al. (2011) 
has reported that the sensitivities and specificities of both the EPDS and BDI-II were very similar 
when administered antenatally and postnatally (28 weeks antenatal to 26 weeks postnatal).  A 
validity study of 708 women using the BDI and EPDS from pre-conception to 26 weeks postnatal 
determined both instruments performed in the good to excellent range with the EPDS achieving 
 
2 The BDI-II is copyrighted, and questions cannot be extracted for use in study questionnaires.  For the 
Sleep HAPi study, copies of the BDI-II were purchased from Pearson Australia, New Zealand and attached 
as a separate form to the pregnancy and postnatal questionnaires.  Reproduction of the BDI-II is not 
permitted, therefore it is not included in the appendices.   
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excellent validity in the preconception, first trimester and third trimester and the BDI in the 
second trimester, early postpartum and late postnatal (Ji et al., 2011).  This was consistent with 
a systematic review by Gaynes et al. (2005), who found that the specificity of the BDI and EPDS 
used in perinatal populations (in this instance described as during pregnancy or one year 
postnatal) to be high with substantial overlap.  Sensitivity assessment was generally lower and 
while the EPDS was more sensitive than the BDI, the wide confidence intervals overlapped nearly 
completely.  Both screening tools were used in this study to provide additional exploratory 
scope. 
2.3.11 Statistical analyses 
Statistical analyses are described in brief in Chapters 5 and 6 however they will also be described 
at this point for clarification.  Descriptive statistics (means, standard deviations, proportions) 
were calculated in SPSS (version 25, IBM SPSS Statistics for Windows, Armonk, NY).  As no 
differences were found between the first and second actigraphy weeks in each trimester these 
weeks were averaged.  Changes to sleep or depressive symptoms over time were assessed using 
linear mixed models calculated in SAS (version 9.4, SAS Institute Inc., Cary, NC).  The Kenward-
Roger adjustment was applied to the degrees of freedom estimation (Littell, Milliken, Stroup, 
Wolfinger, & Schabenberger, 2007).  Normality, linearity and constant variance assumptions 
were visually checked and the Shapiro-Wilk test used to assess the distribution of the residuals 
(Tabachnick & Fidell, 2012).  Where outlying residual values were identified, the model was re-
run without the outlier(s).  If removing the outlier(s) altered the findings of the model, the 
reported results exclude the outlier(s), otherwise the results are reported including the 
outlier(s).  Post-hoc tests were used to investigate comparisons of interest where main effects 
were statistically significant.  Bonferroni’s adjusted p-values were calculated for post-hoc tests. 




3 SLEEP HEALTH IN PREGNANCY: A SCOPING REVIEW 
Scoped reviews aim to map the existing literature in a field of interest and are commonly 
undertaken to examine the extent, nature, and characteristics of research activity in a topic area 
(Arksey and O'Malley, 2005).  Scoped reviews are useful to summarize and disseminate research 
findings; identify research gaps in the existing literature; and determine the value, potential 
scope and cost of undertaking a full systematic review (Arksey and O'Malley, 2005). 
Both scoped reviews and systematic reviews share the same comprehensive, rigorous and 
transparent methods to identify and examine the relevant literature relating to a research 
question, however scoped and systematic review are performed for different reasons and have 
some key methodological differences.  Firstly, a scoped review aims to present an overview of a 
potentially large and diverse body of literature pertaining to a broad topic, whereas a systematic 
review attempts to present empirical evidence on a focused research question (Arksey and 
O'Malley, 2005).  Secondly, scoped reviews include a greater range of study designs and 
methodologies, while systematic reviews generally address the effectiveness of interventions 
(Arksey and O'Malley, 2005).  And thirdly, scoped reviews provide a descriptive overview of the 
reviewed literature without critically evaluating the design and methodology of individual 
studies, while systematic reviews aim to provide a synthesis of evidence from studies assessed 
for risk of bias (Arksey and O'Malley, 2005).  
Based on this guidance, a scoped review was chosen for Study 1.  Prior to this study, literature 
pertaining to sleep health throughout all trimesters of pregnancy had not been previously 
examined, hence the breadth and nature of previous research was unknown.  Including a range 
of study designs was considered important to understand the extent of the current literature 




The following manuscript was prepared by the researcher (Appendix 28) and was published by 
the journal Sleep Medicine Clinics in September 2018.  All rights reserved© Ladyman C. I., Signal 
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3.1 Abstract 
Background:  For most pregnant women, altered sleep is one of the most noticed changes and 
a topic that women regularly seek information on, yet there is still limited empirical information 
available on what constitutes healthy sleep in each trimester of pregnancy.   
Methods:  Using scoping review methodology, underpinned by Buysse’s definition of sleep 
health, we investigated the literature on sleep duration, continuity/efficiency, timing, daytime 
sleepiness/alertness and perceived sleep quality in each trimester of pregnancy.  Using key 
search terms, selected databases were used to identify 24 relevant studies. 
Results:  Information is limited to a small number of geographic areas (USA and Asia) and 
focuses primarily on sleep duration and sleep continuity/efficiency.  Average polysomnographic 
and actigraphically determined total sleep time was less than seven hours, with standard 
deviations of approximately one hour.  Sleep efficiencies ranged from ≃70-90% and sleep onset 
latencies from ≃10-30 mins.  Based on limited information, a third of women report excessive 
daytime sleepiness across pregnancy and average PSQI scores were greater than five in the first 
and third trimester.   
Conclusions:  Limited literature is available on changes in sleep timing, perceived sleep quality, 
alertness/sleepiness across pregnancy.  Data suggests significant variability in sleep between 
women, with less evidence to support large changes in sleep health across trimesters, but some 




research on sleep health and sleep positioning to better inform women and their health 
providers. Future studies should ensure sample screening criteria are clearly specified and 
women are screened for complications throughout data collection not just at recruitment. 
3.2 Introduction 
For most women, altered sleep is one of a multitude of physiological changes occurring during 
pregnancy.  It is also one of the most noticed changes (Kennedy et al., 2007), and a topic women 
regularly seek information on, yet there is still limited empirical information available on what 
constitutes healthy sleep in each trimester of pregnancy.  This makes it difficult for maternal 
health providers to advise women on what changes are within the range of normal. 
Previous literature suggests there are alterations to sleep duration, the architecture of sleep, 
and perceptions of sleep quality with clear changes occurring from one trimester to the next 
(Brunner et al., 1994; K. A. Lee, Zaffke, et al., 2000; Tsai, Lee, Lin, & Lee, 2016a).  Many studies 
in this area have focused on the possible consequences of altered or disturbed sleep for the 
health of pregnant women and the health of their growing babies.  They have revealed 
important findings, showing for example, that short and/or long sleep duration and/or disturbed 
sleep are risk factors for pre-term birth (Micheli et al., 2011; Okun, Schetter, & Glynn, 2011), 
gestational diabetes (Facco, Grobman, Kramer, Ho, & Zee, 2010; Qiu, Enquobahrie, Frederick, 
Abetew, & Williams, 2010), hypertension (Williams et al., 2010), pre-eclampsia (O'Brien et al., 
2012), increased labor duration and a greater likelihood of caesarean delivery (K. A. Lee & Gay, 
2004).  Poorer antenatal mood and depression (Dørheim, Bjorvatn, & Eberhard-Gran, 2012; 
Okun, Kiewra, et al., 2011; Swanson, Pickett, Flynn, & Armitage, 2011) and poorer postpartum 




health outcomes have consequences for women and children both in the short term and across 
the lifespan. 
Like the studies that have investigated sleep during pregnancy, sleep science and sleep medicine 
more generally focus on what can go wrong with sleep.  This approach has been important in 
advancing our understanding of the role of sleep in the development of ill health and disease 
(Cappuccio & Miller, 2017; Farrell & Richards, 2017; Jike, Itani, Watanabe, Buysse, & Kaneita, 
2017).  However, there is growing recognition that healthy sleep is more than just an absence 
of sleep problems or a sleep disorder.  A sufficient amount of good quality sleep is being 
acknowledged as one of the fundamental components of good health, along with diet and 
physical activity (Canadian Society for Exercise Physiology, 2016; New Zealand Ministry of 
Health, 2017b). 
Recently there has been an effort to frame sleep positively and look at the potential benefits of 
good sleep.  Buysse (2014) has defined sleep health as “…a multidimensional pattern of sleep-
wakefulness, adapted to individual, social, and environmental demands, that promotes physical 
and mental well-being”, and he proposes five dimensions of good sleep health:  “subjective 
satisfaction, appropriate timing, adequate duration, high efficiency, and sustained alertness 
during waking hours.” 
This shift in focus is highly relevant during pregnancy, a time when women have greater 
awareness of their own health and are concerned about the consequences for their child.  
Women also have more frequent interaction with health professionals and are receptive to 
information on maintaining or improving their health.  Pregnancy is normally viewed as a 
positive time for most women and it is therefore relevant to focus on sleep health as a positive 




based information about different aspects of sleep and what constitutes normal healthy ranges.  
Such information would also allow health professionals to know when women need further 
assessment and possibly referral for sleep problems. 
To our knowledge there has been no previous attempt to define sleep health in pregnancy.  The 
aim of the review is to summarise the available research evidence on healthy sleep in each 
trimester of pregnancy.  To achieve this we have used a scoping review underpinned by Buysse’s 
(2014) definition of sleep health.   
3.3 Methods 
The methodology outlined by Arksey and O’Malley (2005) was used as the basis for this scoping 
review.  The following key steps were followed: (1) consultation; (2) identifying the research 
question; (3) identifying the relevant studies; (4) study selection; (5) charting the data; and (6) 
collating, summarising and reporting the results.   
3.3.1 Identifying the research question 
To ensure the topic addressed by the review was relevant and the findings practically useful, 
consultation with potential end users occurred.  These were healthcare providers working with 
pregnant women and included an obstetrician, community-based midwife, antenatal 
information coordinator at a large regional hospital, and a pregnancy and childbirth education 
manager of a community-based service.  All agreed that information on healthy sleep in 
pregnancy is sparse at best, and that information on this topic would be useful in their clinical 
environment.  This consultation formed the rationale for our scoping review.   
Based on Buysse’s multi-dimensional definition of sleep health (2014), this review examined the 




alertness/sleepiness and perceived satisfaction/quality of sleep.  It is proposed that healthy 
sleep is most likely to occur in a healthy, uncomplicated pregnancy, therefore studies included 
in this review needed to clearly specify criteria used to assure that participating women were 
healthy.  Thus, the research question was “What do we know about sleep health in each 
trimester of pregnancy?” 
3.3.2 Identifying the relevant studies 
The initial literature search was conducted in the Cochrane Library, PubMed, Medline, psycINFO, 
Web of Science, CINAHL Complete and Scopus databases.  These databases were systematically 
searched using key terms for sleep and pregnancy to form a Boolean string.  Our final string was 
(pregnan* OR gestat*) AND (sleep*) AND (quality OR duration OR timing) AND (week* OR 
trimester* OR early OR mid OR late).   
3.3.3 Inclusion/exclusion criteria 
To ensure broad coverage, studies published in the English language from January 1975 to 
December 2017 were considered eligible. Only studies that reported sleep in a healthy sample 
or sub-sample of pregnant women were included.  Data from control groups or sub-samples that 
sufficiently screened participating women were eligible for consideration.  For a study to be 
included in the review, sleep data needed to be presented in sufficient detail, and report means 
and SDs or proportions above/below specified cut-offs, and trimester or gestational week.   
Due to an established relationship with altered sleep, the exclusion criteria in each study had to 
stipulate that participating women self-reported or were screened for current mood disorders 
and sleep problems.  At a minimum, each sample also had to be screened for pregnancy 




to include gestational diabetes, hypertensive disorders (e.g. hypertension and/or pre-
eclampsia/eclampsia) and other health concerns associated with small for gestational age 
infants and pre-term birth.   
3.3.4 Study selection 
Endnote reference management software was used to import and manage references. The 
initial search produced 1946 articles, of which 1218 were duplicates, leaving 728 for initial 
screening.  The titles, abstract and keywords of the 728 identified articles were reviewed by two 
researchers and 503 records were excluded as not relevant to the topic.  Full text records of the 
remaining 225 articles were read by both researchers to assess topic relevance, and a further 57 
articles were excluded. Thirty-nine articles were considered central to the topic and eight 
articles were identified as review papers.  The reference lists of these review papers and key 
articles were reviewed and yielded a further 88 studies (14 were additional review papers and 
the reference lists of these were also screened).   
Careful screening of the participant inclusion/exclusion criteria was completed for 248 articles 
and 224 records were excluded.  This resulted in 24 studies being included in the review.  Figure 
3.1 outlines the study selection pathway.  Throughout the entire process, a conservative 
approach was taken and if there was uncertainty about the inclusion/exclusions criteria, both 















3.3.5 Charting the data 
Data was extracted from the final 24 studies and charted in Excel.  The following information 
was recorded:  Author, year of publication, journal name, geographical location, sample size and 
characteristics, measurement tools, dimension of sleep reported, aims and conclusions.  Table 
3.1 summarises descriptive characteristics of the included studies.












Participant Characteristics Measure Sleep Parameters Reported Aim/Overview Conclusions 
Baker et al. 
(2016); USA 
172 1st Trimester  
(10-12 wks) 
2nd Trimester (14-
16 wks and 18-20 
wks) 
Parity: Does not specify  
Mean Age: 29.3 ± 4.9 yrs 
Recruitment Setting: Self-referral, 
physician referrals, local 
advertisements, or University 
research registries 
Other characteristics reported: 
BMI, marital status, household 













Satisfaction/Quality:  PSQI (global) 
To examine whether varying 
degrees of exercise were 
associated with better nocturnal 
sleep among pregnant women 
during early gestation. 
Some level of exercise among 
pregnant women appears to be 
more advantageous than no 








3rd Trimester  
(32-35 wks) 
Parity: 5 primiparous, 4 
multiparous 
Mean Age: 30.6 ± 2.9 yrs 
Recruitment Setting: University 
Obstetrics Clinic 
Other characteristics reported: Nil 
Objective:  
In-lab PSG 






Other: REM Latency(min)psg, N1(min)psg, 
N2(min)psg, N3(min)psg, N4(min)psg, 
REM(min)psg, SWS sleep(min)psg, 
Movement time(min)psg 
To investigate changes in sleep in 
the course of pregnancy, PSG 
was recorded and analysed in 9 
healthy women on 2 consecutive 
nights during each trimester.  
Documents alterations in EEG 
spectral power that may be 
associated with hormonal 




14 2nd Trimester (21.0 
± 1.0 wks) 
Parity: All primiparous 
Mean Age: 29.9 ± 4.7 yrs 
Recruitment Setting: Community 
Other characteristics reported: 
Ethnicity, education, family income, 












Pilot study to examine 
associations among stress-
related physiological factors 
(including GABA-ergic 
neurosteroids) and stress-related 
behavioral indices of anxiety 
during pregnancy. 
Data suggest that cortisol, 
progesterone and ALLO + 
pregnanolone levels in 2nd 
trimester are inversely related to 
negative emotional symptoms 
and the negative impact of acute 
stress challenge appears to exert 
its effects by reducing these 
steroids to further promote 










Participant Characteristics Measure Sleep Parameters Reported Aim/Overview Conclusions 
Ebert et al. 
(2015); USA  
161 1st Trimester  
(10-12 wks) 
2nd Trimester (14-
16 wks and 18-20 
wks) 
Parity: 83 primiparous, 78 
multiparous 
Mean Age: 29.3 ± 4.9 yrs 
Recruitment Setting: Self-referral, 
physician referrals, local 
advertisements, or university 
research registries 
Other characteristics reported: 
Education, ethnicity, marital status, 
income, children at home, pre-
weight, BMI at week 10, BP at week 













Other: Naps taken 
To assess whether daytime naps 
negatively impact nocturnal 
sleep. 
The number of daytime naps 
have minimal impact on 
nocturnal sleep parameters; 
however, long nappers did 
exhibit modestly impaired sleep 
continuity and sleep quality. 
Overall, daytime naps were a 
beneficial countermeasure to 
sleep disruption commonly 
reported by pregnant women.  
Elek et al. 
(1997); USA 
24 3rd Trimester  
7th month  
(26.0 ± 0.8 wks) 
8th month  
(31.3 ± 1.0 wks) 
9th month  
(36.4 ± 1.1 wks) 
Parity: All primiparous 
Mean Age: 25.3 yrs (range 21 to 32 
yrs) 
Recruitment Setting: Private 
physician offices 
Other characteristics reported: 
Ethnicity, marital status, minimum 
education, employment status, 








Continuity/Efficiency: Number of 
undisturbed 90-minute sleep cycles  
SUBJECTIVE 
Other: Morning and Evening Fatigue 
This pilot study examined 
parents’ levels of morning or 
evening fatigue, number of 
uninterrupted sleep periods and 
length of sleep during 3rd 
trimester; and relationship of 
sleep to parents’ reports of 
fatigue. 
The findings support the 
multidimensional nature of 
fatigue and indicate need for 
perinatal health caregivers to 
develop individualised 
interventions for mothers during 
the 3rd trimester.  Fathers should 
also participate in future 
research on factors influencing 
prenatal and postpartum 
experience. 
Haney et al. 
(2014); USA 




16 wks and 18-20 
wks) 
Parity: Does not describe (37% with 
at least 1 child <18 years old living at 
home) 
Mean Age: 29.0 ± 5.0 yrs 
Recruitment Setting: Community 
Other characteristics reported:  
Pre-pregnancy weight, weight at 1st 
trimester, BMI at 1st trimester,  
BP at 1st trimester, PSS (Perceived 
Stress Scale), IDS (Inventory of 
Depressive Symptoms), ethnicity, 













To examine whether women with 
poor sleep (defined as short 
sleep duration, longer WASO or 
longer SOL at 10–12 wks, 
measured by sleep diary and 
actigraphy, would have higher BP 
or higher BMI across early 
pregnancy (10–20 wks) and 
whether women with sleep 
disturbance (i.e., poor sleep 
between 10 and 20 wks) would 
have greater increases in BP or 
BMI. 
A subset of women report 
substantial difficulty initiating 
and maintaining sleep during 
early pregnancy and this may 
augment risk of higher BP and 
BMI. Assessing sleep in early 
pregnancy is important to allow 










Participant Characteristics Measure Sleep Parameters Reported Aim/Overview Conclusions 
Hertz et al. 
(1992); USA 
12 3rd Trimester  
(30-38 wks) 
Parity: 7 primiparous, 5 multiparous 
Mean Age: 30.5 ± 5.1 yrs 
Recruitment Setting: Hospital 
Obstetrics Department 
Other characteristics reported: Nil  
Objective:    
In-lab PSG 





SOL(min)psg, WASO(min)psg, No of 
awakeningspsg 
Other: REM Latency(min)psg, 




Satisfaction/Quality: Restless Sleep 
Other: Snoring, Bad dreams 
To present a detailed 
investigation of sleep patterns, 
respiration and leg muscle EMG 
of 12 women in third trimester. 
In accordance with subjective 
reports, women in 3rd trimester 
demonstrated PSG patterns of 
sleep maintenance insomnia. 
Hux et al. 
(2017); USA  
103 1st Trimester (12.2 
± 1.1 wks) 
Parity: 63 primiparous, 40 
multiparous 
Mean Age: 29.8 ± 5.0 yrs 
Recruitment Setting: Self-referral, 
physician referrals, local 
advertisements, or university 
research registries 
Other characteristics reported: 
Ethnicity, income, education, 
Socioeconomic score, mean 
gestational age at delivery, preterm 
birth, pre-eclampsia, gestational 
diabetes 






To validate previously developed 
novel model of Allostatic Load 
(AL) in early pregnancy by 
evaluating associations between 
AL scores and subjective 
measures of stress and proxies of 
chronic stress, including 
race/ethnicity, sleep quality, and 
socioeconomic status. 
Higher AL, measured by the 
pregnancy-specific model, was 
associated with poorer sleep 
quality and lower educational 
attainment, both considered 
chronic stressors. These 
relationships were consistent 
with previous findings in non-
pregnant populations and 
suggest that AL may be useful for 
capturing the physiologic impact 
of chronic stress in early 
pregnancy. 
Lee et al. 
(2000); USA 
31 3rd Trimester  
(35-36 wks) 
Parity: Does not specify 
Mean Age: 31.6 ± 4.5 yrs 
Recruitment Setting: Media 
advertisements, flyers on University 
campus 
Other characteristics reported: 
Annual income, employment status, 
marital satisfaction 








Other: REM Latency(min)psg, N1(%)psg, 
N2(%)psg, SWS(%)psg, REM(%)psg 
SUBJECTIVE 
Other: Fatigue(POMS) 
To test the hypothesis that 
increases in endogenous 
progesterone levels during luteal 
phase of menstrual cycle will 
alter REM sleep and mood state, 
and that decrease in endogenous 
progesterone levels postpartum 
will also alter REM sleep and 
mood state. 
REM sleep and mood state were 
related to low progesterone 
levels during menstrual cycle, but 
postpartum REM sleep and mood 
state were related to increased 










Participant Characteristics Measure Sleep Parameters Reported Aim/Overview Conclusions 
Lee et al. 
(2000); USA 
33 1st Trimester 
(11-12 wks) 
3rd Trimester  
(35-36 wks) 
Parity: 16 primiparous, 17 
multiparous 
Mean Age: 30.5 ± 3.7 yrs 
(primiparas), 31.5 ± 3.0 yrs 
(multiparas) 
Recruitment Setting: 
Advertisements on University 
campus 
Other characteristics reported: 
Ethnicity, annual income, 








Continuity/Efficiency: SE(%)psg, SOL(min)psg, 
Wake(%)psg  
Other: REM Latency(min)psg, N1(mins)psg, 
N2(min)psg, N3/4(mins)psg, REM(min)psg 
To describe changes in women’s 
sleep patterns from pre-
pregnancy to postpartum. 
Sleep disturbance was greatest 
during the first postpartum month, 
particularly for first-time mothers. 
Okun et al. 
(2015); USA  
143 1st Trimester  
(10-12 weeks) 
2nd Trimester (14-
16 wks and 18-20 
wks) 
Parity: 85 primiparous, 54 
multiparous 
Mean Age: 30.4 ± 5.8 yrs (with 
insomnia), 29.1 ± 4.6 yrs (no 
insomnia)  
Recruitment Setting: Self-referral, 
physician referrals, local 
advertisements, or university 
research registries 
Other characteristics reported: 
Education, ethnicity, marital status, 







Duration: TST(min)acti, TIB(min)acti,  
Continuity/Efficiency: WASO(min)acti, 
SOL(min)acti, SE(%)acti,  
Timing: Bedtimeacti 
SUBJECTIVE 





To provide additional 
psychometric evaluation and 
validation of ISQ and to establish 
prevalence rates of insomnia 
among a women during early 
gestation. 
Insomnia is a health problem for 
many pregnant women at all stages 
in pregnancy. These data support 
validity and reliability of the ISQ to 
identify insomnia in pregnant 
women. The ISQ is a short and cost-
effective tool that can be quickly 
employed in large observational 
studies or in clinical practice where 




220 2nd Trimester (20-
29 wks) 
Parity: Does not specify 
Mean Age: Does not specify 
Recruitment Setting: Obstetric 
practices 
Other characteristics reported: Nil 






Continuity/Efficiency: SE(%)psqi, SE(score)psqi, 
SOL(min)psqi, SOL(score)psqi, Disturbancespsqi 
Alertness/Sleepiness: ESS, Dysfunctionpsqi, 
Satisfaction/Quality: PSQI(global), Qualitypsqi 
Other: Use of sleep medications  
This study examined subjective 
sleep quality and daytime 
sleepiness in relation to preterm 
birth. 
Disturbed sleep in pregnancy may 
be associated with preterm birth.  
Future studies should examine 
specific physiological factors that 











Participant Characteristics Measure Sleep Parameters Reported Aim/Overview Conclusions 
Tsai et al. 
(2017); 
Taiwan 
204 1st Trimester (11.8 
± 2.30 wks) 
2nd Trimester (16-
28 wks) 
3rd Trimester (>29 
wks) 
Parity: 107 primiparous, 97 
multiparous 
Mean Age: 32.5 ± 4.0 yrs 
Recruitment Setting: Medical 
centre outpatient obstetric clinic 
Other characteristics reported: 
Marital status, education, weekly 










Other: Daytime sleepacti 
SUBJECTIVE 
Alertness/Sleepiness: ESS (global), ESS 
(global>=10) 
Satisfaction/Quality: PSQI (global), PSQI (global>5) 
Other: Snoring(n,%) 
To examine 1st trimester 
maternal characteristics 
associated with persistent and 
new onset daytime sleepiness in 
pregnancy. 
Snoring in the 1st trimester is 
involved in both persistent and 
new-onset daytime sleepiness with 
elevated depressive symptoms 
related to new-onset daytime 
sleepiness. Intervention strategies 
for alleviating daytime sleepiness in 
pregnant women should focus on 
managing snoring and symptoms of 
depression in early pregnancy with 
special attention to primiparous 
and employed women. 
Tsai et al. 
(2012); 
Taiwan 
38 3rd Trimester (32.6 
± 2.8 wks) 
Parity: 38 primiparous 
Mean Age: 32.1 ± 5.1 yrs 
Recruitment Setting: University-
affiliated hospital Other 
characteristics reported: BMI, 







OBJECTIVE Duration: TST(nighttime)(min)acti 




Timing: Bedtimeacti, Risetimeacti, 
Alertness/Sleepiness: Morning fatigue, Midday 
fatigue, Afternoon fatigue, Evening fatigue 
Satisfaction/Quality: PSQI(global), PSQI(global>5) 
Other: Number days nappedpsqi, Number naps on 
a given daypsqi  
To examine association among 
nighttime sleep and daytime 
napping behaviours, depressive 
symptoms, and perception of 
fatigue in pregnant women. 
Interventions designed to increase 
sleep duration and decrease 
depressive symptoms have the 
potential to prevent, ameliorate, or 
reduce fatigue in pregnant women. 
Depressive symptoms during 
pregnancy likely share some 
psychological and behavioral 
tendencies with fatigue or sleep 
disturbance which may complicate 
evaluation of intervention effect. 
Tsai et al. 
(2016); 
Taiwan 
164 1st Trimester (11.7 
± 2.4 wks) 
2nd Trimester (22.3 
± 2.3 wks) 
3rd Trimester (33.7 
± 2.3 wks) 
Parity: 85 primiparous, 79 
multiparous 
Mean Age: 32.7 ± 4.0 yrs 
Recruitment Setting: University 
affiliated hospital 
Other characteristics reported: 









Continuity/Efficiency: WASO(mins)acti, SE(%)acti 
SUBJECTIVE 
Satisfaction/Quality: PSQI(global), PSQI(global>5) 
To examine cross-sectional and 
longitudinal association between 
sleep and health-related quality 
of life in pregnant women. 
Sleep disturbances are highly 
prevalent and a persistent problem 
in pregnant women. Adequate 
sleep is essential at all pregnancy 
stages and improving nocturnal 
sleep quantity and quality in early 
gestation is important for health-











Participant Characteristics Measure Sleep Parameters Reported Aim/Overview Conclusions 
Tsai et al. 
(2013); 
Taiwan 
80 3rd Trimester (32.8 
± 2.7 wks) 
Parity: 80 primiparous 
Mean Age: 31.7 ± 4.6 yrs 
Recruitment Setting: University 
Hospital obstetric clinics 
Other characteristics reported: 
Education years, employment 






VAS-F (7-item)  
OBJECTIVE Duration: TST(nighttime)(min)acti, 
TST(daytime)(min)acti,  TST(in 24hr)(min)acti, 





Satisfaction/Quality: PSQI(global), PSQI(global>5) 
Other: Total naps over 7 daydiary, Number women 
taking > 1 nap on a given daydiary 
To examine temporal association 
of nighttime sleep quality and 
quantity with subsequent 
daytime naps and temporal 
association of daytime naps with 
sleep quality and quantity the 
following night in 3rd trimester. 
Naps during pregnancy might 
indicate insufficient nighttime 
sleep, and longer daytime naps 
could compromise subsequent 
nighttime sleep. Further research is 
needed to determine if short sleep 
duration and longer daytime naps 
are associated with negative 
pregnancy outcomes. 
Tsai et al. 
(2011); 
Taiwan  
30 3rd Trimester (32.9 
± 2.7 wks) 
Parity: 30 primiparous 
Mean Age: 30.8 ± 4.8 yrs 
Recruitment Setting: University 
associated hospital prenatal clinics 
Other characteristics reported: 











SE(%)acti, SE(wkend)(%)acti, SE(wkday)(%)acti, 
SOL(min)acti, SOL(wkend)(%)acti, SOL(wkday)(%)acti,  
Timing: Bedtimeacti, Bedtime(wkend)acti, 
Bedtime(wkday)acti, Risetimeacti, Risetime(wkend)acti, 
Risetime(wkday)acti 
SUBJECTIVE 
Duration: Bedtimepsqi, Risetimepsqi,  TIB(hr)psqi, 
TST(hr)psqi 
Continuity/Efficiency: SE(%)psqi, SOL(min)psqi 
Satisfaction/Quality: PSQI(global), PSQI(global>5) 
Other: Number naps/day, Number naps/week, 
Number naps on weekdays, Number naps on 
weekends, Use of sleep enhancement strategies 
To identify sociodemographic, 
lifestyle, and health-related 
factors associated with poor 
sleep quality in women during 
3rd trimester. 
Primiparous women experience 
both objective and subjective sleep 
disturbances, and their sleep 
patterns differ between weekdays 
and weekends during 3rd trimester. 
Maternal sleep patterns may be 
improved by maintaining a regular 
and earlier bedtime, so women 
have more opportunity to obtain 
sufficient nocturnal sleep and 
improve sleep quality. 
Tsai et al. 
(2016); 
Taiwan 
274 3rd Trimester (33.2 
± 2.6 wks) 
Parity: All primiparous 
Mean Age: 31.9 ± 4.1 yrs 
Recruitment Setting: University 
affiliated obstetrics and gynecology 
clinics 
Other characteristics reported: 
Marital status, employment status, 
BMI, caffeine intake, smoking and 








Duration:  TST(nighttime)(min)acti, 
TST(nighttime<6hrs)acti, TST (daytime)(min)acti, 
TST(24hrs)(min)acti, TST(24hrs<7hr)acti 
Continuity/Efficiency: SOL(mins)acti, 
SOL(>30min)acti,  SE(%)acti, SE(<85%)(%)acti 
SUBJECTIVE  
Alertness/Sleepiness: ESS(global), ESS(global>10),  
Satisfaction/Quality: PSQI(global), PSQI(global>5),  
Other: Napping 
To examine objective and self-
reported sleep disturbances and 
symptoms of depression and 
daytime sleepiness in a group of 
healthy pregnant women. 
Both objective nighttime sleep < 6 
hrs and self-reported poor sleep 
quality in healthy 3rd trimester 
pregnant women is associated with 
significant risks for clinical 
depression. Improving sleep may 
reduce depression symptom 
severity and attenuate prevalence 









Participant Characteristics Measure Sleep Parameters Reported Aim/Overview Conclusions 
Tsai et al. 
(2016); 
Taiwan 
197 3rd Trimester (33.2 
± 2.7 wks) 
Parity: All primiparous 
Mean Age: 32.0 ± 4.2 yrs 
Recruitment Setting: Medical 
center 
Other characteristics reported: 








Duration:  TST(nighttime)(min)acti,  TST 
variability(nighttime)(min)acti, TST(daytime)(min)acti, 
TST variability(daytime)(min)acti  
Continuity/Efficiency: SOL(min)acti, SOL 
variability(min)acti, WASO(min)acti, WASO 
variability(min)acti 
SUBJECTIVE  
Other: SHPS score 
A descriptive study examining 
associations of sleep hygiene and 
actigraph measures of sleep with 
self-reported sleep quality in 
pregnant women. 
Findings support avoiding 
physically, physiologically, 
emotionally, or cognitively arousing 
activities before bedtime as a 
target for sleep-hygiene 
intervention in pregnant women. 
Tsai et al. 
(2013); 
Taiwan 
120 3rd Trimester (33.7 
± 2.7 wks) 
Parity: 120 primiparous 
Mean Age: 31.3 ± 4.2 yrs 
Recruitment Setting: University 
affiliated hospital 
Other characteristics reported: 
Gestational age at delivery, pre-
pregnancy BMI, CES-D, infant birth 
weight, marital status, education, 
working hours per week, gender of 







TST(nighttime<6)(%)acti, TST(daytime)(min)acti, TST(in 
24hr)acti 
Continuity/Efficiency: SE(%)acti, SE(<85%)(%)acti 




Satisfaction/Quality: PSQI(global), PSQI(global>5) 
To examine associations of 
nighttime and daytime sleep 
during 3rd trimester with labor 
duration and risk of cesarean 
deliveries. 
There was a beneficial effect of 
sleep on labor duration, suggesting 
that studies of sleep duration 
effects on labor and pregnancy 
outcomes should consider amount 






139 3rd Trimester 
(36 wks)  
Parity: 53 primiparous, 86 
multiparous 
Mean Age: 33.6 ± 3.8 yrs 
Recruitment Setting: Antenatal 
clinics 
Other characteristics reported: 
Education, employment status, 
prenatal exercise, planned 
pregnancy, anaemia, use of PCA 
(patient-controlled analgesia), use 
of pain medication, pre-pregnancy 
BMI, EPDS 
Objective:    
Nil 
Subjective: 
PSQI, FCF  
SUBJECTIVE 
Duration: TSTpsqi, Duration(subscale)psqi, 
Continuity/Efficiency: SOL(subscale)psqi, 
SOL(mins)psqi, SE(subscale)psqi, SE(%)psqi, 
Disturbances(subscale)psqi 
Alertness/Sleepiness: Daytime Function(subscale)psqi 
Satisfaction/Quality: PSQI (global), 
Quality(subscale)psqi 
Other:  Fatigue(FCF), Sleep medicationpsqi, 
Insomnia(%)psqi 
Two aims: 1) identify distinct 
classes of sleep-disturbance 
trajectories in women 
considering elective cesarean 
from 3rd trimester pregnancy to 
6 months postpartum and 2) 
examine associations of sleep 
trajectories with BMI, depressive 
symptoms, and fatigue scores. 
Women had 3 distinct sleep-
disturbance trajectories before and 
after elective cesarean. These poor-
sleep courses were associated with 
BMI and psychological well-being. 
Findings suggest need to 
continuously assess sleep quality in 
women considering elective 
















31 3rd Trimester  
(35-36 wks) 
Parity: 12 primigravida, 19 
multigravida 
Mean Age: 31.3 ± 3.3 yrs 
(primiparas), 32.4 ± 5.1 yrs 
(multiparas) 
Recruitment Setting: 
Advertisements in Obstetric offices 
and newspapers 
Other characteristics reported: 
Ethnicity, marital status, number of 











Other:  Fatigue(VAS-F), vitality(VAS-F) 
To describe differences between 
primigravidae and multigravidae 
in their experience of sleep 
efficiency, fatigue and vitality, 
and level of functioning in 3rd 
trimester of pregnancy and 1st 
month postpartum. 
Maternal role ‘acquisition’ 
experienced by primigravidae 
results in more fatigue and sleep 
disruption than maternal role 
‘expansion’. The significant 
decrease in sleep efficiency and 
increase in fatigue in primigravidae 
after delivery indicates that health 
care professionals need to provide 
anticipatory guidance to 
primigravidae to help smooth the 






48 1st Trimester  
(9-14 wks) 
 
3rd Trimester  
(30-38 wks) 
Parity: 9 primiparous and 12 
multiparous (1st Trimester), 15 
primiparous and 12 multiparous 
(3rd Trimester) 
Mean Age: 29.6 ± 3.4 yrs (1st 
Trimester), 32.3 ± 3.5 yrs (3rd 
trimester) 
Recruitment Setting: Hospital 
Outpatient Obstetrics Clinic 
Other characteristics reported: Pre-
pregnancy BMI, marital status, 
education, employment status 






Continuity/Efficiency: SOL(min)psg, WASO(min)psg, 
Arousals/hrpsg, Awakeningspsg, SE(%)psg 
Other: REM latency(min)psg, Resp arousalspsg, limb 
arousalspsg, Spont arousalspsg, N1(min)psg, 




Continuity/Efficiency: SOL(>20mins)(%), Difficulty 
falling asleep(%), Number of awakenings 
Satisfaction/Quality: Quality & Tiredness (study 
specific questionnaire) 
Other: Reasons for overnight awakenings 
To objectively measure sleep 
architecture and investigate 
subjective sleep quality in 1st and 
3rd trimester, when compared to 
non-pregnant state. 
Sleep during pregnancy is 
compromised by higher amounts of 
wake and cortical arousals leading 
to sleep fragmentation, with 
greater amounts of light sleep and 
less deep sleep. Mood state did not 
have an effect on sleep. Findings 
may help healthcare providers 
recognise when severe sleep 
disruption may warrant referral to 






38 3rd Trimester (34.5 
± 2.3 wks) 
Parity: All primiparous 
Mean Age: 30.0 ± 3.8 yrs 
Recruitment Setting: Antenatal 
classes 
Other characteristics reported: 
ethnicity, marital status, education 











Timing: Bedtimediary, Risetimediary 
To describe and compare diary 
reported sleep–wake variables 
and depressive symptoms during 
last wks of pregnancy, at 2–4 wks 
postpartum, 12–16 wks 
postpartum, and at 12–15 mths 
postpartum; and compare sleep–
wake variables between 
depressed and non-depressed 
mothers at 2–4 wks postpartum. 
Mothers who developed clinically 
elevated depressive symptoms 
(CES–D ≥ 16) at 2–4 wks 
postpartum reported more total 
sleep time, later rise times, and 
more time napping at end of 
pregnancy compared to mothers 
who reported fewer symptoms 





Studies identified in the scoping review are predominantly from Taiwan (38%) and the USA 
(54%), with only one study from Australia (Brunner et al., 1994) and one from Switzerland 
(Wilson et al., 2011).  In reviewing studies from the same authors or groups of authors, it became 
evident that different studies potentially used the same sample of participating women, 
although this was not always explicitly stated in any publication.  To ensure data from the same 
cohort of participants was not included in the review multiple times, sample sizes and data 
collection time frames (when given) were carefully considered.  In the first instance, data are 
presented from studies with the largest number of participants and the widest timeframe.  Data 
from additional studies, thought to using the same sample of women, are included if different 
sleep variables are provided or if data are presented by sub-groups of women (e.g. those with 
and without insomnia symptoms). 
The majority of studies used well-validated and widely accepted sleep measurement tools.  PSG 
was used in six studies, actigraphy in 14 studies and sleep diary in 17 studies. Subjective sleep 
scales were used in a majority of the studies, with the Pittsburgh Sleep Quality Index (PSQI) being 
the most common (n=14).  The Epworth Sleepiness Scale (ESS) and various forms of the Visual 
Analogue Scale for Fatigue (VAS-F) were used in a limited number of studies (18-item, 13-item 
and 7-item).  The Fatigue Continuum Form (FCF), the Profile of Mood States (POMS) fatigue 
subscale, Insomnia Symptom Questionnaire (ISQ), Stanford Sleepiness Scale (SSS) and the Sleep 
Hygiene Practice Scale (SHPS) were each reported once.  It is important to note that although 
studies may have indicated they used the above tools, authors may have chosen not to present 
data on all measures.   
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Figure 3.2 shows an overview of publication dates of the included studies.  Recent publications 
dominate the review with 71% of the studies published after 2009.  However current literature 
using PSG measures of sleep is limited, with five of the six studies published prior to 2000 and 
the sixth study was published in 2011.  The six actigraphy studies are more current (range 2011-
2016), however, all are published by Tsai and colleagues.  
 
Sleep data are centred around the third trimester with 17 articles providing data from this 
gestational period.  Ten articles report on first trimester, while only eight articles report on the 
second trimester.  Six studies span two trimesters, while only three studies provide data from 
all three trimesters (Brunner et al., 1994; Tsai, Lee, Lin, et al., 2016a, 2016b). 
As seen in Figure 3.3, most articles report on sleep efficiency/continuity (42%) and sleep 
duration (24%).  Data are limited for other dimensions of sleep including quality, timing and 
alertness/sleepiness.  Over 50% of the data comes from five measures of sleep; nighttime TST, 
sleep efficiency, sleep onset latency, wake after sleep onset and PSQI scores. 





There are PSG, actigraphy and self-report data available on the duration of nighttime sleep in 
each trimester of pregnancy (see Table 3.2).  Mean polysomnographic and actigraphic nighttime 
TST values are on average less than seven hours, with standard deviations of approximately one 
hour.  At each trimester, self-reported TST is longer than PSG and actigraphic TST, with women 
Figure 3.3  Hierarchical representation of reported sleep parameters from included studies. 
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reporting sleep durations over seven hours on average, particularly in the first and second 
trimester.  In the third trimester, self-reported TST is similar to PSG and actigraphic measured 
sleep duration.  There is limited actigraphic and subjective data on the amount of time pregnant 
women spend in bed at night, which on average is over eight hours. 
 
Table 3.2  Sleep duration in each trimester as reported for night-time and day-time 
periods, in studies using PSG, actigraphy and self-reported measures 
(Brunner et al., 1994; Ebert, Wood, & Okun, 2015; Elek, Hudson, & Fleck, 
1997; Haney et al., 2014; Hertz et al., 1992; K. A. Lee, McEnany, & Zaffke, 
2000; K. A. Lee, Zaffke, et al., 2000; Okun, Buysse, & Hall, 2015; Tsai et al., 
2011; Tsai, Kuo, Lee, Lee, & Landis, 2013; Tsai, Lee, Wu, et al., 2016; Tsai, Lee, 
Lin, et al., 2016a, 2016b; Tsai, Lin, Kuo, Lee, & Landis, 2013; Tsai, Lin, Kuo, & 
Thomas, 2012; Tsai, Lin, et al., 2016; Tzeng, Chen, Chen, Wang, & Kuo, 2015; 
Wilson et al., 2011; Wolfson et al., 2003). 
 
 
 1st trimester 2nd trimester 3rd trimester 
Measure Mean ± SD Mean ± SD Mean ± SD 
PSG TIB (mins) (no data) (no data) 462 ± 52  
Actigraphy TIB 
(mins) 
478 ± 43  (with insomnia) 
483 ± 49  (no insomnia) 
(no data) (no data) 
Self-report TIB 
(mins) 
509 ± 39  (with insomnia) 
508 ± 53  (no insomnia) 
(no data) 493 ± 70  
PSG TST (mins) 389 ± 10* 
446 ± 66  
401 ± 15          
 
370-415 ± 59-65           
430 ± 33  (negative 
postpartum affect) 




390-412 ± 54-64   
380 ± 64  (frequent 
nappers) 
439 ± 45  (non-nappers) 
400 ± 60  (short nappers) 
372 ± 66  (long nappers) 
394 ± 65  (with insomnia) 
365 ± 69  (no insomnia)  
396-398 ± 50-51  
383 ± 53  (frequent 
nappers) 
422 ± 51  (non-nappers) 
405 ± 47  (short nappers) 
381 ± 56  (long nappers) 
 
 
386-394 ± 52-61               
441 ± 61  (frequent 
nappers) 
476 ± 55  (non-
nappers) 
388 ± 52  (good 
sleeper) 
390 ± 47  (poor 
sleeper) 
388 ± 45  (vaginal 
delivery) 
406 ± 58  (cesarean 
delivery) 
376 ± 54  (frequent 
nappers) 






461 ± 52  
450 ± 49  (frequent 
nappers) 
474 ± 46  (non-nappers) 
464 ± 49  (short nappers) 
455 ± 57  (long nappers) 
444 ± 55  (with insomnia) 
466 ± 52  (no insomnia) 
454 ± 54  
441 ± 61  (frequent 
nappers) 
476 ± 55  (non-nappers) 
462 ± 48  (short nappers) 
439 ± 65  (long nappers) 
               
408-454 ± 56-92                    
375 ± 63  (weekdays) 
414 ± 72  (weekends) 
417 ± 74  (vaginal 
delivery) 






42 ± 33   
97 ± 60  (moderate 
nappers) 
82 ± 29  (frequent 
nappers)  
34 ± 26  
83 ± 36  (moderate 
nappers) 
91 ± 37  (frequent 
nappers) 
49-84 ± 51-52  
46 ± 46  (good sleeper) 
38 ± 34  (poor sleeper) 
42 ± 36  (vaginal 
delivery) 
41 ± 57  (cesarean 
delivery) 
75 ± 60  (frequent 
nappers) 





83 ± 46  (moderate 
nappers) 
93 ± 48  (frequent 
nappers) 
78 ± 41  (moderate 
nappers) 
104 ± 59  (frequent 
nappers) 
18 ± 5* 
Actigraphy 24-hr 
TST (mins) 
(no data) (no data) 435-442 ± 57-58  
430 ± 51  (vaginal 
delivery) 
448 ± 64  (cesarean 
delivery) 
451 ± 58  (frequent 
nappers) 
433 ± 58  (infrequent 
nappers) 
TST <8hrs  71% (PSG, nighttime TST) (no data) 74% (PSG, nighttime 
TST) 
TST <7hrs  38% (Actigraphy, 
nighttime TST) 
24% (Diary, nighttime TST) 
25% (Actigraphy, 
nighttime TST) 
26% (Diary, nighttime 
TST) 
42% (actigraphy, 24hr 
TST) 
TST <6hrs (no data) (no data) 26% (actigraphy, 
nighttime TST) 
PSG %TST in 
supine 
41 ± 24  (no data) 19 ± 15  




Detail on the percentage of time and number of minutes spent in the different stages of sleep 
and wake, REM latency and movement time can be found in Table 3.3.  With the exception of 
N1 light sleep, the amount of time spent in the different stages of sleep is markedly different 
from one study to the next. 
 
Table 3.3  Sleep stages, REM latency and movement time in each trimester, measured 
by PSG (Brunner et al., 1994; Hertz et al., 1992; K. A. Lee, Zaffke, et al., 2000; 
Wilson et al., 2011). 
 
 1st trimester 2nd trimester 3rd trimester 
 Mean ± SD (% sleep) Mean ± SD (% sleep) Mean ± SD (% sleep) 
N1 (mins) 34 ± 4* 
30 ± 16 
 
(3 ± 1%) 
31 ± 4* 
 
(no data) 36 ± 5* 
35 ± 15 
 
(4 ± 1%)  
(19 ± 13%) 
N2 (mins) 215 ± 14* 
166 ± 44 
 
(54 ± 6%) 
234 ± 17* 
 
(no data) 221 ± 14* 
162 ± 41 
 
(56 ± 6%)  
(55 ± 14%) 
N3 (mins) 40 ± 4* 
85 ± 38 
 
(9 ± 3%)# 
39 ± 3* 
 
(no data) 36  ± 3* 
67 ± 28 
 
(8 ± 4%)#    
(12 ± 3%)# 
N4 (mins) 20 ± 4* 
62 ± 27 
(no data) 24 ± 5* (no data) 18 ± 6* 
55 ± 24 
(no data) 
REM (mins) 80 ± 2* 
64 ± 16 
 
(24 ± 5%) 
73 ± 43* 
 
(no data) 71 ± 6* 
60 ± 23 
 
(21 ± 5%)   
(14 ± 4%) 
REM Latency 
(mins) 
  79 ± 8* 
118 ± 61  
  74 ± 26  
(no data) 70 ± 43* (no data)   65 ± 3* 
125 ± 51  
126 ± 55  
(no data) 
Wake (mins) (no data) (9 ± 6%) (no data) (no data) (no data) (11 ± 6%) 
Movement 
Time (mins) 
10 ± 1* (no data) 11 ± 41* (no data) 11 ± 1* (no data) 
*SEM rather than SD; # Combined N3 & N4 
 
Daytime nap duration is reported in Table 3.2, with average durations ranging widely from 
approximately 20 minutes to over 100 minutes, depending on the study.  Three studies describe 
the frequency of napping in the third trimester (Tsai et al., 2011; Tsai, Lin, et al., 2013; Tsai et 
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al., 2012).  The first study reports the prevalence of daytime napping as 97.5% (Tsai, Lin, et al., 
2013), while a second describes 50% of their cohort napping on 4 days or more (21% on four to 
five days and 29% napping on six to seven days) (Tsai et al., 2012) and the third study reported 
that the average number of naps per week was 4 ± 3, with 0.64 ± 0.45 naps on weekdays and 
0.53 ± 0.45 naps on weekends (Tsai et al., 2011).  There is a small amount of data on TST in 24 
hours, but only in the third trimester, and values average seven hours (see Table 3.2).  Some 
studies also reported the proportion of women obtaining <8, <7 and <6 hours sleep per night 
(see Table 3.2) and a single study reported on the percentage of time women spent in the supine 
position, dropping from nearly half the night in the first trimester to 20% of the night in the third 
trimester (Wilson et al., 2011).  Together this information demonstrates that during a healthy 
pregnancy both nighttime and daytime sleep duration is highly variable from one woman to the 
next. 
3.4.2 Continuity/sleep efficiency (SE) 
Compared to other dimensions of sleep, there is a large amount of data available on 
continuity/sleep efficiency (SE) (see Table 3.4).  Objective SE measured using both PSG and 
actigraphy range from 71-91% while subjective values of SE have a narrower range (83-91%).  
PSG WASO values (in mins) are highest in the third trimester, but one study that reports WASO 
(% of sleep) showed little difference between the first and third trimesters (K. A. Lee, Zaffke, et 
al., 2000).  WASO (in mins) is generally lowest in the third trimester when measured by 
actigraphy. When measured by self-report, WASO values (in mins) are lower than either PSG or 
actigraphically determined WASO.  Objective and subjective reports of SOL were similar, ranging 
from 10-27 mins with a SD of up to 23 min.  As with sleep duration, the data indicates how 




Table 3.4  Continuity/Sleep Efficiency in each trimester reported by SE, WASO and SOL, 
in studies using PSG, actigraphy and self-reported measures (Baker, Okun, 
Rothenberger, & Kline, 2016; Brunner et al., 1994; Crowley et al., 2016; Ebert 
et al., 2015; Haney et al., 2014; Hertz et al., 1992; K. A. Lee, McEnany, et al., 
2000; K. A. Lee, Zaffke, et al., 2000; Okun et al., 2015; Strange, Parker, 
Moore, Strickland, & Bliwise, 2009; Tsai et al., 2011; Tsai, Kuo, et al., 2013; 
Tsai, Lee, Wu, et al., 2016; Tsai, Lee, Lin, et al., 2016a; Tsai, Lin, et al., 2013; 
Tsai et al., 2012; Tsai, Lin, et al., 2016; Tzeng et al., 2015; Waters & Lee, 1996; 
Wilson et al., 2011; Wolfson et al., 2003). 
 
 1st trimester 2nd trimester 3rd trimester 
Measure Mean ± SD Mean ± SD Mean ± SD 
PSG SE (%) 85-91 ± 6-8  
87 ± 2* 
84 ± 7  (primiparous)  
86 ± 9  (multiparous) 
88 ± 3* 78-89 ± 6-14  
75 ± 15  (primiparous)  
86 ± 8  (multiparous) 
90 ± 4  (primigravidae)  
87 ± 7  (multigravidae) 
90 ± 6  (negative 
postpartum affect) 




82 ± 7  
74 ± 13  (inactive)  
76 ± 12  (insufficiently 
active) 
76 ± 12  (sufficiently active) 
76 ± 12  (frequent nappers) 
82 ± 7  (non-nappers) 
78 ± 10  (short nappers) 
74 ± 11  (long nappers) 
71 ± 13  (with insomnia) 
77 ± 11  (no insomnia) 
83 ± 6  
78 ± 9  (inactive)  
81 ± 8  (insufficiently 
active) 
79 ± 8  (sufficiently active) 
80 ± 9  (frequent nappers) 
80 ± 6  (non-nappers) 
80 ± 7  (short nappers) 
78 ± 9  (long nappers) 
 
80-81 ± 6-7  
81 ± 6  (vaginal delivery) 
82 ± 5  (cesarean delivery) 
80 ± 6  (frequent nappers) 
82 ± 6  (infrequent 
nappers) 
80 ± 7  (weekdays) 




87 ± 7  (frequent nappers) 
89 ± 4  (non-nappers) 
89 ± 6  (short nappers) 
85 ± 6  (long nappers) 
87 ± 8  (with insomnia) 
91 ± 5  (no insomnia) 
86 ± 13  
88 ± 6  (frequent nappers) 
89 ± 5  (non-nappers) 
90 ± 5  (short nappers) 
89 ± 8  (long nappers) 
 
83-87 ± 13-19 
87 ± 13  (vaginal delivery) 
82 ± 13  (cesarean 
delivery) 
 
SE <85% (no data) (no data) 67% (actigraphy) 
PSG WASO 
(mins) 
49 ± 36  
33 ± 10* 
55 ± 36  (primiparous)  
45 ± 36  (multiparous) 
23 ± 5* 
 
62-80 ± 37-44  
58 ± 6* 
77 ± 38  (primiparous)  





91 ± 57  
86 ± 54  (frequent nappers) 
73 ± 33  (non-nappers) 
88 ± 59  (short nappers) 
97 ± 54  (long nappers) 
113 ± 58  (with insomnia) 
91 ± 59  (no insomnia) 
28-72 ± 10-38  
70 ± 40  (frequent 
nappers) 
69 ± 25  (non-nappers) 
70 ± 31  (short nappers) 
76 ± 45  (long nappers) 
54 ± 27  
57 ± 21  (good sleeper) 
54 ± 23  (poor sleeper) 
53 ± 19  (frequent 
nappers) 
56 ± 21  (infrequent 
nappers) 
53 ± 21  (weekdays) 
56 ± 28  (weekends) 
Self-report 
WASO (mins) 
24 ± 18  
24 ± 18  (frequent nappers) 
16 ± 12  (non-nappers) 
24 ± 19  (short nappers) 
25 ± 17  (long nappers) 
38 ± 22  (with insomnia) 
23 ± 17  (no insomnia) 
20 ± 14  
20 ± 14  (frequent 
nappers) 
19 ± 12  (non-nappers) 
20 ± 14  (short nappers) 
20 ± 18  (long nappers) 
 
(no data) 
WASO >=30min 98% (actigraphy) (no data) (no data) 
PSG SOL (mins) 11 ± 8  (to stage 2) 
20 ± 4*(to stage 2) 
20 ± 17  (3 consecutive 
stages of sleep) 
22 ± 8*(to stage 2) 
 
14 ± 12*(to stage 1) 
13 ± 11  (to stage 2) 
25 ± 4*(to stage 2) 
18 ± 13  (no criteria) 
Actigraphy SOL 
(mins) 
15 ± 11   
15 ± 13  (frequent nappers) 
11 ± 6  (non-nappers) 
12 ± 9  (short nappers) 
19 ± 14  (long nappers) 
15 ± 9  (with insomnia) 
15 ± 12  (no insomnia) 
10-13 ± 6-10   
 
22 ± 16-21   
23 ± 20  (weekdays) 
21 ± 17  (weekends) 
Self-report SOL 
(mins) 
20 ± 15  
20 ± 17  (frequent nappers) 
17 ± 8  (non-nappers) 
17 ± 12  (short nappers) 
25 ± 18  (long nappers) 
27 ± 21  (with insomnia) 
20 ± 14  (no insomnia) 
16-27 ± 13-17   
 
23-27 ± 3-23   
 
SOL >20min 37% (actigraphy) (no data) 44% (self-report) 
(37% difficulty getting to 
sleep & 63% difficulty 
falling asleep after waking) 
SOL >30min (no data) (no data) 23% (actigraphy) 
*SEM rather than SD 
CHAPTER 3 
142 
3.4.3 Sleep disturbances 
In trimester one, a single study provided information on arousals (Mdn=11, range=8-16) and 
number of awakenings (mean=16, ±5) as measured by PSG (Wilson et al., 2011).  This study also 
reported that 24% of women had an Apnea-Hypopnea Index (AHI) of >5 and 10% a Periodic Limb 
Movement Index (PLMI)  of >5. The same study reported that 57% self-reported awakening one 
to two times per night, 48% had difficulty falling asleep after waking up at night.  The main causes 
of nighttime awakenings were the need to urinate (76%) and care for children/partner (45%).  
Another study reported the prevalence of snoring to be 29% in the first trimester when 
measured using the “Do you snore?” item of the Berlin Questionnaire (Tsai, Lee, Lin, et al., 
2016b).   
For the second trimester, there is minimal data published on sleep disturbances.  One study 
reported an actigraphy sleep fragmentation index of 28 ± 10 (Crowley et al., 2016) and another 
study measured sleep disturbance with the PSQI disturbance subscale (1.6 ± 0.6) (Strange et al., 
2009). 
In the third trimester, two PSG studies report on the number of awakenings per hour (19 ± 7 and 
37 ± 11) (Hertz et al., 1992; Wilson et al., 2011).  Objectively, there is limited data on arousals, 
with only one PSG study presenting data on total arousals per hour (Mdn=15, range=11-19), 
respiratory arousals per hour (Mdn=2, range=1-5), and spontaneous arousals per hour (8 ± 5) 
(Wilson et al., 2011).  This study also found that 31% of women had an AHI>5, and 30% of women 
had a PLMI of >5.  One study that utilised actigraphy reported a fragmentation index of 22 ± 5 
(Tsai, Kuo, et al., 2013).  Two subjective studies found that women report between 2-3 ± 1 
awakenings per night (Hertz et al., 1992; Tsai, Kuo, et al., 2013).  Another study indicated self-
reported awakenings with the following frequencies; 4% of women with no awakenings, 30% 
with one to two awakenings, 44% with three to four awakenings and 22% with five or more 
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awakenings per nights (Wilson et al., 2011).  This same study also provides information on the 
primary causes of the awakenings, with the need to urinate and feeling uncomfortable as the 
most prevalent.  Women have also reported almost an hour of sleep disruptions per night (59 
mins ± 6 SEM) (Wolfson et al., 2003). 
Only one study has reported on snoring in the third trimester, with 42% of women reporting 
that they never snored, 58% reporting they sometimes snored and 0% reporting they always 
snored (Hertz et al., 1992).  This same study reported on the percentage of women reporting 
restless sleep (17% never, 50% sometimes, 33% always) and bad dreams (25% never, 75% 
sometimes, 0% always). 
3.4.4 Timing 
This review yielded three studies on sleep timing in pregnancy, measured with actigraphy and 
diary self-reports in the first and third trimester (see Table 3.5).  In the first trimester, actigraphy 
and self-report bedtime were after 23:00. There is no information on rise times. On average in 
the third trimester, bedtime and sleep onset was after midnight on both weekdays and 
weekends and average wake times ranged between 6:50am and nearly 8:00am on weekdays 









Table 3.5  Sleep timing in each trimester as measured by actigraphy (bedtime, onset 
and offset) and self-report (bedtime and wake time) (Okun et al., 2015; Tsai 
et al., 2011; Wolfson et al., 2003). 
 
 1st trimester 2nd trimester 3rd trimester 
Measure Mean Time ± SD (min) Mean Time ± SD (min) Mean Time ± SD (min) 
Actigraphy 
Bedtime 
23:24 ± 72  (with 
insomnia) 
23:15 ± 65  (no insomnia) 
(no data) (no data) 
Self-Report 
Bedtime 
23:12 ± 60  (with 
insomnia) 
23:19 ± 61  (no insomnia) 
(no data) 00:24 ± 150  
22:43 ± 7* 
Self-Report 
Wake time 
(no data) (no data) 7:46 ± 78  
6:50 ± 9* 
Actigraphy 
Onset 
(no data) (no data) 00:30 ± 60  (week) 
00:28 ± 60  (weekdays) 
00:39 ± 72  (weekends) 
Actigraphy 
Offset 
(no data) (no data) 7:55 ± 72  (week) 
7:37 ± 72  (weekdays) 
8:30 ± 84  (weekends) 
*SEM rather than SD 
 
3.4.5 Alertness/sleepiness  
Data on alertness/sleepiness is limited (see Table 3.6).  In the first and second trimester, daytime 
sleepiness and alertness was primarily measured using the ESS, with approximately a third of 
pregnant women reporting excessive daytime sleepiness. Similar proportions of women 
reported excessive daytime sleepiness in the third trimester. Measures of fatigue (using a visual 
analogue scale) were also utilised in studies focused on the third trimester, however, due to 
differences in the construction of each scale it is difficult to compare or summarise findings from 





Table 3.6  Alertness/Sleepiness in each trimester, measured by the ESS, FCF, POMS and  
VAS-F (Elek et al., 1997; Hertz et al., 1992; K. A. Lee, McEnany, et al., 2000; 
Strange et al., 2009; Tsai, Lee, Lin, et al., 2016b; Tsai et al., 2012; Tsai, Lin, et 
al., 2016; Tzeng et al., 2015; Waters & Lee, 1996; Wilson et al., 2011). 
 
 1st trimester 2nd trimester 3rd trimester 
Measure Mean ± SD or % Mean ± SD or % Mean ± SD or % 
ESS (global) 8.4 ± 3.9  9.0 ± 4.1  8.0 ± 3.8  
ESS ≥10 (%) 37% 32% (>10) 37% 
FCF (global)   51.3 ± 12.0  
SSS (global)   4.1 ± 1.4  
POMS (fatigue 
subscale) 
  10.5 ± 7.4  (negative postpartum 
affect) 
11.8 ± 7.0  (positive postpartum 
affect) 
Fatigue (VAS-
F 18 item) 
  64.2 ± 17.9  (primigravidae)  
64.8 ± 19.3  (multigravidae) 
Vitality (VAS-F 
18 item) 
  30.5 ± 13.4  (primigravidae)  
26.2 ± 16.9  (multigravidae) 
Morning 
Fatigue (VAS-
F 13 item) 
  36.2 ± 17.1 (7th month) 
41.6 ± 21.0 (8th month) 
47.9 ± 23.3 (9th month) 
Afternoon 
Fatigue (VAS-
F 13 item) 
  74.8 ± 16.3 (7th month) 
74.5 ± 16.2 (8th month) 
77.6 ± 13.2 (9th month) 
Fatigue (VAS-
F 7 item) 
  4.2 ± 1.3 (overall fatigue) 
3.4 ± 1.6 (morning fatigue) 
3.6 ± 1.6 (midday fatigue) 
4.4 ± 1.2 (afternoon fatigue) 











3.4.6 Satisfaction/quality  
Perceived sleep satisfaction and quality were all measured using the PSQI, with average scores 
>5 in first and third trimester across all studies, and slightly lower averages in the second 
trimester.  The proportion of women with PSQI scores >5 was approximately 40% in the first and 
second trimesters. In the third trimester, proportions with scores >5 were higher and ranged 
from 45-76% depending on how groups of women were defined. Table 3.7 details the measures 
and findings relating to perceived satisfaction and quality of sleep. 
 
Table 3.7  Sleep quality in each trimester, using the PSQI, ISQ and the SHPS (Baker et 
al., 2016; Crowley et al., 2016; Hux, Roberts, & Okun, 2017; Okun et al., 2015; 
Strange et al., 2009; Tsai, Kuo, et al., 2013; Tsai, Lee, Wu, et al., 2016; Tsai, 
Lee, Lin, et al., 2016a, 2016b; Tsai, Lin, et al., 2013; Tsai et al., 2012; Tsai, Lin, 
et al., 2016; Tzeng et al., 2015). 
 
 1st trimester 2nd trimester 3rd trimester 
Measure Mean ± SD or % Mean ± SD or % Mean ± SD or % 
PSQI 
(global) 
5.4-5.6 ± 2.4-2.5  5.2-6.7 ± 2.7-3.1  
4.9 ± 2.6  (inactive)  
4.2 ± 2.3  (insufficiently 
active) 
4.0 ± 2.4  (sufficiently active) 
5.7-8.4 ± 2.8-3.7  
5.8 ± 3.2  (vaginal delivery) 
6.7 ± 3.3  (cesarean delivery) 
7.9 ± 3.4  (frequent nappers) 
5.2 ± 3.3  (infrequent nappers) 
PSQI global 
>5 (%) 
45% 37% 45-66% 
48% (vaginal delivery) 
66% (cesarean delivery) 
76% (frequent nappers) 
36% (infrequent nappers) 
ISQ (met 
criteria) (%) 
13%   
SHPS 
(global) 





A scoping review was used to collect and summarise the available research evidence on healthy 
sleep in each trimester of pregnancy.  Consultation with maternal health providers confirmed 
the need for empirical information on this issue and although findings show that some data are 
available for most dimensions of healthy sleep in each trimester, information is relatively 
limited.  The growth in the number of studies published on this topic since 2011 points to an 
increased awareness of the importance of healthy sleep in pregnancy and to an increased need 
for information on the topic from pregnant women and their health providers. 
Most of the available data on healthy sleep in pregnancy focuses on sleep duration, the 
architecture of sleep, and sleep continuity/efficiency.  There is limited information on daytime 
sleepiness and alertness, and on subjective perceptions of sleep satisfaction and quality.  Very 
little information is available on sleep timing.  Recent literature points to the importance of 
stable sleep timing in health (Landhuis, Poulton, Welch, & Hancox, 2008), but we know little 
about how sleep timing might change across pregnancy and what the consequences may be for 
maternal and child health.  This is certainly an area deserving of further research attention.   
Another aspect of sleep, potentially relevant to sleep health during pregnancy, is the position in 
which women slept.  Position was only reported in one of the studies included in this review.  
Given the possible relationship between sleep position and stillbirth (Cronin et al., 2017; Gordon 
et al., 2015; Stacey et al., 2011) position is an important aspect of sleep that should be described 
for pregnant women, and one which women and health care providers are seeking information.   
This study did not aim to compare dimensions of healthy sleep across trimesters. However, 
several longitudinal studies were identified.  PSG recorded TST in a laboratory setting was similar 
across all three trimesters (Brunner et al., 1994), whereas PSG recording in the home indicated 
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that women obtained more sleep in the first trimester than the third trimester (K. A. Lee, Zaffke, 
et al., 2000).  Two studies showed that sleep continuity and efficiency were reduced in the third 
trimester (Brunner et al., 1994; Wilson et al., 2011).  Brunner et al. (1994) found that WASO was 
higher in the third trimester compared to the second trimester, despite comparable TST.  Wilson 
et al. (2011) examined changes between the first and third trimesters using PSG and found that 
SOL was similar, but that arousals, awakenings, AHI >5, and PLMI >5 were all higher in the third 
trimester, while time spent in the supine position was halved.  Self-report data from this study 
showed that SOL >20 min was greater in the third trimester and reports of >5 awakenings per 
night doubled from the first to the third trimester.  No other studies we reviewed used statistical 
comparisons to examine changes in sleep across trimesters.  
A strength of this study is the use of the framework proposed by Arksey and Malloy (2005) for 
conducting a scoping review and the incorporation of Buysse’s (2014) definition of sleep health, 
which places a positive focus on sleep and considers sleep health as a multi-faceted concept.  
None of the studies in this review were specifically designed with Buysse’s (2014) recent 
definition in mind, therefore no single paper provided data for all dimensions of sleep in each 
trimester of pregnancy.  
Studies provided different amounts of detail on exclusion and inclusion criteria, which in some 
instances, produced uncertainty on how women were screened.  Given that mood disorders 
have a strong and consistent relationship with alterations in sleep in pregnancy (Dørheim et al., 
2012; Okun, Kiewra, et al., 2011; Swanson et al., 2011) we decided that for a publication to be 
included, these aspects of health needed to be clearly described in the screening process.  Many 
other aspects of maternal health and infant health have also been associated with changes in 
sleep (e.g. gestational diabetes, hypertension, small for gestational age infants, preterm infants) 
(Facco, Grobman, et al., 2010; Micheli et al., 2011; O'Brien et al., 2012; Okun, Schetter, et al., 
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2011; Qiu et al., 2010; Williams et al., 2010), but the majority of studies did not specifically state 
all the conditions for which women were excluded (refer to Figure 1).  Instead, they referred to 
women being “healthy”, or having an “uncomplicated” pregnancy or, being free of “chronic 
illnesses.”  Our approach may have resulted in studies being included that did not sufficiently 
screen women for all health conditions currently shown to have a relationship with altered 
sleep, but to have required this criteria would have resulted in only three studies in our scoping 
review.  We may have also excluded studies from this review that did screen for sleep and mood 
disorders but did not state this explicitly in the methods.  We recommend that in the future, for 
studies that focus on a healthy sample of pregnant women, the authors clearly specify the health 
issues considered in the screening process. 
Related to screening and enrolling pregnant participants for research, is the issue of on-going 
health for women participating in longitudinal studies.  No studies included in this review 
discussed screening women throughout the course of the study to ensure they remained free of 
health complications.  As a consequence, it is possible that women developed health issues later 
in pregnancy (i.e. hypertension or pre-eclampsia) that could affect sleep or could be associated 
with changes in sleep.  
Another limitation of this scoping review is that 38% (n=9) of the publications were conducted 
in Taiwan and 54% were conducted in the USA, biasing results towards cultural practices in those 
areas of the world.  There may be cultural differences in sleep practices (i.e. napping) during 
pregnancy that would influence the findings presented in this review.  Furthermore, half of the 
studies had small sample sizes (< 40) which may limit the generalisability of the results. 
We have provided information on the range (and variability) of values presented for each 
dimension of sleep but have not made judgements on when maternal healthcare professionals 
should refer women to other healthcare providers for further assessment or treatment.  It is 
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argued that recommendation should be made only after using a consensus approach, similar to 
the process for developing other guidelines (Hirshkowitz et al., 2015; Ohayon et al., 2017).  A 
consensus group would also consider if there was sufficient data presently available on which to 
base such guidelines.  Unfortunately, even if guidelines were in place, many countries may not 
have clearly defined treatment pathways for pregnant women with sleep problems or disorders.  
In New Zealand, for example, there are clinical sleep services, but the public health system often 
experiences long waiting times.  It would important for pregnant women to be given priority in 
such circumstances. 
3.6 Conclusion 
While data on each of the five dimensions of sleep detailed in Buysse’s (2014) definition of sleep 
health are presented in this scoping review, diverse and extensive evidence of healthy sleep in 
pregnancy is limited.  The majority of studies are relatively recent, with 92% of studies 
originating from only two countries and from a limited group of authors and cohorts. 
Comparable data on sleep duration and measures of continuity/efficiency are available, but 
reports of sleep timing, perceived sleep quality and alertness/sleepiness measures are lacking. 
The data presented in this scoping review indicate that sleep in each trimester of pregnancy is 
highly variable from one woman to the next but does not support the idea of large changes in 
sleep across pregnancy in healthy pregnant woman.  There is some evidence of more disturbed 
sleep in the third trimester, but at this stage there is limited information on which to draw firm 
conclusions.  Further research is needed to clearly differentiate between healthy sleep and 
insufficient or disturbed sleep where intervention might be necessary. Knowing when to 
intervene if women need help with their sleep is vital in ensuring the short-term and long-term 
health and wellbeing of mothers and their children. 
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4 MULTIPLE DIMENSIONS OF SLEEP ARE CONSISTENTLY 
ASSOCIATED WITH CHRONICALLY ELEVATED DEPRESSIVE 
SYMPTOMS FROM LATE PREGNANCY TO THREE YEARS 
POSTNATAL IN INDIGENOUS AND NON-INDIGENOUS NEW 
ZEALAND WOMEN   
A key finding from the scoped review in the previous chapter was an absence of large changes 
in sleep throughout a physically and mentally healthy pregnancy.  Due to the recognised bi-
directional relationship between sleep and mental health, it was hypothesised that sufficient 
good quality sleep that remained stable over time (i.e. fewer or smaller changes from one 
trimester to the next) would support good mental health throughout pregnancy. This prompted 
the intervention study detailed in Chapters 5 and 6.  The scoped review also highlighted the 
limited longitudinal data available across pregnancy and influenced the design of the 
intervention study. 
Findings of the scoped review noted that prior research focused on measuring and reporting 
sleep duration, quality and continuity, during pregnancy, while there was a lack of information 
on daytime sleepiness and sleep timing.  All five dimensions of sleep health, as described by 
Buysse (2014), have a demonstrated impact on health outcomes, including pregnancy 
outcomes.  This finding prompted the inclusion of Buysse’s five sleep health dimensions into the 
subsequent studies in this thesis. 
While the review in the previous chapter focused on sleep during a healthy pregnancy, the 
broader goals of this thesis were to understand the relationship between sleep and depression.  
The next chapter begins by investigating patterns of depression of 856 New Zealand women 
throughout the perinatal period to three years post birth.  Because of the existence of ethnic 
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inequities in maternal mental health, and the Kaupapa Māori research framework that 
underpinned this study, the trajectories of Māori and non-Māori women were explored, in 
addition to examining trajectories of the total cohort.  The relationship between the patterns of 
depression and dimensions of sleep health were also considered.   
The following manuscript was prepared by the researcher (Appendix 29) and has been prepared 
for publication in the journal Australian and New Zealand Journal of Psychiatry.  All rights 
reserved© Ladyman, C. I., Signal, T. L., Sweeney, B. S., Jefferies, M., Gander, P. H., Paine, S-J & 
Huthwaite, M. 
4.1 Abstract 
Introduction:  Poor sleep and depressive symptoms are common throughout the perinatal 
period, but little is known about the extended time course of depression and the sleep 
dimensions associated with these trajectories. 
Purpose:  This study investigated different depression trajectories in New Zealand Māori and 
non-Māori women from late pregnancy through to three years postnatal.  Relationships 
between multiple dimensions of sleep and depression trajectories was also investigated. 
Methods:  Data from 856 women (30.6% Māori and 69.4% non-Māori) from the longitudinal 
Moe Kura cohort study were used.  Depressive symptoms and multiple dimensions of sleep 
(quality, duration, latency, continuity and daytime sleepiness) were collected at 36 weeks 
gestation, 12 weeks postnatal and three years postnatal.  Trajectory analysis was completed 
using latent class analysis (LCA). 
Results:   LCA revealed two distinct groups of depressive symptom trajectories; ‘chronic high’ 
and ‘stable mild’ for both Māori and non-Māori women.  Māori women in both trajectories were 
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more likely than non-Māori women to have clinically significant depressive symptoms at every 
time point.  Poorer sleep quality, latency, continuity and greater daytime sleepiness were 
consistently associated with the chronic high depressive symptom trajectory at all three time 
points, after controlling for sociodemographic factors. 
Conclusions:  A significant proportion of Māori and non-Māori women experience chronically 
high depressive symptoms during the perinatal period and following years. Across this extended 
timeframe Māori women have a higher probability of experiencing clinically significant 
depressive symptoms compared to non-Māori women.  These persistent patterns of depressive 
symptoms occur concurrently with multiple dimensions of poor sleep.  Given the well described 
impact of maternal depression on the mother, child, family and community, this highlights the 
importance of healthcare professionals asking about mothers’ sleep quality, continuity, latency 
and daytime sleepiness as potential indicators of long-term mood outcomes.   
Keywords: Pregnancy, Postnatal, Indigenous, Depression, Sleep 
4.2 Introduction 
There is clear evidence that maternal depression can have severe and enduring adverse 
consequences for both mother and child, as well as the extended family (Letourneau et al., 
2012).  Depression in pregnancy can lead to inadequate uptake of antenatal care; adverse 
obstetric outcomes; poor family functioning; poor infant bonding, feeding and sleeping 
(Chuang et al., 2011) and deficits in children’s social, behavioural, learning and cognition 
development (Burke, 2003).  Mothers experiencing perinatal depression are more likely to 
experience future episodes (McMahon et al., 2008), while their children, partners and 
grandchildren are also at greater risk of experiencing depression (Weissman et al., 2005).  In 
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New Zealand, suicide is the leading single cause of maternal death, with rates higher than 
those seen in the United Kingdom and Australia (Perinatal and Maternal Mortality Review 
Committee, 2015). 
Ethnic inequities in maternal mental health exist (Watson et al., 2019).  In New Zealand, Māori 
women are at higher risk of experiencing symptoms of perinatal depression (22%) compared to 
non-Māori (15%) (Signal et al., 2016). These reported rates may be conservative, due to 
inequities in access to care and the quality of care received, resulting in Māori women being less 
likely to be detected or treated for depression by maternal care providers (Oakley Browne et al., 
2006).  Māori women also have higher overall maternal mortality and suicide rates (Perinatal 
and Maternal Mortality Review Committee, 2018), often experience earlier onset of mental 
health conditions, depressive symptoms of greater severity and are more likely to have 
simultaneous risk factors, such as younger age, lower socioeconomic status, poorer access to 
services and less partner support (New Zealand Ministry of Health, 2008). 
Prolonged or recurrent episodes of maternal depression are likely to have long term physical 
and psychological effects on the mother and child (Slomian, Honvo, Reginster, Bruyère, & 
Emonts, 2019; Weissman et al., 2006).  Importantly, recent studies have shown that depression 
is not uniform and trajectories differ between individual women (Nandi, Beard, & Galea, 2009).  
In a systematic review of longitudinal depression studies, Vliegen et al. (2014) identified two 
community-based studies that included women with depression at three to four months 
postnatally, of whom 17%-62% experienced depressive symptoms three years later.  
Furthermore, this review showed that in two clinical samples, 39%-58% of mothers with early 
postnatal depression continued to experience it three to three and a half years later.  Since this 
review, an increasing number of studies have utilised trajectory analysis to examine the time 
course of perinatal depression.  Analyses of this type are valuable because they could reveal 
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variability and patterns in the development and/or persistence of depression (Tomfohr, Buliga, 
Campbell, Giesbrecht, & Letourneau, 2015).   
Poor or insufficient sleep are linked to depression (Peterson & Benca, 2008) and it appears that 
a proportion of women are unable to consistently achieve healthy sleep throughout pregnancy 
(Ross et al., 2005; Yang et al., 2017).  Early pregnancy sleep disturbances have been associated 
with later pregnancy depressive symptoms (Skouteris, Wertheim, Germano, et al., 2009) and 
late pregnancy poor sleep is independently linked to postnatal depression (Tomfohr et al., 2015).  
The few studies that have examined trajectories of sleep and depression across the perinatal 
period, show that poor sleep patterns are associated with depressive symptoms (Tzeng et al., 
2015; G. Wang et al., 2018) or conversely, trajectories of depressive symptoms are associated 
with poor sleep (S.-Y. Kuo, Yang, Kuo, Tseng, & Tzeng, 2012).  These studies have typically only 
examined one dimension of sleep, such as sleep duration or sleep quality.  To our knowledge, 
no study to date has investigated whether multiple dimensions of sleep are associated with 
depressive symptom trajectories.  Sleep is a series of complex physiological processes that are 
not easily portrayed by a single measure and it may be that various sleep dimensions, or more 
importantly combinations of dimensions, are more predictive of mood changes at particular 
time points throughout the perinatal period (J. L. Paulson & Miller-Graff, 2019). 
Investigating how sleep and depressive symptoms are related could provide the basis for early 
detection and interventions.  Sleep is a critical health behaviour, and necessary to maintain and 
improve mental and physical health outcomes. It is also one of the few potentially modifiable 
risk factors for depression.  In New Zealand, the prevalence of sleep problems and disorders are 
higher amongst Māori compared with non-Māori (Paine & Gander, 2013).  Recognising and 
treating poor sleep health as a vital aspect of a mother’s overall health and could be a novel 
intervention to reduce inequities in maternal mental health. 
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This study investigates the trajectories of depressive symptoms from late pregnancy to three 
years post birth in a large community-based sample of Māori and non-Māori women and the 
different dimensions of sleep associated with those trajectories. Buysse’s ‘Sleep Health’ 
conceptual model (Buysse, 2014) underpinned the selection of measures used to assess sleep. 
This approach considers sleep as a multidimensional model that “promotes physical and mental 
well-being”. We investigated four of Buysse’s five sleep health dimensions: quality, quantity, 
continuity, and daytime sleepiness.  The fifth sleep dimension, sleep timing, was not available 
for the comparison group, and instead data on sleep latency (onset insomnia) was included in 
analyses. 
4.3 Methods  
4.3.1 Participants 
Data for this analysis were drawn from the Moe Kura prospective observational cohort study, 
collected between October 2009 and April 2015.  Details of the recruitment process for Moe 
Kura are described elsewhere (Signal et al., 2016).  Questionnaires were completed by women 
at 35- to 37-weeks gestation (T1), 12-weeks postnatal (T2) and at three years postnatal (T3). 
Women  provided demographic and lifestyle information as well as responding to items on their 
sleep, and prior and current health and mood.  Inclusion criteria for participation in the study 
included carrying a single foetus, 16 years of age or older, and being between 35- and 37-weeks 
gestation.  The Moe Kura study was designed to investigate ethnic inequities in maternal sleep 
and health between Māori and non-Māori in New Zealand, with Kaupapa Māori epidemiological 
research principles informing the study design, analysis and reporting (Paine & Gander, 2013; 
Simmonds, Robson, Cram, & Purdie, 2008).  The Kaupapa Māori principles employed in the Moe 
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Kura study are aligned with the CONSIDER criteria and broadly meet the same expectations 
(Huria et al., 2019).   
Ethical approval for the study was obtained from the Central Region Health and Disability Ethics 
Committee (protocol CEN 09/09/070).   Prior to statistical analysis, any outliers in the database 
(data not possible within the scale limits) were checked and either removed/ or corrected by 
referring back to the original questionnaire.   
4.3.2 Measures 
4.3.2.1 Demographic, health and lifestyle  
The following measure were collected: maternal age; ethnicity (categorised as Māori [anyone 
who identified as Māori either alone or in combination with another ethnic group/s] or non-
Māori [all others] (Statistics New Zealand, 2017); currently pregnant; having an additional child 
younger than their Moe Kura child; relationship satisfaction using an 8-point Likert scale (range 
0-7; where <3 signifies greater satisfaction, ≥3 signifies less satisfaction or not applicable); 
history of diagnosed depression; stressful life events (using the 13-item Pregnancy Risk 
Monitoring System (PRAMS) where low stress was considered <2 stressors, and high stress ≥2 
stressors) (Mukherjee et al., 2017); and an area-level measure of socioeconomic deprivation.  
Women were assigned to a socioeconomic deprivation decile based on their residential address 
using the 2006 NZDep Index at T1 and T2 and the 2013 NZDep Index at T3, which are based on 
the respective 2006 and 2013 population census (decile 1 = 10% of small areas with lowest levels 
of deprivation to decile 10 = 10% of small areas with highest levels of deprivation).  In analyses 
these were utilised as quintiles (i.e. five levels, each representing 20% of small areas) (Atkinson 
et al., 2014).   
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4.3.2.2 Sleep Measures 
Sleep duration was measured at each time point by the question “How many hours sleep do you 
usually get in 24 hours, including naps?”  Sleep quality, latency and continuity were assessed 
using the relevant General Sleep Disturbance Scale (GSDS) subscales (K. A. Lee & Gay, 2004).  
Each item in the GSDS was rated from 0 (never) to 7 (every day) and if a subscale is comprised 
of two or more items, the mean was calculated.  Sleep quality was assessed using the GSDS 
Quality Subscale items; “How often in the last week did you feel rested upon awakening at the 
end of a sleep period?”, “How often in the last week did you sleep poorly?” and “How often in 
the last week did you feel satisfied with the quality of your sleep?”  The first and last items are 
reversed scored.  Sleep latency was assessed using the GSDS Onset Insomnia Subscale item; 
“How often in the last week did you have difficulty getting to sleep?”  Sleep continuity was 
measured by the GSDS Maintenance Insomnia Subscale items; “How often in the last week did 
you wake up during your sleep period?” and “How often in the last week did you wake up too 
early at the end of your sleep period?”  Validity and reliability of the GSDS have been 
demonstrated in childbearing women (K. A. Lee & Gay, 2004).  Daytime Sleepiness was 
measured by the Epworth Sleepiness Scale (ESS).  The ESS assesses daytime sleepiness in eight 
everyday situations using the question “How likely are you to doze off in the following situations, 
in contrast to feeling just tired…?”  The ESS has been demonstrated to be reliable and valid for 
use in pregnant populations (Baumgartel et al., 2013) and excessive daytime sleepiness is 




4.3.2.3 Mental Health Measures 
Depressive symptoms were measured by the 10-item Edinburgh Postnatal Depression Scale 
(EPDS) at T1 and T2, with scores at or above 13 considered clinically significant (Cox et al., 1987; 
National Collaborating Centre for Mental Health, 2014).  The EPDS is a screening tool used 
internationally to detect depressive symptomatology in women during pregnancy and postnatal 
periods.  While validated for use in pregnancy and postnatally (Kozinszky & Dudas, 2015), the 
EPDS has not been used extensively beyond one year post birth.  For this reason, the 10-item 
Kessler (K-10, using a 0-4 Likert scale) was used to identify psychological distress at T3.  The K-
10 was developed for use in the US National Health Interview Survey and has been used in the 
annual New Zealand Health Survey since 2006-07 (New Zealand Ministry of Health, 2006) and 
the New Zealand Mental Health Survey since 2003/04, with scores of 12 or more strongly 
associated with having a depressive disorder in the previous month and in the previous year 
(Oakley Browne, Wells, Scott, & McGee, 2010).   
Even though depressive symptoms were assessed using different scales, both the EDPS and K-
10 cut-offs are recognised as indicating clinically significant depressive symptoms.  In the 
trajectory analysis described below, a binary variable (having clinically significant depressive 
symptoms or not) was used. 
4.3.3 Statistical analysis 
Latent Class Analysis (LCA) is an advanced statistical approach for identifying discrete subgroups 
of participants within a study cohort.  Classes (or groups) are not directly observable, they are 
dormant, hence the term latent (Roeder, Lynch, & Nagin, 1999).  LCA is similar to factor or cluster 
analysis, in that it classifies participants into mutually exclusive and exhaustive subgroups based 
on observed patterns in the data.  Furthermore, LCA is person-orientated rather than variable-
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orientated.  While variable-orientated approaches focus on identifying relationships between 
variables with the assumption that the relationships are stable across the sample, person-
orientated approaches identify groups of people that exhibit similar trajectories or 
characteristics with the number and type of classes not known a priori.  Although group and 
individual trajectories cannot be exactly identical, individuals follow approximately the same 
course as other individuals in their group (Nagin & Tremblay, 2005).  In line with the Kaupapa 
Māori epidemiological research principles applied in the Moe Kura cohort (Paine & Gander, 
2013), LCA were conducted for Māori and non-Māori women separately to determine if the 
number of classes and shape of trajectories differed between these populations. 
A two-step statistical approach was taken.  Firstly, patterns of clinically significant depressive 
symptoms were modelled at three time points using LCA (T1, T2 and T3) and subgroups of 
women with specific trajectories were identified.  Two and three group LCA models were fit and 
compared and included both linear and quadratic terms (given there were only three time 
points, no further orders beyond quadratic were included in models). Where the model could 
not be fit, due to a paucity of data, the models were condensed either to two groups, and/or to 
include only linear terms.  The optimal model was chosen using the Bayesian Information Criteria 
(BIC), with greater (less negative) absolute BIC values indicating a better model fit.  Parsimony 
and clinical interpretability were also taken into account (M. Zhou, Thayer, & Bridges, 2017).   
Class (trajectory group) prevalences and posterior probabilities were used to interpret the 
model, with prevalences providing the proportion of people belonging to a class and posterior 
probabilities reflecting the chance that an individual is correctly classified.   Individuals were 
assigned to each latent class with the highest posterior probability, with a figure above 0.80 
suggesting a good fit (Nagin & Tremblay, 2005).  Kruskall Wallis rank sum test (for proportions) 
and ANOVA (for means) were used to test for differences between the depressive symptom 
variables in each of the latent classes at each time point.   
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Complete case logistic regression was used to investigate the association between each sleep 
variable and the likelihood of membership in the trajectory groups at each time point.  We 
conducted univariate analysis between potential covariates and the outcome variable.  Being 
currently pregnant and having a younger child had no significant relationship with the outcome 
and were not included in the final models, which were adjusted for maternal ethnicity, maternal 
age, stressful life events, prior history of depression, NZDep and relationship with partner.  
Further adjusting for parity made no material difference to the results.  Data are reported as 
odds ratios (OR) and 95% confidence intervals (CI).  Analyses were performed in STATA (version 
15).   
4.4 Results 
4.4.1 Sample characteristics 
The study included 856 women (n=262 Māori women and n=594 non-Māori) who completed 
questionnaires at each of the three times points, representing 75% of the baseline cohort.  
Women who did not complete all data collection time points and were not included in the 
analysis were more likely to be younger (p=0.000), identify as Māori (p=0.000), live in a more 
deprived area (p=0.000), have more life stress (p=0.000), be unhappy with their partner 
relationship (p=0.004), and have higher depressive symptom scores (p=0.030) than women with 
complete data sets at T1.  No difference was seen for parity, a prior history of depression, or 
scoring at or above a cut-off of 13 on the EPDS. 
Sample characteristics are summarised in Table 4.1.  There was a significant difference (p=0.020) 
between Māori and non-Māori for parity, with 45.5% of Māori and 53.8% of non-Māori women 
being nulliparous (51.3% of the total cohort).  At T3, 35.1% of Māori and 38.7% of non-Māori 
had a child younger than their Moe Kura child and 10.7% of Māori and 9.7% of non-Māori were 
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currently pregnant (there were no statistical differences between these proportions).  As 
illustrated in Table 4.1, Māori women were younger, lived in more deprived areas, experienced 
more stressful life events and had a less happy relationship with their partner. 
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Table 4.1  Sample characteristics 
 
T1 T2 T3 
Mean & SD (range) or n (%) Mean & SD (range) or n (%) Mean & SD (range) or n (%) 
Māori non-Māori Total p value 
(M-nM) 
Māori non-Māori Total p value 
(M-nM) 
Māori non-Māori Total p value 
(M-nM)     
n = 262 n = 594 n = 856 n = 262 n = 594 n = 856 n = 262 n = 594 n = 856 
Maternal age 28.92 ± 6.23 32.41 ± 5.06 30.85 ± 5.68 0.000 
    
31.53 ± 6.23 35.21 ± 5.07 34.07 ± 5.71 0.000 
Gestational or child 
age£ 
35.91 ± 0.97 
(32-40) 
35.82 ± 0.85 
(34-40) 
35.85 ± 0.89 
(32-40) 
0.177 
12.05 ± 1.28 
(8-20) 
12.05 ± 1.18 
(6-20) 
12.05 ± 1.21 
(6-20) 
0.964 
3.14 ± 0.30 
(2.78-5.00) 
3.15 ± 0.27 
(2.55-4.94) 





127 (48.5) 162 (27.3) 289 (33.8) 0.000 150 (57.5) 174 (29.2) 324 (37.9) 0.000 150 (56.4) 205 (34.7) 355 (41.5) 0.000 
Relationship with 
partner# 
            
 
Happy 184 (76.0) 487 (82.5) 671 (80.6) 0.001 163 (66.5) 501 (85.9) 664 (80.2) 0.000 135 (51.7) 428 (73.8) 563 (66.9) 0.000 
 
Unhappy 46 (19.9) 97 (16.4) 143 (17.2) 
 
56 (22.90 76 (130 132 (15.9) 
 
84 (32.2) 125 (21.6) 209 (24.9) 
 
 
Not applicable 12 (5.0) 6 (1.0) 18 (2.2) 
 
26 (10.6) 6 (1.0) 32 (3.9) 
 
42 (16.1) 27 (4.7) 69 (8.2) 
 
NZDep quintiles^ 
            
 
1 (least deprived) 30 (11.5) 170 (28.7) 200 (23.4) 0.000 34 (13.0) 167 (28.2) 201 (23.5) 0.000 32 (12.6) 196 (34.4) 228 (27.7) 0.000 
 
2 31 (11.8) 143 (24.1) 174 (20.4) 
 
26 (9.9) 148 (25.0) 174 (20.4) 
 
34 (13.4) 149 (26.2) 183 (22.3) 
 
 
3 56 (21.4) 134 (22.6) 190 (22.2) 
 
58 (22.1) 131 (22.1) 189 (22.1) 
 
43 (17.0) 111 (19.5) 154 (18.7) 
 
 
4 66 (25.2) 87 (14.7) 153 (17.9) 
 
68 (26.0) 87 (14.7) 155 (18.1) 
 
49 (19.4) 66 (11.6) 115 (14.0) 
 
  5 (most deprived) 79 (30.2) 59 (9.9) 138 (16.1) 
 76 (29.0) 60 (10.1) 136 (15.9)  95 (37.5) 47 (8.3) 142 (17.3)  
£Gestational age at T1 & T2 measured in weeks and child age at T3 measured in years; #15, 28, 24 missing for Relationship with partner (T1, T2 & T3 respectively); 
^1, 1, 34 missing for NZDep Quintiles (T1, T2 & T3 respectively)
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4.4.2 Sleep and depression results 
Sleep and depressive symptom scores for Māori and non-Māori women are shown in Table 4.2.  
Twenty two percent of Māori women had clinically significant EPDS scores at T1 compared with 
14.5% of non-Māori women, a statistically significant difference.  This difference continued at 
T2 (11.9% Māori vs 6.8% non-Māori) and with K-10 scores at T3 (21.8% Māori vs 13.0% non-
Māori).  Mean scores on the EPDS was significantly different (T1 and T2) and the K-10 (T3) 
(p=0.001, p=0.047, and p=0.000) as was the proportion of women with a clinically significant 




Table 4.2 Sleep and depressive symptom scores for Māori and non- Māori at each timepoint 
 
T1 T2 T3 
Mean & SD or n (%) Mean & SD or n (%) Mean & SD or n (%) 
Māori Non-Māori Total p value  
(M-nM) 
Māori Non-Māori Total p value   
(M-nM) 
Māori Non-Māori Total p value 
(M-nM)     n = 262 n = 594 n = 856 n = 262 n = 594 n = 856 n = 262 n = 594 n = 856 
Duration#             
 Mean (hrs) 7.51 ± 1.94 7.26 ± 1.60 7.34 ± 1.71 0.050 7.79 ± 1.83 7.36 ± 1.20 7.49 ± 1.43 0.001 7.75 ± 1.44 7.33 ± 0.94 7.46 ± 1.14 0.000 
Quality$    
   
 






4.65 ± 1.59 4.73 ± 1.83 4.70 ± 1.75 0.518 3.75 ± 1.79 3.73 ± 1.85 3.74 ± 1.83 0.905 4.17 ± 1.75 4.29 ± 1.75 4.25 ± 1.75 0.387 
Daytime Sleepiness&    
   
 
   
 
 
 ESS Mean 7.63 ± 4.10 6.76 ± 3.78 7.03 ± 3.90 0.003 6.33 ± 4.02 5.80 ± 3.88 5.96 ± 3.93 0.069 5.25 ± 3.48 5.18 ± 3.45 5.20 ± 3.45 0.773 
Continuity^    
   
 




GSDS Maint. Insom. 
Subscale 
5.25 ± 1.57 5.25 ± 1.62 5.25 ± 1.60 0.995 3.45 ± 2.45 3.74 ± 2.29 3.65 ± 2.28 0.094 3.93 ± 1.90 4.19 ± 2.01 4.11 ± 1.98 0.075 
Onset Insomnia@    
   
 




GSDS Onset Insom. 
Subscale 
3.32 ± 2.49 2.39 ± 2.23 2.67 ± 2.35 0.000 1.56 ± 1.89 1.33 ± 1.60 1.40 ± 1.70 0.092 1.97 ± 1.85 1.52 ± 1.68 1.66 ± 1.74 0.001 
EPDS / K-10 Score"    
   
 
   
 
 
 Mean 8.80 ± 5.02 7.61 ± 4.71 7.97 ± 4.83 0.001 6.01 ± 4.70 5.49 ± 4.06 5.65 ± 4.27 0.047 7.65 ± 6.22 6.07 ± 4.91 6.56 ± 5.40 0.000 
  High (≥13) 57 (22.0) 86 (14.5) 143 (16.8) 0.007 31 (11.9) 40 (6.8) 71 (8.3) 0.015 57 (21.8) 77 (13.0) 134 (15.7) 0.002 
Missing data at T1, T2 & T3 respectively: #6 (T1), 12 (T2), 16 (T3); $8 (T1), 5 (T2), 7 (T3); &19 (T1), 16 (T2), 19 (T3); ^5 (T1), 3 (T2), 15 (T3); @2 (T1), 2 (T2), 9 (T3); "3 (T1), 3(T2), 0 (T3) 
GSDS=General Sleep Disturbance Scale, ESS=Epworth Sleepiness Scale, EPDS=Edinburgh Postnatal Depression Scale, K-10 Kessler Psychological Distress Scale (10-item) 
EDPS reported at T1 & T2, K-10 reported at T3 
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4.4.3 Identification of depressive symptom trajectories 
Across the entire sample two distinct depressive symptom groups, stable mild (SM) and chronic 
high (CH), were identified using LCA (Figure 4.1, Panel C).  The two-class model was selected for use 
due to statistical instability in fitting the three-class model, which is likely due to sparse data.  A 
quadratic term model had better fit and better mean posterior membership compared to a model 
with one linear and one quadratic group.  In the chosen model, average posterior probabilities (the 
chance of being correctly assigned to the trajectory group) for the CH group was 0.98 and SM group 
was 0.81.  In the model including the entire sample, 91.5% of women belonged to the SM group 
and 8.5% of women followed the CH trajectory.  Plots describe time across the horizontal axis while 
the probability of experiencing clinically significant depressive symptoms is presented on the 
vertical axis.  Results for the total sample showed that the probability of experiencing clinically 
significant depressive symptoms in the CH group was 80.4% at T1, 51.9% at T2 and 84.2% at T3 and 
the SM group was 10.8% at T1, 4.2% at T2 and 9.3% at T3. 
Table 4.3 details the median and inter-quartile range for the EPDS and K-10 scores for the total 
sample at the three time points, which shows significant between group differences at all-time 
points.  There were also within group differences found between T1-T2 (SM p=<0.001; CH p=<0.001) 
and T2-T3 (SM p=<0.001; CH p=<0.001) but not between T1-T3 (SM p=0.360; CH p=0.810). 
Table 4.3  Median and inter-quartile range for the EPDS (T1 & T2) and K-10 (T3) for the 
total sample, and separately for Māori and non-Māori 

















T1 8 (5-11) 16 (14-18) <0.0001 6 (4-9) 15 (14-16) <0.0001 7 (4-10) 15 (14-18) <0.0001 
T2 5 (2-8) 14 (10-16) <0.0001 4 (2-7) 8 (5-12) <0.0001 4 (2-7) 13 (10-16) <0.0001 
T3 6 (3-9) 16 (15-24) <0.0001 5 (2-7) 9 (5-14) <0.0001 5 (2-8) 15 (13-20) <0.0001 
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4.4.4 Depressive symptom trajectories for Māori and non-Māori 
LCA was applied to Māori and non-Māori women’s data separately.  Similar to the model for the 
total sample, two depressive symptom groups were revealed for each population, stable mild 
(SM) and chronic high (CH), as illustrated in figure 4.1 (Panel A & B).  Linear terms for the SM 
group and quadratic for the CH group proved a better fit than quadratic terms for both 
trajectories for Māori.  Quadratic terms for both groups were only slightly better for non-Māori 
(-614.5 vs -616.1), so for consistency, models with a quadratic term for the CH group and a linear 
term for the SM group were selected for use.  For Māori women, 90.3% of women belonged to 
the SM group and 9.7% of women followed the CH trajectory.  The probability of Māori women 
experiencing clinically significant depressive symptoms in the CH group was 99.6% at T1, 64.0% 
at T2 and 95.9% at T3 and the SM group was 13.6% at T1, 6.3% at T2 and 13.8% at T3.  For non-
Māori women, 80.1% of women belonged to the SM group and 19.9% of women followed the 
CH trajectory.  The probability of non-Māori women experiencing clinically significant depressive 
symptoms in the CH group was 59.5% at T1, 22.4% at T2 and 42.5% at T3 and the SM group was 
3.3% at T1, 2.9% at T2 and 5.6% at T3. 
Table 4.3 provides the median and inter-quartile ranges of EPDS and K-10 scores for both Māori 
and non-Māori at the three time points.  These also show significant between group differences 
at all time points.  Māori within group differences were seen between T1-T2 (SM p=0.019; CH 
p=0.001) and T2-T3 (SM p=0.016; CH p=0.001) but not between T1-T3 (SM p=0.900; CH p=0.990).  
Non-Māori intra-group differences were seen between T1-T2 (SM p=<0.001; CH p=<0.001), T2-
T3 (SM p=0.003; CH p=0.006) and T1-T3 for the SM group (SM p=<0.001) but not between T1-




Figure 4.1  Trajectories of depressive symptoms for the Māori and non-Māori and 
the total sample.  Data points measured at mean 36 weeks gestation, 
12 weeks postnatal and 3 years post birth. 
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4.4.5 Sleep variables associated with chronic high trajectory group 
The association between sleep dimensions and trajectory group membership was also 
investigated.  In these models, the sleep dimensions were modelled as continuous variables, so 
the odds ratios are interpreted as the likelihood of being in the CH group, per unit change in the 
sleep subscale (for example, at T1 every additional night per week a women reported difficulty 
getting to sleep, increased the odds of being in the CH group by 21%).  As can be seen in Table 
4.4, at all three time points, poorer sleep quality, reduced sleep continuity and latency and 
greater day time sleepiness increased the odds of being in the CH group.  After adjusting for age, 
ethnicity, partner relationship, history of depression and stressful life events, all associations 
remained significant, with the exception of daytime sleepiness at T3.  No association was found 











Table 4.4  Sleep variables associated with the CH trajectory group.  Adjusted for socio-demographic variables (age, ethnicity, relationship with 
partner, history of depression, NZDep and PRAMS SLEs) 
  n Crude OR 95% CI Adjusted OR 95% CI 
T1 (36 weeks gestation)      
Duration (24 hr TST) 822 0.96 0.83 to 1.12 0.92 0.78 to 1.07 
Quality (GSDS Quality Subscale) 820 1.30 1.11 to 1.53 1.27 1.06 to 1.52 
Continuity (GSDS Maint. Insom. Subscale) 823 1.35 1.12 to 1.62 1.35 1.12 to 1.63 
Daytime Sleepiness (Epworth Sleepiness Scale) 810 1.12 1.06 to 1.19 1.11 1.04 to 1.18 
Latency (GSDS Onset Insom. Subscale) 826 1.30 1.17 to 1.44 1.21 1.08 to 1.35 
T2 (12 weeks postnatal)      
Duration (24 hr TST) 813 0.99 0.82 to 1.18 0.93 0.77 to 1.13 
Quality (GSDS Quality Subscale) 821 1.35 1.17 to 1.57 1.32 1.12 to 1.55 
Continuity (GSDS Maint. Insom. Subscale) 823 1.13 1.01 to 1.26 1.12 0.99 to 1.26 
Daytime Sleepiness (Epworth Sleepiness Scale) 809 1.08 1.02 to 1.14 1.05 0.99 to 1.12 
Latency per unit (GSDS Onset Insom. Subscale) 823 1.35 1.20 to 1.52 1.28 1.12 to 1.46 
T3 (three years post birth)      
Duration (24 hr TST) 788 0.92 0.73 to 1.16 0.79 0.65 to 1.07 
Quality (GSDS Quality Subscale) 798 1.40 1.19 to 1.65 1.35 1.15 to 1.63 
Continuity (GSDS Maint. Insom. Subscale) 791 1.23 1.07 to 1.40 1.22 1.08 to 1.44 
Daytime Sleepiness (Epworth Sleepiness Scale) 787 1.06 0.99 to 1.14 1.05 0.97 to 1.13 




In this population sample, two distinct depressive symptom classes, ‘stable mild’ (SM) and 
‘chronic high’ (CH), were identified from late pregnancy to three years post birth for both Māori 
and non-Māori women.  The CH trajectory demonstrates that for a subsample of women, 
persistent depressive symptoms are experienced well beyond pregnancy and the early postnatal 
period.  In the full sample, 8.5% of women were identified as belonging to the CH class, with 
median scores on the EDPS and K-10 consistently at or above clinical cut-offs for depressive 
symptomology.  Specifically, a mother in the CH group, who has elevated depressive symptoms 
in late pregnancy will also have a very high probability of experiencing depressive symptoms 
three years post birth.   
Our previous work has shown that Māori women are more likely than non-Māori women to 
experience depression in pregnancy (Signal et al., 2016) and the present study adds to this by 
demonstrating that there is a group of Māori women who have a very high probability of 
experiencing clinically significant depressive symptoms from pregnancy through until their child 
is three years of age. This is in contrast to non-Māori women, who show a similar pattern of 
change but a lower probability of clinically significant depressive symptoms from pregnancy 
through to three years of age and lower median scores on the measures of depressive symptoms 
at T2 and T3, although the proportion of women in the non-Māori group is greater than the 
Māori women group.   
These results highlight the enduring nature of depression in perinatal women and suggest that 
mental health support and management in pregnancy and the years post birth are suboptimal 
for New Zealand women, particularly for Māori women given the severity and likelihood of 
persistent depressive symptoms found in the present study.  Fahey & Shenassa (2013) 
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emphasise the need to lengthen maternity care after childbirth as women are vulnerable to 
compromised health, due to the immense physical and psychosocial transition and decreased 
opportunities for self‐care related to the demands of new motherhood.  Verbiest et al. (2018) 
attributes poor maternal health to an infant-centric (and not mother-centred) approach, with 
focus placed on the birth, delivery and immediate postnatal period but not the years post birth.  
These authors appeal for an expanded continuum of care, before conception, throughout 
pregnancy, childbirth, adaption and recovery, and beyond.  Previous studies have revealed that 
mothers experiencing depressive symptoms in late pregnancy may be identified in early 
pregnancy (Skouteris, Wertheim, Germano, et al., 2009), providing an opportunity for novel 
interventions throughout pregnancy to help minimise persistent perinatal depressive 
symptoms.  Moreover, there is an urgent need for health care providers and policy advisors to 
raise awareness of the persistent nature and severity of depression past traditional perinatal 
timeframes and to advocate for quality primary care (including identification, referral and timely 
treatment) during pregnancy and the years beyond.   
In both Māori and non-Māori populations, depressive symptoms significantly improved at 12 
weeks postnatal.  It is not clear why this occurred, but it may be that the social and professional 
support available for mother and baby in the early perinatal period was of benefit, and/or that 
women place fewer expectations on themselves at this time and have fewer external 
obligations.  An alternative explanation is that based on their involvement in this study, they 
were receiving the necessary mental health support after being referred to their Lead Maternity 
Carer (LMC) or doctor if there was evidence of self-harm or elevated depressive symptoms in 
late pregnancy.    It should be noted however, that Māori women and their families have greater 
exposure to factors associated with depression and experience significant barriers to accessing 
high quality pregnancy and postnatal health care services (Makowharemahihi et al., 2014) and 
health care services in general (New Zealand Ministry of Health, 2008).  This could also be 
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reflected in the lack of difference found between Maori and non-Maori women in the reporting 
of depression history.  That Māori women remained in a chronic depressive symptom group at 
the three-year time point is of serious concern.  Further research is required to document the 
pathways to and through mental health care for Māori women.     
This is the first study to examine the association between depression trajectory classes and 
different dimensions of sleep.  The results extend findings from previous studies, supporting the 
association between sleep quality and depressive symptoms (S.-Y. Kuo et al., 2012; Tomfohr et 
al., 2015; Tzeng et al., 2015; G. Wang et al., 2018).  The current study also demonstrated that 
depressive symptoms were consistently associated with poor sleep quality, continuity, latency 
and daytime sleepiness at each time point and remained significant when adjusting for other 
factors related to depression.  Given that the ORs represent an increased risk of being in the CH 
group per unit change of sleep, these results demonstrate a strong association between sleep 
and mental health outcomes.  The analyses cannot address the causal or directional 
relationships between aspects of sleep and depressive symptoms.  However, this pattern of co-
occurrence supports evidence of the bi-directional nature of sleep and depression.  Thus, early 
pregnancy sleep health interventions may be beneficial for women and further studies are 
needed to investigate whether improving sleep (or indeed, keeping sleep stable over time) can 
minimise depressive symptoms, especially in the early stages of pregnancy. 
Strengths of our study are the large community sample with approximately one third of women 
identifying as Māori, the examination of multiple dimensions of sleep, and controlling for known 
predictors of depression.  The demographic characteristics of the participants in this study 
enhance the generalisability of our findings to a wider perinatal population.  The inclusion of 
measures of depressive symptoms in pregnancy expands the research on the course of maternal 
depression, given that the majority of other population-based samples have examined 
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trajectories across shorter time spans or the postnatal period only.  We also used a sophisticated 
statistical approach to focus on data driven and person–centred outcomes which allows a 
greater emphasis on individual and longitudinal patterns of depressive symptoms.  This is 
particularly important when investigating Indigenous populations, as total population analysis 
can potentially mask inequities concealed in the data.  Posterior probability for each trajectory 
group was high as was the clear separation of classes further supporting the analytical approach 
we have taken. 
Despite the large sample and the longitudinal data, there are several limitations to this study. 
Due to the large sample size, depressive symptoms were assessed using well validated self-
report measures and not clinical interview, so it is unclear how many of these women were 
experiencing clinically diagnosable depression or were receiving antidepressant medication.  
However, this study used cut-off scores on the EPDS and K-10 which are considered to indicate 
major or probable clinical depression, rather than just mild, transient or possible depression 
(Cox et al., 1987; Fellmeth et al., 2019; Khanlari, Barnett Am, Ogbo, & Eastwood, 2019).  The 
EPDS includes an item regarding changes in sleep and this item was included in the analysis of 
this scale to enable standard cut-off scores to be utilised and may have slightly increased the 
scores of some women.  Furthermore, some studies investigating optimal cut-off scores on the 
EPDS have suggested a higher cut-off score in pregnancy (Matthey et al., 2006) although this is 
not universally supported.   The sub-group used in the analyses presented here differed in some 
respects to those who did not have complete data.  However, the proportion of women 
experiencing clinically significant depressive symptoms did not differ between the groups and 
this was the variable used to determine trajectories.  The study only used three time points, so 
we are not able to comment on the course of depressive symptoms between time points, 
specifically during the long period of time between three months and three years postnatal, 
which may be why our analyses support a two-class model.  Follow-up periods are a critical 
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dimension in determining the number of trajectory groups, thus if we had more data time 
points, the classes may have split into sub-groups following divergent trajectories (Nagin & 
Tremblay, 2005).  Furthermore, we do not currently have data past three years post birth, so 
cannot comment on depressive symptoms trajectories past this time.  However, three 
depression trajectory studies have identified groups of mothers with increasing depressive 
symptoms in the child’s preschool years (Hammerton et al., 2015; Matijasevich et al., 2015; Van 
Der Waerden et al., 2015).  Thus, more studies with additional timeframes within and beyond 
three years and that include Indigenous women would be valuable.  We did not control for 
women receiving behavioral or pharmacological treatment for depression, which could have 
altered the natural course of symptoms, or led to misclassification. 
To our knowledge, this is the first study investigating depressive symptoms throughout the 
extended perinatal period and the association with multiple dimensions of sleep.  Notably, 
persistent patterns of depressive symptoms occurred concurrently with poor sleep at distinct 
time points from late pregnancy to three years post birth.  Given the well described impact of 
maternal depression on the mother, child and community, this highlights the importance for 
healthcare professionals to ask about and assess mothers sleep quality, continuity, latency and 
daytime sleepiness as potential indicators for depressed mood beyond the perinatal period.  
These results are congruent with much of the literature on maternal depression trajectories and 
add to the mounting evidence on the relationships between sleep and depression.  In addition, 
the study includes important findings on the specific aspects of sleep involved.  Mothers with 
poor sleep are at risk of experiencing chronic depressive symptoms.  Given the higher incidence 
and more pervasive nature of depressive symptoms in Indigenous Māori women, priority should 
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5 SLEEP HAPI: A FEASIBILITY AND DESCRIPTIVE ANALYSIS OF 
AN EARLY AND LONGITUDINAL SLEEP EDUCATION 
INTERVENTION FOR PREGNANT WOMEN  
Study 2 (discussed in Chapter 4) examined trajectories of depressive symptoms from late 
pregnancy until three years post birth, and whether these trajectories were associated with 
different dimensions of sleep health.  This provides new information on longitudinal patterns of 
depressive symptoms for Indigenous Māori and non-Māori women.  
Results from the longitudinal analysis revealed two distinct trajectories: 
• ‘Chronic high’ - A group of women with elevated depressive symptoms from late 
pregnancy through until three years post birth.  
• ‘Stable low’ - A group of women with minimal or no depressive symptoms from late 
pregnancy through until three years post birth. 
Māori women in the chronically depressed group, also had a much greater probability of 
experiencing depressive symptoms at each timepoint compared to non-Maori women.    
Poorer sleep quality, reduced sleep continuity, increased sleep latency and greater day time 
sleepiness) were consistently associated with clinically elevated and persistent depressive 
symptoms for women throughout the perinatal period and into their child’s preschool years.   
Two key findings from Studies 1 and 2 contributed to the design, development and application 
of Study 3, a pilot sleep intervention for pregnant women.  Firstly, that multiple dimensions of 
poor sleep are associated with depressive symptom trajectories (Study 2); and secondly, that 
women who have good physical and mental health in pregnancy are also likely to have sufficient, 
good quality sleep that remains stable throughout pregnancy (Study 1).  This pilot sleep 
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education intervention aimed to determine whether providing women who had a prior history 
of depression information on the expected changes to sleep dimensions across pregnancy and 
strategies and advice to assist them optimise and/or stabilise their sleep throughout pregnancy, 
could alter their likelihood of being in the ‘chronic high’ depressive trajectory group.   
Chapter 5 and 6 both report the findings from Study 3; Chapter 5 presents and discusses the 
feasibility and acceptability of the pilot study, while the efficacy is detailed in Chapter 6.  Study 
results from these two chapters were also disseminated to participants as a summary brochure 
that the researcher prepared (Appendix 27).  
The following manuscript was prepared by the researcher (Appendix 30) and was published in 
the journal Behavioural Sleep Medicine in June 2020.  All rights reserved© Ladyman, C. I., Gander, 
P. H., Huthwaite, M., Sweeney, B. S. & Signal, T. L. 
 
5.1 Abstract 
Background:  Poor sleep and prior depression are key predictors of perinatal depression, with 
research suggesting depressive symptoms may emerge in early pregnancy.  Sleep is a potentially 
modifiable risk factor for depression.  This pilot study examined the feasibility and acceptability 
of a six-month sleep education intervention designed to optimise sleep and minimise depressive 
symptoms throughout pregnancy.  Sleep measures and depressive symptoms are described 
from 12 weeks gestation to 12 weeks postpartum. 
Participants: A community sample of nulliparous pregnant women with a history of depression 
were recruited prior to 14 weeks gestation.    
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Methods:  An individualised sleep education program was developed, and participants engaged 
in three trimester specific sleep education sessions.  Feasibility and acceptability were 
determined via recruitment and retention rates and participant feedback.  Depressive 
symptoms and sleep were measured at five time points throughout the study.   
Results:  22 women enrolled in the study and 15 completed the intervention.  Participants 
reported the intervention as highly acceptable.  There was minimal change in all dimensions of 
sleep across pregnancy, but sleep measures were significantly worse at six weeks postpartum 
and improved by 12 weeks postpartum.  Depressive symptoms were significantly lower at the 
conclusion of the intervention and 12 weeks postpartum compared to trimester 1.   
Conclusions:  This sleep education program appears feasible, acceptable and may be effective 
in minimising depressive symptoms in pregnant women with a history of depression.  Trials with 
larger and more diverse samples are warranted and further studies to ascertain efficacy should 
be undertaken with a control group. 
Keywords:  Sleep, depression, pregnancy, trimester, intervention 
5.2 Introduction 
Having a baby is often perceived as a positive and celebrated life event for most women, but not 
for all.   One in five women will experience significant depressive symptoms during pregnancy 
(Marcus et al., 2003; Yonkers, Wisner, et al., 2009) and the negative individual and societal 
impacts of perinatal depression are extensive, both in the short and long term (Stein et al., 
2014).  These include maternal suicide (Oates, 2003), adverse pregnancy, birth and infant 
outcomes (Accortt, Cheadle, & Dunkel Schetter, 2014; Stein et al., 2014), and difficulties in 
establishing the mother-infant relationship (Campbell et al., 2004; Hairston et al., 2016).  Long 
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term impacts include poorer cognitive development and behavioural problems in the child 
(Bernard-Bonnin, 2004) as well as greater risk of future depressive episodes for both the mother 
and child (Luoma, Korhonen, Salmelin, Helminen, & Tamminena, 2015; Pearson et al., 2013).   
A history of depression is the most consistent predictor of perinatal depression (Faisal-Cury & 
Menezes, 2012; Jeong et al., 2013).  Poor sleep is also a consistent predictor of perinatal 
depression and with profound physiological, psychological and hormonal changes occurring in 
pregnancy, sleep disruption is experienced by a majority of pregnant women (Howe et al., 2015; 
Mellor et al., 2014).  There is considerable evidence that sleep and depression are linked in 
pregnancy (Peterson & Benca, 2008) and likely share a reciprocal causal relationship (Fang, Tu, 
Sheng, & Shao, 2019).  This relationship has been established across all perinatal time points, 
with cross-sectional and longitudinal studies demonstrating that insufficient and poor sleep 
quality is associated with elevated depressive symptoms at the same time point (Jomeen & 
Martin, 2007; Sattler et al., 2017).  Additionally, poor sleep in early pregnancy predicts 
worsening depressive symptoms in later pregnancy (Eichler et al., 2019; Skouteris, Wertheim, 
Germano, et al., 2009) and poor sleep in late pregnancy presents an increased risk of postpartum 
depression (Tomfohr et al., 2015; Wolfson et al., 2003).  Only a few studies have investigated 
depression in early pregnancy and these show an increased vulnerability in the first trimester 
compared to later in pregnancy (Fan et al., 2009; Teixeira, Figueiredo, Conde, Pacheco, & Costa, 
2009; Truijens et al., 2017) and for women who become depressed early in pregnancy, an 
increased risk of postpartum depression (Skouteris, Wertheim, Rallis, Milgrom, & Paxton, 2009; 
Truijens et al., 2017). 
The first trimester is a window of opportunity to predict and prevent many pregnancy 
complications (Poon et al., 2018) including the early detection of both poor sleep and depressive 
symptoms.  Early detection is important but even more so are effective interventions to improve 
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sleep, being one of only a few modifiable risk factors for depression (Franzen & Buysse, 2008).  
This is highly pertinent for women seeking non-pharmacological, inexpensive and non-invasive 
health interventions in pregnancy.    
This research uses a novel sleep education intervention for pregnant women, called Sleep HAPi 
(Sleep Health and Pregnancy Information) which gives women the opportunity to  understand 
and improve their sleep health.  This intervention was developed by the researchers and aimed 
to: 1) establish the feasibility of recruiting women in the first trimester of pregnancy and 
maintaining their involvement through to late pregnancy; 2) ascertain the use and acceptability 
of this sleep education program during pregnancy; and 3) describe the changes in the 
participants’ sleep health and depressive symptoms throughout pregnancy and early post-
partum period.  The intervention incorporates the ‘Sleep Health’ principles identified by Buysse 
(2014), which considers sleep as a multidimensional model that “promotes physical and mental 
well-being”, described through measures of quality, duration, continuity, timing and daytime 
sleepiness.   
5.3 Methodology 
5.3.1 Study design 
The Sleep HAPi pilot study covered six time points: Pre-pregnancy (PP), pregnancy (T1=trimester 
1; T2=trimester 2; T3=trimester 3) and postpartum (P1=six weeks postpartum; P2=12 weeks 
postpartum) (see figure 5.1).  Collection of pre-pregnancy data was retrospective, and these 
data are not reported here.  Questionnaires, completed in the participants own time, collected 
sleep (all time points) and mental health data (T1, T2, T3, P1 and P2) at a defined gestational or 
postpartum week. Actigraphy was used to obtain sleep data at T1, T2 and T3.  Three sleep 





Women were recruited from the Greater Wellington area or Palmerston North, New Zealand 
through advertisements in medical centres, midwifery clinics, mental health clinics, hospitals, 
parent and community centres, libraries, schools, crèches/kindergartens, supermarkets, 
community fairs, and various social and traditional media channels.  Presentations were also 
given to hospital staff, midwifery groups, continuing medical education (CME) workshops and 
fertility clinics to encourage medical professionals to refer patients/clients.    
Eligible participants had a history of previously diagnosed depression but were currently non-
symptomatic and had been medication-free for at least three months prior to study enrolment.  
They were at or less than 14 weeks pregnant, nulliparous, had a singleton pregnancy and were 
at least 16 years of age and proficient in English.  They were also required to have a primary 
health care provider and no children under three years of age living in the home.  Participants 
were excluded if they had a diagnosed sleep disorder, medical condition or mental health 
disorder (other than depression) known to be associated with sleep abnormalities. 




Written consent was obtained prior to study commencement and ongoing consent and 
screening for symptoms of depression was completed at each time point.  As required for ethical 
approval, a protocol was in place for participants reporting elevated depressive symptoms or 
thoughts of self-harm, which included women providing consent for the researchers to notify 
their doctor or lead maternity carer (LMC).  Women received a $50 gift card at the end of the 
pregnancy component and a further $20 gift card at the conclusion of the study. 
At study commencement the participants filled out a retrospective pre-pregnancy sleep 
questionnaire and received instructions on using the actigraph and sleep diary.  At T1, T2 and T3 
participants completed further questionnaires and their sleep was recorded and assessed using 
actigraphy and sleep diaries over seven nights.  Actigraphs, diaries and questionnaires were 
either delivered by the researcher (to home or work addresses) or provided at education 
sessions.  Analysed actigraphy and questionnaire data were presented to the participant at the 
education sessions (see below for details).  Immediately after the education sessions, a further 
seven days of actigraphy data and sleep diary recordings were collected.  At P1 and P2, only 
sleep and mental health questionnaires were completed were completed (using post and reply-
paid envelopes).  The first education session (T1) was 60-90 minutes in duration and sessions at 
T2 and T3 lasted 45-60 minutes.  
At the completion of the pregnancy component of the study, participants filled out a feedback 
questionnaire, requesting information on their sleep knowledge, the structure, content and 





5.3.4 Sleep education sessions 
Sleep HAPi is a sleep education package developed by the study researchers that incorporated 
three main sleep topics: 1) general sleep and circadian information; 2) how and why sleep 
changes in each trimester of pregnancy; and 3) trimester specific strategies to improve sleep.  
Printed information was presented in a folder that allowed subsequent trimester information 
and actigraphy printouts to be progressively added, creating a comprehensive and personalised 
‘Sleep in Pregnancy’ booklet (52 pages in total).  After each education session, women were 
encouraged to refer back to the booklet and share with their family/social supports.  To ensure 
consistency, one researcher performed all communication using standardised checklists and 
letters/emails.  The same researcher also presented education sessions in a standardised 
format, guided by the education booklet.  
The aim of the educational information was to increase women’s understanding of the benefits 
of good sleep and consequences of poor sleep, practices and factors that promote or hinder 
sleep, ‘normalise’ the sleep changes experienced in pregnancy and to improve overall sleep 
health.  There was no expectation that all of the information and advice would be used by all 
women, rather that they would have a ‘tool kit’ of knowledge they could use when necessary.  
All meetings and education sessions were scheduled at times and places convenient to the 
women (homes, cafés, community libraries, university meeting spaces), and were one-on-one 
and face-to-face. 
5.3.5 Measures 
The participants completed paper-based questionnaires, previously used in the “E Moe, Māmā: 
Maternal Sleep and Health in Aotearoa/ New Zealand” pregnancy and postpartum studies, 
(Signal et al., 2016) which asked participants about their sleep, mood and general health.   
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5.3.5.1 Sleep measures 
Actigraphy and sleep diary - Objective sleep was recorded using a wrist-worn Micro-
Motionlogger actigraph (Ambulatory Monitoring, Inc., Ardsley, NY, USA).  Actigraphy provides a 
long-life, light-weight, non-invasive, objective measure of sleep that has been validated against 
polysomnography (PSG) (Kosmadopoulos et al., 2014; Marino et al., 2013).  The actigraph was 
worn continuously for seven nights on the non-dominant wrist, recording movement in one-
minute epochs.  Participants were instructed to press the event marker at the start and end of 
attempted sleep periods.  Data were analysed using Action-W (Version 2.7; Ambulatory 
Monitoring, Inc) software using the Cole Kripke algorithm.  Each woman was also asked to record 
sleep, wake and removal of the watch in a sleep diary, based on previous studies used in this 
research group (Signal et al., 2007) and The Core Consensus Sleep Diary (CSD) (Carney et al., 
2012).   
Sleep quality - Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a 19-
item measure of sleep quality over the past month, yielding a total score ranging from 0 to 21 
with higher scores indicating poorer sleep quality (Buysse et al., 1989).  In differentiating good 
and poor sleepers, a global PSQI score >5 has a sensitivity of 89.6% and a specificity of 86.5% 
(Buysse et al., 1989). This cutoff has been validated in a pregnant population investigating 
associations between sleep and mood (Qiu et al., 2016).  In addition, the question “In the last 
week, how often did you get a good night’s sleep?” was dichotomised into good (>3 nights a 
week) or poor (≤3 nights a week) (Howe et al., 2015). 
Sleep duration - Sleep duration was measured by self-reported nighttime sleep duration (TST) 
and actigraphic TST in each sleep period, calculated as the number of minutes of sleep from the 
first 10 consecutive minutes scored as sleep by the software algorithm, until final wake-up (Tsai 
et al., 2011). 
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Sleep timing - The midpoint of sleep was calculated from actigraphically determined weekday 
and weekend bedtimes and wake times, and from self-reported items in the Munich Chronotype 
Questionnaire (Roenneberg, Wirz-Justice, & Merrow, 2003).  Weekday midsleep was subtracted 
from weekend midsleep to calculate the ‘Midsleep Difference’ and used as both a continuous 
and a categorical variable (0-60mins, 61-120mins, and 120+ mins) (Levandovski et al., 2011; 
Wittmann et al., 2006). 
Sleep continuity - Sleep continuity was measured by the General Sleep Disturbance Scale (GSDS) 
Maintenance Insomnia Subscale which includes the items; “How often in the last week did you 
wake up during your sleep period?” and “How often in the last week did you wake up too early 
at the end of your sleep period?”  Items were rated from 0 (never) to 7 (every day) and the mean 
calculated (K. A. Lee & Gay, 2004).  
Daytime sleepiness - Daytime sleepiness was measured using the Epworth Sleepiness Scale 
(ESS).  The ESS assesses daytime sleepiness in eight everyday situations using the question “How 
likely are you to doze off in the following situations, in contrast to feeling just tired…?”  The ESS 
has been deemed reliable and valid for use in pregnant populations (Baumgartel et al., 2013) 
and excessive daytime sleepiness is typically defined as a total score ≥ 10 (Johns, 1991). 
Additional sleep measures - Additional sleep measures including the Insomnia Severity Index 
(ISI), total GSDS score, reasons for awakenings; getting a comfortable sleep position, frequency 
of napping, frequent snoring, frequent breathing pauses, frequent leg twitching and Restless 




5.3.5.2 Depression symptom measures 
Depressive symptoms were measured using the Beck Depression Inventory (BDI-II) (Beck et al., 
1996) and the Edinburgh Postpartum Depression Scale (EPDS) (Cox et al., 1987).  The EPDS is a 
ten-item screening tool used internationally to detect depressive symptomatology and has been 
validated for use in pregnancy and the postpartum (Kozinszky & Dudas, 2015), although it is not 
widely utilised in early pregnancy.  Women selected a response that described how they felt 
over the past seven days on ten items. 
The BDI II (Beck et al., 1996) is also widely used to screen for depression in the perinatal period, 
however, there is some concern about false positives due to pregnancy symptoms mimicking 
somatic symptoms associated with depression (Čuržik & Begić, 2012). Others argue that the 
occurrence of such somatic symptoms during pregnancy is important for mental state and 
question the EPDS’s inability to detect these symptoms (Yonkers, Smith, Gotman, & Belanger, 
2009), as women with a higher EPDS scores have been shown to present with greater somatic 
complaints (Apter et al., 2013).   
5.3.5.3 Demographic measures  
Participants provided information on age, gestational age, parity, ethnicity, health status, 
education, height and weight to compute body mass index (BMI), current work commitments, 
status of partner relationship, alcohol and drug intake, and time since last depressive episode.  
Stressful life events were drawn from the 13-item Pregnancy Risk Monitoring System (PRAMS) 
survey questions (Shulman, D'Angelo, Harrison, Smith, & Warner, 2018), used to assess women’s 
experience of traumatic, emotional, financial and partner related stressors in the past year.  
Women with higher levels of stressors (two or more) have been shown to have higher adjusted 
odds of postpartum depression symptoms (Mukherjee et al., 2017). 
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5.3.5.4 Acceptability measures 
Questions used to measure usability and acceptability of the intervention included; knowledge 
of sleep prior to commencing the study, helpfulness of the information received and ease or 
difficulty of the study components.  There were additional questions that covered the readability 
and understandability of the information as well as session format and timing.  Women were 
also able to answer open ended questions about key learnings and their overall experience. 
5.3.6 Statistical analysis 
Descriptive statistics (means, standard deviations, proportions) were calculated in SPSS (version 
25, IBM SPSS Statistics for Windows, Armonk, NY).  As no differences were found between the 
first and second actigraphy weeks in each trimester these weeks were averaged.  Changes to 
sleep or depressive symptoms over time were assessed using linear mixed models in SAS 
(version 9.4, SAS Institute Inc., Cary, NC).  The Kenward-Roger adjustment was applied to the 
degrees of freedom estimation (Littell et al., 2007).  Normality, linearity and constant variance 
assumptions were visually checked and the Shapiro-Wilk test used to assess the distribution of 
the residuals (Tabachnick & Fidell, 2012).  Where outlying residual values were identified, the 
model was re-run without the outlier(s).  If removing the outlier(s) altered the findings of the 
model, the reported results exclude the outlier(s), otherwise the results are reported including 
the outlier(s).  Post-hoc tests were used to investigate comparisons of interest where main 
effects were statistically significant.  Bonferroni’s adjusted p-values were calculated for post-hoc 
tests. A p-value of <0.05 was considered significant. 
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5.3.7 Ethical approval 
The study was approved by the Massey University Human Ethics Committee:  Human Ethics 
Southern A Committee (SOA 16/29).    It was reviewed and registered with the Australian and 
New Zealand Clinical Trials Registry (ACTRN12617000055303).   
5.4 Results 
5.4.1 Participants 
Over a 12-month period from February 2017 to February 2018, 53 women responded to the 
recruitment advertisements. Twenty-two were screened and accepted into the study.  Six 
withdrew and one was excluded, resulting in 15 participants completing the study (see figure 
5.2). 
Participants ranged from 28 to 34 years of age.  All were of New Zealand European ethnicity, 
had a history of depression, did not report smoking nor recreational drugs consumption 
throughout the study and were not employed in shift work.  Five women had required assisted 
reproductive technology (ART) to become pregnant, four had previously miscarried and for 13 




One had finished secondary schooling while 14 were tertiary qualified.  Two thirds had a  
household income of $100,000 or more and the other third ranged from $50,000 to $100,000, 
indicating that the majority of women in this study were financially advantaged.  Pre-pregnancy 
BMI calculations categorised 11 in the healthy, two in the overweight and two in the obese 
weight ranges.  Mean age was 31.47 years (SD ± 5.19) at study commencement.  Four women 
had experienced some depressive symptoms three to 12 months prior to becoming pregnant, 
four had experienced symptoms between one and three years ago and seven women had not 
experienced any symptoms for over three years (mean 6.18 ± 6.12 years).  A family history of 
mental illness was reported by 13 women, of which seven had multiple family members, 
spanning at least two consecutive generations.  Five women also reported that female family 
members experienced either antepartum or postpartum depression.  Additional characteristics 
that altered over the study period are summarised in Table 5.1. 
Figure 5.2  Recruitment and retention flow diagram. 
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Table 5.1  Sample characteristics 












Age           
Gestational Age (wks) 11.50 ± 1.55 23.07 ± 1.05 36.13 ± 0.51     
Baby's Age (weeks)       7.01 ± 0.78 12.29 ± 0.46 
Health Status           
Fair/Poor 0 (0) 2 (13) 2 (13) 1 (7) 1 (7) 
Good or better 15 (100) 13 (87) 13 (87) 13 (93) 13 (93) 
Work Commitments           
Currently Working 15 (100) 15 (100) 7 (47) 0 (0) 1 (7) 
Currently on Paid 
Maternity Leave 
0 (0) 0 (0) 8 (53) 14 (100) 13 (93) 
Hours of Work#  36.67 ± 10.49 38.63 ± 11.32 39.07 ± 1.64 0 (0) 10 ± 0.00 
Relationship with partner           
Happy 12 (80) 12 (80) 13 (87) 10 (71) 10 (71) 
Unhappy 2 (13) 2 (13) 1 (7) 3 (21) 3 (21) 
Not Applicable 1 (7) 1 (7) 1 (7) 1 (7) 1 (7) 
PRAMS           
Highscorer (≥2) 5 (33) 6 (40) 6 (40) 4 (29) 2 (14) 
Alcohol Frequency           
Never 15 (100) 15 (100) 15 (100) 8 (57) 6 (43) 
Less than once a week 0 (0) 0 (0) 0 (0) 5 (36) 6 (43) 
Once every 3-7 days 0 (0) 0 (0) 0 (0) 1 (7) 2 (14) 
Once every 2 days 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Daily 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Alcohol Volume           
None 15 (100) 15 (100) 15 (100) 8 (57) 5 (36) 
Less than 2 drinks 0 (0) 0 (0) 0 (0) 6 (43) 8 (57) 
More than two drinks 0 (0) 0 (0) 0 (0) 0 (0) 1 (7) 
Results reported as mean & SD or n (%) 
# of those working 
 
5.4.2 Recruitment and retention 
Complete data sets were analysed for 15 women during pregnancy (68% retention rate) and 14 
in the postpartum period (64% retention rate).  All questionnaires, education sessions and 
actigraphy were completed except for one woman who did not complete her second trimester 
sleep education session due to work travel (99.7% completion rate).   
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5.4.3 Intervention acceptability 
While many women claimed a reasonable knowledge of sleep in general, few considered they 
had knowledge of their own sleep, trimester changes to sleep or sleep strategies prior to the 
intervention (figure 5.3a).  Most found the information covered in the education sessions either 
‘really’ or ‘quite’ helpful (figure 5.3b).  And that various components of the study were easy to 
manage, with the exception of remembering to ‘press the event maker’ on the actigraph (figure 
5.3c). 
Figure 5.3  Panel A: Participants sleep knowledge prior to starting the intervention; 
Panel B: Level of helpfulness of information received in the 
intervention; Panel C: Ease or difficulty of the study components 
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All participants endorsed that contact once per trimester was ideal and while the overall time 
commitment was also found to be ideal, one third said they could have dedicated more time to 
the study.  Over two thirds of women preferred having the researcher guide them through the 
material and although the remaining third said they could have understood the material on their 
own, they noted similar comments to “you get more out of it when someone else explains it to 
you”.  Over one third of the women stated they were not expecting their sleep to change 
throughout pregnancy, but all confirmed their sleep had changed, with six women saying their 
sleep changed a lot and nine saying it had changed a little.  
A majority of women reported benefits from participation in the intervention, stating that they 
‘definitely’ understood their sleep better (93%), ‘definitely’ had a positive experience (86%) and 
would ‘definitely’ recommend the study to others (86%).  Three quarters of the women said that 
what they learnt about sleep would ‘definitely’ be useful in the future and that the benefits of 
the study ‘definitely’ outweighed the burden. 
When asked about the most helpful thing they had learned, over a third of women said 
consistency in sleep timing between weekends and weekdays.  Other key learnings were 
understanding sleep changes during pregnancy, safe sleeping positions, napping advice, 
understanding sleep architecture, keeping the bedroom dark, cool and quiet, and managing 
sleep stress.  Comments such as “My sleep is better than I thought”, or “My sleep is quite normal” 
were also common.  Notably an email received from a participant’s midwife who stated, “*** 
had a great birth a week ago and was listing taking part in your study as one of several 
contributing factors that kept her positive and able to cope”, indicating the benefits of 
participating in the study. 
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5.4.4 Sleep characteristics 
Descriptive statistics for measures of sleep quality, duration, continuity, timing and daytime 
sleepiness, across all time points, are presented in Table 5.2. 
 
Table 5.2  Descriptive results of sleep and depressive symptom measures 












Sleep Duration           
Self-report (hrs) 7.47 ± 1.48 8.07 ± 1.19 7.37 ± 0.93 5.75 ± 1.85 6.86 ± 1.49 
Actigraphy (hrs) 7.87 ± 1.19 7.90 ± 0.88 7.59 ± 1.08     
Sleep Quality           
PSQI Total 7.27 ± 3.34 5.87 ± 2.20 6.93 ± 2.15 9.50 ± 3.84 7.43 ± 3.48 
PSQI ≥5 11 (73) 9 (60) 14 (93) 12 (86) 11 (79) 
Good night's sleep (per week) 3.67 ± 2.32 4.27 ± 1.53 3.33 ± 1.18 1.71 ± 2.27 2.71 ± 2.13 
Good night's sleep (Good >3 
nights/wk) 8 (53) 10 (67) 5 (33) 4 (29) 5 (36) 
Daytime Sleepiness           
ESS Total 7.20 ± 4.23 6.80 ± 3.80 6.07 ± 3.90 8.71 ± 5.25 4.93 ± 4.39 
ESS High scorer (≥10) 5 (33) 4 (27) 3 (20) 8 (57) 3 (20) 
Sleep Continuity           
GSDS Maintenance Insomnia 
Subscale 4.86 ± 1.56 4.23 ± 1.53 4.80 ± 1.42 6.29 ± 1.12 5.07 ± 2.40 
Sleep Timing           
Self-report (hrs) 57.00 ± 36.66 39.40 ± 26.26 34.46 ± 32.97 54.91 ± 44.06 40.23 ± 34.74 
Actigraphy (hrs) 41.57 ± 29.15 41.83 ± 26.81 30.00 ± 22.35     
BDI II Score           
Total 10.80 ± 3.84 10.00 ± 6.48 7.33 ± 2.66 11.00 ± 3.53 7.64 ± 4.94 
Highscorer (≥13) 4 (27) 4 (27) 0 (0) 4 (29) 2 (14) 
EPDS Score           
Total 7.47 ± 4.10 7.47 ± 5.00 5.67 ± 3.37 7.14 ± 4.04 5.21 ± 3.38 
Highscorer (≥13) 1 (7) 2 (14) 0 (0) 2 (14) 1 (7) 




5.4.4.1 Sleep duration  
Sleep duration measured either by actigraphy (F(4,54)=19.44; p=<0.0001) or self-report 
(F(4,24)=4.26; p=0.0259) varied significantly over time, though post hoc analyses of self-reported 
duration showed no differences in pregnancy.  Self-reported TST at P1 was significantly shorter 
than at all other time points and sleep was significantly shorter at P2 compared to T2 (Figure 
5.1, panel C).  Post hoc analysis of actigraphic TST data showed sleep duration at T3 was 
significantly shorter than at T2 (p=0.0086), but not compared to T1 (p=0.1255).  Sleep durations 
measured using actigraphy were not significantly different to subjective sleep durations at any 
time point in pregnancy.  
5.4.4.2 Sleep quality 
Sleep quality variables also varied significantly across the study; for PSQI (F(4,53)=6.13; p=0.0004) 
and GNS (F(4, 54)=6.03; p=0.0004).  Post hoc analyses for both measures showed that differences 
occurred in the postpartum, and not throughout pregnancy, with sleep quality at P1 significantly 
worse compared to all trimesters of pregnancy (Figure 5.1, panel A & B).  The proportion of 
women reporting >3 good nights sleep in the last week also decreased between T2 and P2.    
5.4.4.3 Sleep continuity 
Sleep continuity, as measured by the GSDS Maintenance Insomnia Scale (F(4, 54)=4.15; p=0.0053) 
varied significantly across the study, with post hoc analyses showing a significant decrease 
between T2 and P2 (p=0.0022) (Figure 5.1, panel D).    
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5.4.4.4 Daytime sleepiness 
Sleepiness, as measured by the ESS, (F(4,54)=4.08; p=0.0058), varied across time points, but post 
hoc analyses only found an improvement in daytime sleepiness between P1 and P2 (p=0.0033) 
(Figure 5.1, panel F).   
5.4.4.5 Sleep timing 
Self-reported midsleep difference (F(4,47)=1.98; p=0.0389), varied significantly across the study, 
but none of the post hoc analyses reached significance.  No significant effect of time was seen 
for actigraphically measured midsleep difference (Figure 5.1, panel E).   
5.4.5 Depressive symptoms 
Descriptive statistics across all time points are presented in Table 5.2.  At T1, BDI II scores ranged 
from 4-19, while at T3 scores ranged from 3-12.  Four women who experienced clinically relevant 
depressive symptoms at T1 had non-clinical scores by T3. Nine of the remaining ten women also 
saw reductions in BDI II scores over this time period.  BDI II scores (but not EPDS scores) changed 
across the study (F(4,52)=2.40; p=0.0013).  As illustrated in Figure 5.1, panel G, post hoc pairwise 
comparisons revealed multiple significant differences among BDI II scores, notably a decrease 






Figure 5.4  Linear mixed model sleep and depressive symptom results throughout 
pregnancy (T1 (trimester 1), T2 (trimester 2), T3 (trimester 3)) (n=15) and 





To our knowledge, this is the first prospective study to determine the feasibility of a longitudinal 
sleep education program throughout pregnancy, following nulliparous pregnant women with a 
history of depression and using both multi-dimensional objective and subjective sleep and 
mental health measures.  The 22 women who were eligible to enrol all participated in the study 
and retention rates were 68% and 64% for pregnancy and the postpartum period respectively.  
Notably, four of the seven women that withdrew or were excluded from the study did so for 
reasons outside their control (i.e. miscarriage, pre-term birth, multiple birth), highlighting the 
unpredictable nature of pregnancy.  Questionnaires, education sessions, actigraphy and diaries 
were all fully completed except one, equating to a 99.7% completion rate, which is an 
endorsement of the study given it occurred at a complex and demanding time in women’s lives.  
These findings are not dissimilar to the range seen in previous pregnancy intervention studies 
with retention rates ranging from 63-85% and completion rates ranging from 34-93% (Bosaeus 
et al., 2015; Knight & Wyatt, 2010; McNulty et al., 2013).  The sleep education intervention also 
proved highly acceptable, with most women enthusiastic about participating and noting they 
could have dedicated more time.  Women stated they felt positive about participating, would 
definitely recommend the study to others, and felt they received valuable information about 
their sleep that would be helpful throughout their pregnancy and in the future. 
Developing close relationships with community and hospitals midwives was pivotal to 
recruitment, with eight of the women being referred by these clinicians.  Health professionals 
are recognised as a key gateway in pregnancy research as their support provides women with a 
level of trust and validation of study procedures and intent (Frew et al., 2014).  In New Zealand, 
women generally engage with their desired LMC (usually a midwife) immediately after 
confirmation of pregnancy, which makes midwives a key strategic partner in early pregnancy 
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recruiting.  However, a critical shortage of midwives and immense time demands rendered 
midwives in our recruitment area hesitant to provide assistance.  Forming strong reciprocal 
arrangements with LMCs, particularly midwives, would need to be a key focus area in a larger 
recruitment drive.   
Sleep results in this small sample indicate that self-reported sleep duration, quality, timing, 
continuity and daytime sleepiness remained stable throughout pregnancy.  Actigraphically 
measured sleep also remained stable except for a decrease in sleep duration from the second 
to the third trimesters suggesting that changes in sleep across pregnancy for most healthy 
women may not be as great as previous evidence suggests.   There is a widely held belief that 
sleep progressively worsens with gestation, however longitudinal studies that follow women 
across all three trimesters are limited.  With most longitudinal studies focusing only on trimester 
two and three, it is understandable studies conclude that sleep worsens as pregnancy 
progresses.  However, statements such as “the prevalence of poor sleep was highest in trimester 
three”, may be misleading when only two out of three trimesters are being examined.  Future 
longitudinal studies, including data on first trimester sleep, may reveal a different story.  A recent 
review by Okun (2019), states that limited longitudinal actigraphic findings show that “sleep is 
quite disturbed in the first trimester, modestly improves in the second trimester and progressively 
worsens by the end of pregnancy”, and that limited longitudinal studies show that sleep 
architecture (measured by polysomnography) is not significantly modified throughout 
pregnancy.  Our findings of sleep stability across pregnancy support those of Suzuki et al. (1994), 
Mindell et al. (2000), Mindell (2015), Skouteris et al. (2008) and Ladyman & Signal (2018).   
An alternative explanation of the findings in the present study, is that increased knowledge and 
better sleep habits over a long period of time could have helped stabilise sleep in our sample at 
a time when sleep may worsen.  In describing successful interventions with parents, Cowan et 
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al. (1995) notes that ongoing, meaningful relationships for over three months make parents 
more receptive and the program more successful, as it takes time for parents to experiment and 
implement new ideas.  Similarly, Heinicke et al. (1988) found more successful outcomes for 
family-focused interventions when they are started early and extended over a minimum of three 
months.   Because we were able to intervene early and throughout pregnancy, women in our 
study had time to employ specific strategies to guide, reinforce and support positive sleep 
behaviours at relevant times.   
Women are eager for health information when finding out they are pregnant, with over 90% of 
pregnant women using the internet to source pregnancy-related information (Huberty et al., 
2013).  Additionally, a systematic review on internet use by pregnant women found they search 
for pregnancy information most often during the early stages of pregnancy and not 
unexpectedly, that nulliparous women search more than multiparous (Sayakhot & Carolan-Olah, 
2016).   A recent review on 27 Australian Government and leading industry websites reported 
that only two websites included information on sleep during pregnancy but neither 
communicated evidenced based guidelines (Cannon et al., In press).  Alarmingly, the majority of 
women perceive the health information they read on the internet to be trustworthy, reliable 
and useful (Sayakhot & Carolan-Olah, 2016).  Pregnant women, who can often find themselves 
confused and worried about how their actions might affect their baby, are in a no-win situation 
of either not finding accurate, regulated information or not knowing if the information can be 
trusted.  Hence, evidenced-based sleep health information, such as the education material in 
Sleep HAPi, would prove useful to both mothers and those in maternal healthcare services. 
In this study, women with elevated depressive symptoms in early pregnancy had improved by 
the end of pregnancy and those with minimal depressive symptoms in early pregnancy remained 
that way throughout pregnancy.  This suggests the intervention assisted in averting or 
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minimising depressive symptoms.  Previous research indicates that half of our sample could be 
expected to have experienced low mood either in pregnancy or postpartum (Jeong et al., 2013), 
yet none of the intervention group were experiencing low mood at the end of pregnancy and 
only one woman had persistent low mood in the postpartum.   Women in the study may have 
benefited from an increase in sleep knowledge and consequently had improved ability to deal 
with the impact of poor sleep, which provided a protective effect.  Stability in sleep health over 
time may also have minimised depressive symptoms.  Women’s mood may also have benefited 
from the extra support provided by the research team and the clinical support provided to the 
four women who were referred for elevated depressive symptoms in their first trimester.  
Baiardi et al. (2016) has suggested that “sleep is a black box” for early perinatal depression 
detection and that early recognition of poor sleep in pregnancy is valuable for developing and 
implementing interventions in affected women.  Okun et al. (2009) postulates that the effects 
of ongoing poor sleep are cumulative and that this interacts with women’s individual 
vulnerability to depression, concluding that behavioural sleep interventions to improve sleep 
quality could decrease depression risk.  The results from this study support these previous 
findings, suggesting that if poor sleep can be avoided in early pregnancy, the risk of experiencing 
depression in later pregnancy may be minimised.  It may also be that the women’s perception 
of poor sleep can be altered by moderating their expectations and normalising sleep changes.  
Either way, the impact of a sleep health intervention would be beneficial. 
While these findings suggest a larger study is warranted, the number of measures used could be 
reduced to minimise both researcher and participant burden.  Given that actigraphically 
measured sleep did not differ between weeks within a trimester, a single 7-day period of 
recording could be employed. No formal comparisons were made between the various 
measures used for sleep thus firm recommendation about the use of one measure over another 
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cannot be made.   However, it is important to balance participant burden with information on  
multiple aspects of sleep which can be obtained from well validated scales such as the PSQI and 
GSDS.  Given the small and homogeneous sample, it is also not appropriate to make decisions 
about the usefulness of one measure of depression over the other.  Further research in the area 
is warranted. 
This study was not without limitations.  First, this is a small community-recruited sample which 
included nulliparous, predominantly socially and financially advantaged women of a similar age, 
which limits generalisability.  While this has methodological benefits for restricting confounders, 
we cannot determine whether the intervention would be successful for other groups of women.  
Enrolment was voluntary and women were aware of the intervention’s purpose, so positive 
outcomes may be amplified by their motivation for change or from being a “good participant” 
(Nichols & Maner, 2008).  Data was collected over 18 months and thus seasonality cannot be 
excluded as a reason for changes in sleep or mental health.  A validity study of the BDI and EPDS 
by Ji et al. (2011) raised concerns about learning effects for both tools in longitudinal studies.   
This study also had significant strengths, including the use of both objective and subjective 
measures of sleep.  This is important in sleep research during this life stage as subjective sleep 
assessments, but not objective measures, have been associated with depressive symptoms (Park 
et al., 2013; Volkovich et al., 2016).  The study also examined multiple sleep dimensions, as 
described by Buysse (2014) for a comprehensive representation of sleep health.  While quality, 
continuity and duration are well described in the literature, there is mounting evidence for 
daytime sleepiness and timing (Bei et al., 2010) being important in the sleep-depression 
relationship.  It is therefore necessary that future research considers these multi-faceted 




The findings from the Sleep HAPi intervention demonstrate the feasibility of this approach and 
indicate that a sleep education program shows promise in optimising sleep health and 
minimising depressive symptoms during pregnancy.  However, findings would need to be 
replicated in a larger study to prove efficacy.     
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5.7 Appendix A 
5.7.1 Additional sleep measures 
Insomnia symptoms were measured by the Insomnia Severity Index (ISI), a 7-item questionnaire 
validated against sleep diaries and polysomnography, with excellent internal consistency in both 
population-based and clinical samples (Morin et al., 2011).  A cut off score of 10 has been 
identified to classify insomnia cases in a population-based sample (Morin et al., 2011).  An 
additional measure of sleep disturbance was assessed by the total GSDS score.  The GSDS asks 
about frequency of various poor sleep experiences on a numerical scale of 0 (never) to 7 (every 
day).  It has shown good internal consistency in pregnant women (Cronbach = .81) (K. A. Lee & 
Gay, 2004).  
Other sleep items questioned: reasons for awakenings; getting a comfortable sleep position 
(nights/wk); frequency of napping (days/wk); frequent snoring (≥3 days/wk); frequent breathing 
pauses (≥3 days/wk); frequent leg twitching (≥3 days/wk).   Restless Legs Syndrome (RLS) was 
also identified if all four of the following criteria were met: 1) the urge to move the extremities 
usually accompanied by unpleasant sensations; 2) worse symptoms at night; 3) more noticeable 
at rest; and 4) relieved by movement.  
5.7.1.1 Additional Sleep Measure Results 
Scores on the GSDS differed significantly across the study (F(4,55)=5.27; p=0.0012), with post-hoc 
tests indicating a change between both T2 and T3 to P2.   No significant change in ISI scores were 
seen.  Twenty percent of women reported experiencing RLS at T3, one woman reported frequent 
snoring at T2 and P2 and two women reported frequent leg twitching at T1 which persisted at 
T2 and T3 for one woman.  Common reasons for waking at different times across the study are 
shown in table 5.3.  Going to the bathroom and feeling too hot or cold remained common at all 
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pregnancy and postpartum time points.  Waking due to discomfort, pain, heartburn, 
dreams/nightmares and fetal movements were common throughout pregnancy, but not in the 
postpartum.  As expected, common reasons for waking in the postpartum were to feed and care 

































Other Sleep Measures 
     
GSDS Total 46.47 ± 10.69 37.47 ± 8.77 42.80 ± 11.23 52.71 ± 8.62 43.43 ± 10.83 
ISI Total 9.20 ± 5.71 8.67 ± 4.70 7.67 ± 2.85 8.93 ± 5.92 7.50 ± 5.14 
ISI High scorer (≥10) 8 (53) 6 (40) 2 (13) 5 (36) 4 (29) 
Comfortable Sleep 
Position (nights/wk) 5.31 ± 2.21 5.27 ± 1.67 4.53 ± 1.98 5.57 ± 2.03 6.43 ± 1.16 
Frequency of Napping 
(days/wk) 2.07 ± 1.62 1.00 ± 1.00 1.20 ± 1.15 1.93 ± 1.81 1.07 ± 1.00 
Restless Legs Syndrome 2 (13) 1 (7) 3 (20) 1 (7) 1 (7) 
Frequent Snoring (≥3 
days/wk) 0 (0) 1 (7) 0 (0) 0 (0) 1 (7) 
Frequent Breathing 
Pauses (≥3 days/wk) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Frequent Leg Twitching 
(≥3 days/wk) 2 (13) 1 (7) 1 (7) 0 (0) 0 (0) 
Common Reasons for 
Waking 
     
Going to the Bathroom 12 (80) 13 (87) 13 (87) 6 (43) 7 (50) 
Too Hot/Too Cold 9 (60) 8 (53) 13 (87) 8 (57) 8 (57) 
Hungry/Thirsty 9 (60) 6 (40) 9 (60) 4 (29) 4 (29) 
Stress/Worry 7 (47) 7 (47) 5 (33) 5 (36) 5 (36) 
No Reason 7 (47) 7 (47) 10 (67) 4 (29) 4 (29) 
Dreams/Nightmares 7 (47) 7 (47) 4 (27) 1 (7) 1 (7) 
Partner 6 (40) 8 (53) 8 (53) 3 (21) 3 (21) 
Noise 6 (40) 5 (33) 5 (33) 8 (57) 7 (50) 
Uncomfortable 5 (33) 8 (53) 12 (80) 3 (21) 2 (14) 
Nasal Congestion 5 (33) 2 (13) 6 (40) 0 (0) 0 (0) 
Pets 5 (33) 4 (27) 3 (20) 1 (7) 3 (20) 
Pain 3 (20) 4 (27) 10 (67) 1 (7) 2 (14) 
Light 3 (20) 5 (33) 1 (7) 1 (7) 3 (20) 
Heartburn 0 (0) 1 (7) 6 (40) 0 (0) 0 (0) 
Fetal movements 0 (0) 5 (33) 9 (60) 
  
Baby moving or making 
noises 
   
14 (100) 12 (86) 
Feeding/caring for baby 
   
13 (93) 12 (86) 
Results reported as mean & SD or n (%) 
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6 A PILOT LONGITUDINAL SLEEP EDUCATION INTERVENTION 
FROM EARLY PREGNANCY AND ITS EFFECT ON OPTIMISING 
SLEEP AND MINIMISING DEPRESSIVE SYMPTOMS  
The following manuscript was prepared by the researcher (Appendix 31) and was published 
with the journal Sleep Health in June 2020.  All rights reserved© Ladyman C. I., Signal T. L., 
Sweeney B. S., Gander P. H., Paine S-J., Huthwaite M. 
6.1 Abstract 
Objectives:  To investigate the efficacy of a pilot longitudinal sleep education program for 
optimising sleep and minimising depressive symptoms in a sample of nulliparous pregnant 
women. 
Design: Early and longitudinal sleep education intervention pilot study.  
Setting: Community-based convenience sample of New Zealand women. 
Participants:  15 nulliparous women who were involved in a pilot of a longitudinal sleep 
education intervention during pregnancy (N=15) were compared to a comparison group (n=76) 
from another observational study with the same time points.  Groups were matched on 
depression history and parity.    
Intervention: A longitudinal sleep education program (Sleep HAPi) was developed.  Women in 
the intervention group participated in three individualised and trimester specific education 
sessions designed to increase sleep knowledge and improve sleep practices.  The comparison 
group received no sleep education. 
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Measurements:  Self-reports of depressive symptoms and five dimensions of sleep (duration, 
quality, continuity, latency, daytime sleepiness) were compared between groups using linear 
mixed model analysis of variance. 
Results:   At the conclusion of the intervention, the intervention group had fewer depressive 
symptoms with none experiencing clinically significant depressive symptoms, while 21% of the 
comparison group were considered to have clinically significant depressive symptoms.  The 
intervention group also had better sleep quality, sleep initiation and sleep continuity than the 
comparison group at late pregnancy.  
Conclusions:  Findings suggest that a longitudinal sleep education intervention commencing 
early in pregnancy may be effective in optimising sleep and minimising depressive symptoms for 
nulliparous women with a history of depression.  Further investigation of sleep education 
interventions to improve maternal mental health in pregnancy and postnatally is warranted. 
Keywords: pregnancy, postnatal, depression, sleep, intervention, trimester 
6.2 Introduction 
Pregnancy is a common time for the manifestation of both depression and poor sleep (Okun, 
Kiewra, et al., 2011), and their co-occurrence is due to their strong bidirectional relationship 
(Fang et al., 2019).  The adverse obstetric, neonatal (Accortt et al., 2014; Szegda, Markenson, 
Bertone-Johnson, & Chasan-Taber, 2014), child and adolescent development outcomes 
(Brunton, 2013; Stein et al., 2014) as well as the economic cost of depression (Bauer, Knapp, & 
Parsonage, 2016), support the urgent need for longitudinal perinatal research commencing early 
in pregnancy, and timely interventions to limit or, if possible, prevent the severe and enduring 
consequences of depression and sleep disturbance in pregnancy (G. Wang et al., 2018).  Sleep, 
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especially in early pregnancy, is increasingly being considered the ‘black box’ of perinatal 
depression, holding essential information for the early detection of depressive disorders (Baiardi 
et al., 2016).  Further, sleep is one of the modifiable risk factors for depression, so provides a 
unique opportunity for behavioural change interventions.      
With up to one in five women experiencing clinically significant perinatal depressive symptoms 
(Marcus et al., 2003), treatments are being increasingly researched, but the availability of safe, 
cost-effective, readily accessible, non-intrusive and non-pharmacological methods is limited.  
Mothers may be concerned about the risks to their unborn baby, and clinicians can be 
confronted with conflicting evidence about the safety of antidepressant use. (Scime, 2016).  
While it is clear that treating depression results in more favourable outcomes than untreated 
depression, less than 10% of women consider pharmaceuticals their first choice of treatment 
(Goodman, 2009) and report anxious and regretful feelings (Bonari et al., 2005) or poor 
adherence when continuing antidepressant medication during the perinatal period (Boath et al., 
2004).  Furthermore, in an international review guidelines produced by 13 countries on the use 
of antidepressant medications in pregnancy, all but one country recommended behavioural 
interventions before antidepressant use as an initial therapy for mild to moderate depression 
(Molenaar, Kamperman, Boyce, & Bergink, 2018). 
A perinatal review assessing non-pharmacological interventions that aimed to improve sleep to 
reduce depressive symptoms, showed that behavioural treatments, such as bright light therapy, 
exercise, yoga, acupuncture and herbal remedies, show trends for improving sleep (Hollenbach 
et al., 2013).  A study by Tomfohr-Madsen et al. (2016) examined aspects of sleep education as 
an component of their modified Cognitive Behavioural Therapy for Insomnia (CBTi) to treat 15 
third trimester women  suffering insomnia.  Post-intervention measures showed that women in 
the intervention group had improvement in depressive symptoms and sleep measures, while 
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also reporting participation in the intervention to be positive.  These results support a 
recommendation from a recent review on perinatal depression interventions by Johansen et al. 
(2019), who advocates, “intervention for poor sleep in perinatal women is simply education on 
good sleep hygiene”.  While women are keen to find information on pregnancy sleep and over 
90% of pregnant women using the internet as an information source (Huberty et al., 2013), 
resources are limited, unregulated, and not always based on empirical information (Cannon et 
al., In press). 
Longitudinal and interventional studies need to be a priority in maternal mood and sleep 
research.  To our knowledge, the current study is the first to explore if a sleep education 
intervention throughout pregnancy has an impact on the occurrence of depressive symptoms.   
Such interventions are particularly important for women with a history of depression, as 
research has consistently shown a depressive history to be the strongest predictor of both 
antenatal and postnatal depression (Raisanen et al., 2014; Rich-Edwards et al., 2006).  While 
increased efforts have been made to screen, identify and treat women for antenatal or postnatal 
depression, little intervention research has targeted this sub-group of women, even though the 
literature indicates that interventions targeting parents who are disproportionately exposed to 
known risk factor for depression deliver better mental health outcomes (Mihelic et al., 2018). 
This paper describes a trial of the Sleep HAPi (Sleep Health and Pregnancy Information) 
education intervention, which aimed to minimise women’s depressive symptoms by improving 
sleep knowledge and managing sleep expectations.  The effectiveness of the intervention was 
evaluated by comparing Sleep HAPi (SH) participants with a matched sample of pregnant women 
from the E Moe, Māmā: Maternal Sleep in Aotearoa/New Zealand (EMM) study (Signal et al., 
2016) who served as a comparison group.  Both groups completed the same measures of sleep 
and mental health status in the third trimester and at 12 weeks postnatally. 
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6.3 Participants and methods 
Participants for the Sleep HAPi pilot study were recruited from the Greater Wellington area or 
Palmerston North, New Zealand through advertisements in medical centres, midwifery clinics, 
mental health clinics, hospitals, parent and community centres, libraries, schools, 
crèches/kindergartens, supermarkets, community fairs, and various social and traditional media 
channels.  Presentations were also given to hospital staff, midwifery groups, Continuing Medical 
Education (CME) workshops and fertility clinics to encourage medical professionals to refer 
patients/clients.    
Eligible participants completed a screening questionnaire to ensure they met the study criteria, 
which included having a history of previously diagnosed depression but currently non-
symptomatic and medication-free for at least three months prior to study enrolment.  Women 
were at or less than 14 weeks pregnant, nulliparous, had a singleton pregnancy and were at least 
16 years of age and proficient in English.  They were also required to have a primary health care 
provider and no children under three years of age living in the home.  Participants were excluded 
if they had a diagnosed sleep disorder, medical condition or mental health disorder (other than 
depression) known to be associated with sleep abnormalities. 
Data were collected from February 2017 to December 2018.  All women who agreed to 
participate reported being of sole New Zealand European ethnicity.  By 36 weeks gestation, 
participants in the Sleep HAPi intervention group had completed three one-on-one face-to-face 
sleep education sessions (one in each trimester) which included assessments of their own sleep 
and depressive symptoms.  They also completed two post-intervention assessments: one at six 
weeks postnatal and one at 12 weeks postnatal.  
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The intervention group were matched to a group of pregnant women from the E Moe, Māmā 
cohort study who were also nulliparous, had a history of diagnosed depression, were of sole 
New Zealand European ethnicity with a singleton pregnancy (n=76).  The EMM study surveyed 
a community sample of 1057 women during their third trimester of pregnancy (mean 36 weeks 
gestation) and at 12 weeks post birth.  Data was collected from October 2009 to October 2011.  
Details of the recruitment process for EMM are described elsewhere (Signal et al., 2016).  Both 
studies were conducted by the Sleep Wake Research Centre using identical questions, cut off 
scores, and data entry and analysis processes.  If participants in either group had elevated 
depressive symptoms, or thoughts of self-harm, the protocol response was for the researchers 
(with the participants’ consent) to provide a letter to their doctor or maternity health care 
provider.   
Self-reported depressive symptoms and five dimensions of self-reported sleep data collected at 





6.3.1 Sleep HAPi study design 
The Sleep HAPi study design is shown in figure 6.1.   
 
The Sleep HAPi intervention was developed by the study researchers and aimed at increasing 
women’s understanding of the benefits of good sleep and consequences of poor sleep, practices 
and factors that either promote or hinder sleep as well as ‘normalising’ the sleep changes 
experienced in pregnancy and improving overall sleep health practices.  The sleep education 
material covered three main sleep topics: 1) general sleep and circadian information; 2) how 
and why sleep changes in each trimester; and 3) trimester-specific sleep support strategies.  
Further information about session topics can be requested from the authors.  To enhance the 
application of theoretical principles and create greater self-awareness of sleep behaviour and 
patterns, each woman also received feedback on their own actigraphy and self-reported data 
(actigraphy data are reported elsewhere).   
The education sessions in each trimester were scheduled at times and places convenient to the 
women (homes, cafés, community libraries, university meeting spaces), and were one-on-one 
and face-to-face. Printed information was presented in a folder that allowed subsequent 
Figure 6.1 Sleep HAPi study design 
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trimester information and actigraphy printouts to be progressively added, creating a 
comprehensive and personalised ‘Sleep in Pregnancy’ booklet (52 pages in total).  Sessions were 
approximately one to one and a half hours in trimester one, and 45-60 minutes in trimesters 
two and three. There was no expectation that all of the information and advice would be used 
by all women, rather that they would have a ‘tool kit’ of knowledge they could use when 
necessary.  
Over a 12-month period from February 2017 to February 2018, 52 women responded to 
recruitment advertisements, 22 were screened and accepted into the study.  Seven withdrew 
resulting in 15 participants completing the study.  One woman was lost to follow up after the 
intervention was completed. 
6.3.2 Measures 
Women in both the intervention and comparison groups completed paper-based 
questionnaires which collected sleep, mood, demographic and general health information 
using identical questions at 36 weeks gestation and 12 weeks postnatal.   
6.3.2.1 Sleep Measures 
Buysse’s (2014) ‘Sleep Health’ principles underpinned the selection of measures used to assess 
sleep. This approach considers sleep as a multidimensional model that “promotes physical and 
mental well-being”. We investigated four of Buysse’s (2014) five sleep health dimensions: 
quality, quantity, continuity, and daytime sleepiness.  The fifth sleep dimension, sleep timing, 
was not available for the comparison group, and instead data on sleep onset insomnia were 
included in analyses.   
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Self-reported sleep duration was measured at each time point by the question “How many hours 
sleep, including naps, do you usually get in 24 hours?”.  Sleep quality, latency and continuity 
were assessed using the relevant General Sleep Disturbance Scale (GSDS) subscales which have 
been demonstrated to be valid and reliable in multiple studies of childbearing women (K. A. Lee 
& Gay, 2004).  Each item in the GSDS was rated from 0 (never) to 7 (every day) and if a subscale 
is comprised of two or more items, the mean was calculated.  Sleep quality was assessed using 
the GSDS Quality Subscale items; “How often in the last week did you feel rested upon 
awakening at the end of a sleep period?”, “How often in the last week did you sleep poorly?” 
and “How often in the last week did you feel satisfied with the quality of your sleep?”.  The first 
and last items are reversed scored.  In this sample, Cronbach’s alpha was 0.89 (36 weeks 
gestation) and 0.85 (12 weeks postnatal).  Sleep latency was assessed using the GSDS Onset 
Insomnia Subscale item; “How often in the last week did you have difficulty getting to sleep?”.  
Sleep continuity was measured by the GSDS Maintenance Insomnia Subscale items; “How often 
in the last week did you wake up during your sleep period?” and “How often in the last week did 
you wake up too early at the end of your sleep period?”  Daytime Sleepiness was measured by 
the Epworth Sleepiness Scale (ESS).  The ESS assesses daytime sleepiness in eight everyday 
situations using the question “How likely are you to doze off in the following situations, in 
contrast to feeling just tired…?”.  The ESS has been deemed reliable and valid for use in pregnant 
populations (Baumgartel et al., 2013) and excessive daytime sleepiness is typically defined as a 
total score ≥ 10 (Johns, 1991).  In this sample, Cronbach’s alpha was 0.75 (36 weeks gestation) 




6.3.2.2 Mental Health Measures 
Depressive symptoms were measured by the 10-item Edinburgh Postnatal Depression Scale 
(EPDS), with scores at or above 13 considered clinically significant (Cox et al., 1987).  Women 
selected a response that described how they felt over the past seven days on ten items.  The 
EPDS has been validated as a screening tool, and used internationally to detect depressive 
symptomatology in the perinatal period (Kozinszky & Dudas, 2015).  While the EPDS was 
originally developed to be a unitary measure of (postnatal) depression, it has also been found 
to have a distinct 2-factor structure used to identify probable anxiety and/or depression 
disorders, via a depression subscale (EPDS-7D; items 1, 2, 6, 7, 8, 9 & 10) and an anxiety 
subscale (EPDS-3A items 3, 4 & 5) (Jane Phillips et al., 2009).  In this sample, Cronbach’s alpha 
for the EPDS total score was 0.85 (36 weeks gestation) and 0.76 (12 weeks postnatal), for the 
EPDS depression subscale it was 0.82 (36 weeks gestation) and 0.75 (12 weeks postnatal), and 
for the EPDS anxiety subscale it was 0.82 (36 weeks gestation) and 0.68 (12 weeks postnatal). 
6.3.2.3 Demographic, Health and Lifestyle Measures  
Participants provided information on age, gestational age, parity, ethnicity, history of diagnosed 
depression, pre-pregnancy height and weight to compute body mass index (BMI), requiring 
assisted reproductive technology to become pregnant, planned pregnancy and current work 
commitments (including currently working; hours of work; employed in shiftwork, defined as 
working for pay, profit or income for at least three hours between the hours of midnight and 
5am) at 36 weeks gestation.   
6.3.2.4 Statistical Analysis 
Descriptive statistics (means, standard deviations, proportions) were calculated in SPSS (version 
25, IBM SPSS Statistics for Windows, Armonk, NY).  Linear mixed model analysis of variance was 
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conducted using SAS (version 9.4, SAS Institute Inc., Cary, NC) to compare sleep and depressive 
symptoms between intervention and comparison groups.  Covariates in the models at both 36 
weeks gestation and 12 weeks postnatal were: maternal age; relationship happiness (8 point 
scale [range 0-7] where <3 signifies greater happiness, ≥3 signifies less happiness or not 
applicable); and stressful life events (measured by the 13-item Pregnancy Risk Monitoring 
System Stressful Life Events (PRAMS SLEs), where low stress was considered <2 stressors, and 
high stress ≥2 stressors).  The Kenward-Roger adjustment was applied to the degrees of freedom 
estimation (Littell et al., 2007).  Normality, linearity and constant variance assumptions were 
visually checked and the Shapiro-Wilk test used to assess the distribution of the residuals 
(Tabachnick & Fidell, 2012).  When continuous measures met distributional assumptions of 
normality, t-tests were used to test group differences; otherwise, the nonparametric Mann-
Whitney U test was used.  Where outlying residual values were identified in the linear mixed 
models, the model was re-run without the outlier(s).  If removing the outlier(s) altered the 
findings of the model, the reported results exclude the outlier(s), otherwise the results are 
reported including the outlier(s).  Post-hoc t-tests were used to investigate comparisons of 
interest where main effects were statistically significant.  Bonferroni’s adjusted p-values were 
calculated for post-hoc tests.  A 2-sided p-value of <0.05 was considered significant.  
6.3.2.5 Ethical approval  
Sleep HAPi was approved by the Massey University Human Ethics Committee:  Human Ethics 
Southern A Committee (SOA 16/29) and the Australian and New Zealand Clinical Trials Registry 
(ACTRN12617000055303).   E Moe, Māmā was approved by the Central Health and Disability 




6.4.1 Sample characteristics 
Complete data sets were available for 15 women at 36 weeks gestation and 14 women at 12 
weeks postnatal in the intervention study.  Complete data sets were available for 76 women in 
the comparison study.  In both studies, all women were nulliparous, sole New Zealand European, 
had a history of depression and a singleton pregnancy.  As illustrated in table 6.1, the 
intervention and comparison groups were similar on most demographic and sleep 
characteristics, only differing in their current work status and requiring ART to become pregnant.     
6.4.2 Sleep characteristics 
As illustrated in Figure 6.2, univariate analyses show that in late pregnancy, the intervention 
group had significantly better measures of sleep quality (p=0.017) (Figure 6.2, panel B), sleep 
continuity (p=0.017) (Figure 6.2, panel C) and sleep latency (p=0.001) (Figure 6.2, panel D) 
compared to the comparison group, but no significant differences were seen for sleep duration 
(Figure 6.2, panel A) or daytimes sleepiness (Figure 6.2, panel E).  At the postnatal time point, 
the intervention group were significantly better on the measure of sleep latency (p=0.010) 
(Figure 6.2, panel D), but no differences were observed for other sleep dimensions. 
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Table 6.1  Sample characteristics.  
36 Weeks Gestation 
Mean & SD or n (%) 
 
12 Weeks Postnatal 












Maternal Age 31.95 ± 5.20 31.36 ± 5.13 0.683 
    
Family History of Mood Disorder 12 (80) 50 (66) 0.243 
    
Pregnancy 
       
 
Gestation (weeks) 36.13 ± 0.51 35.85 ± 0.89 0.098 
    
 
Planned Pregnancy 13 (87) 57 (75) 0.297 
    
 
Assisted Reproductive Technology 5 (33) 6 (8) 0.016 
    
 
Infant Age (weeks) 
    
12.29 ± 0.46 12.01 ± 0.88 0.114 
BMI 24.11 ± 3.09 25.36 ± 5.54 0.236 
    
Work Status 
       
 
Currently Working 7 (47) 58 (76) 0.020 
 
1 (7) 2 (0) 0.400 
 
Hours of Work (of those working) 39.07 ± 1.64 36.73 ± 11.52 0.596 
 
10 ± 0.00 6.5 ± 2.12 0.377 
 
Night worker#  0 (0) 2 (3) 0.789 
 
0 (0) 0 (0) 
 
Partner Relationship 
       
 
Happy 13 (80) 66 (87) 0.431 
 
10 (71) 60 (83) 0.378 
 
Unhappy 1 (7) 7 (9) 
  
3 (21) 11 (15) 
 
 
Not Applicable 1 (7) 1 (1) 
  
1 (7) 1 (1) 
 
PRAMS SLEs 
       
 
≥2 6 (40) 32 (42) 0.880 
 
3 (21) 33 (43) 0.148 
# Worked for pay, profit or income for at least 3 hours between the hours of midnight and 5am.   
BMI = Body mass index. PRAMS SLEs = Pregnancy Risk Assessment Monitoring System Stressful Life Events 




Figure 6.2  Univariate analyses of sleep and depressive symptoms.  GSDS = General 
Sleep Disturbance Scale, ESS = Epworth sleepiness Scale, EPDS = Edinburgh 
Postnatal Depression Scale. 
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Linear mixed model results are described in Table 6.2.  For sleep latency, linear mixed models 
showed a significant main effect of group (F(1,86)=16.06; p=0.000) and time (F(1,88)=5.86; p=0.018), 
indicating that the intervention group had fewer difficulties falling asleep at both time points 
and all women had less difficulty falling asleep at the postnatal time point.  The covariates of 
maternal age (F(1,86)=16.06; p=0.000) and stressful life events (F(1,86)=16.06; p=0.000) were also 
significant, with younger women and women with fewer stressful life events having more nights 
per week where they had difficulty falling asleep.   
In the models for daytime sleepiness, there was a significant main effect of time (F(1,85)=7.02; 
p=0.010), but no group or interaction effect, indicating that women reported being less sleepy 
postnatally compared to late pregnancy.   
The models for sleep quality and continuity showed a time-by-group interaction (F(1,84)= 4.17; 
p=0.044 and F(1,85)= 6.28; p=0.014 respectively), with post-hocs showing that the comparison 
group had improvements in sleep quality (p<.0001) and continuity (p<.0001) from pregnancy to 
postnatal.  There were no differences between groups at either time point.  Women with greater 
relationship satisfaction had better sleep quality (F(1,85)=7.23; p=0.008) and fewer nights per 
week where they woke early or during their sleep (F(1,85)=4.22; p=0.042).  Maternal age was also 
significantly associated with sleep continuity, with younger women having more nights per week 
where they woke early or during their sleep (F(1,91)=4.47; p=0.037).   
For sleep duration, linear mixed models showed no main effect or interaction effects for group 
and time.  However, relationship satisfaction was independently associated with this aspect of 
sleep (F(1,85)=8.42; p=0.004), such that women who reported greater relationship happiness also 
reported longer sleep durations. 
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Table 6.2  Linear mixed model analysis of variance results. 
 
Late Pregnancy 
Mean & SD or n (%) 
Postnatal 
Mean & SD or n (%) 
    
Intervention 
(n = 15) 
Comparison 
(n = 76) 
p value 
Intervention 
(n = 14) 
Comparison 
(n = 76) 
p value 
Group 
Intervention vs  
Comparison 
Timepoint 
Late Pregnancy vs 
Postnatal 
Interaction 
Timepoint * Group 
Significant Covariate 
Duration            
Sleep Duration (hours) 7.37 ± 0.93 7.22 ± 1.55 0.399 7.33 ± 1.49 7.48 ± 1.23 0.467 F (1,85)=0.07 p=0.793 F (1,87)=3017 p=0.078 F (1,86)=0.46 p=0.500 Relationship F(1,167)=8.42 p=0.004  
Quality           
Good Nights Sleep 
(nights/wk) 
3.33 ± 1.18 2.26 ± 1.91 0.024 2.71 ± 2.13 3.42 ± 2.37 0.302 F (1,86)=0.40 p=0.527 F (1,88)=0.77 p=0.381 F (1,87)=4.79 p=0.031 None 
GSDS Total 45.87 ± 12.59 65.84 ± 15.96 0.000 44.93 ± 19.40 51.97 ± 18.98 0.431 F (1,84)=11.38 p=0.001 F (1,85)=5.75 p=0.019 F (1,84)=6.81 p=0.011 Relationship - F(1,165)=8.94 p=0.003  
GSDS Quality Subscale  
(nights/wk) 
4.09 ± 1.70 5.09 ± 1.79 0.017 4.24 ± 2.10 3.94 ± 2.01 0.573 F (1,84)=1.00 p=0.321 F (1,85)=3.91 p=0.051 F (1,84)=4.17 p=0.044 Relationship - F(1,166)=7.23 p=0.008  




4.80 ± 1.42 5.73 ± 1.41 0.017 5.07 ± 2.4 4.36 ± 2.25 0.214 F (1,88)=0.02 p=0.882 F (1,90)=1.34 p=0.251 F (1,89)=6.28 p=0.014 
Relationship - F(1,160)=4.22 p=0.042;  
Age - F(1,91)=4.47 p=0.037 
Daytime Sleepiness           
ESS Total 6.07 ± 3.90 6.68 ± 3.80 0.575 4.93 ± 4.39 5.63 ± 3.81 0.539 F (1,85)=0.50 p=0.483 F (1,85)=7.02 p=0.010 F (1,83)=0.04 p=0.848 None 
Latency           
GSDS Onset Insomnia 
Subscale (nights/wk) 
1.87 ± 1.55 2.71 ± 2.13 0.001 0.87 ± 0.83 1.94 ± 1.79 0.010 F (1,86)=16.06 p=0.000 F (1,89)=1.87 p=0.175 F (1,88)=0.39 p=0.536 
Age - F(1,92)=6.86 p=0.010;  
PRAMS - F (1,145)=4.92 p=0.028  
EPDS Score           
Mean (Total) 5.67 ± 3.37 8.67 ± 4.95 0.037 5.21 ± 3.38 6.86 ± 4.03 0.206 F (1,84)=5.12 p=0.026 F (1,86)=10.35 p=0.002 F (1,85)=1.14 p=0.288 Relationship - F(1,169)=6.11 p=0.014  
Highscorer (Total) (≥13) 0 (0) 16 (21) 0.042 1 (7) 9 (12) 0.516     
Mean (Depression 
Subscale) 
2.53 ± 1.87 4.55 ± 3.24 0.019 2.50 ± 2.25 3.63 ± 2.96 0.255 F (1,85)=5.18 p=0.025 F (1,87)=6.20 p=0.015 F (1,86)=0.98 p=0.326 Relationship - F(1,169)=8.97 p=0.003  
Mean (Anxiety Subscale) 3.13 ± 4.84 4.12 ± 2.36 0.182 2.71 ± 2.02 3.22 ± 1.79 0.299 F (1,84)=2.53 p=0.115 F (1,86)=8.74 p=0.004 F (1,85)=0.54 p=0.464 None 
GSDS = General Sleep Disturbance Scale, ESS = Epworth Sleepiness Scale, EPDS = Edinburgh Postnatal Depression Scale, PRAMS = Pregnancy Risk Monitoring System  
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6.4.3 Depressive symptoms 
In late pregnancy, univariate analyses (Figure 6.2) show that the intervention group had 
significantly fewer depressive symptoms (p=0.037) (Figure 6.2, panel F), compared to the 
comparison group.  This was also evident in the number of women scoring at or above 13 on the 
EPDS (indicating probable depression), with 21% of the comparison group having clinically 
significant depressive symptoms, compared to none of the intervention group (χ²=0.042). A 
significant difference was seen between the two groups on the depression subscale (p=0.019) 
(Figure 6.2, panel G), but not the anxiety subscale (p=0.182) (Figure 6.2, panel H).   
These differences in EPDS scores were also evident in the linear mixed modelling results (Table 
6.2).  There was a significant main effect of group (F(1,86)=5.12; p=0.026) and time (F(1,86)=10.35; 
p=0.002) but no interaction effect, illustrating that the intervention group experienced fewer 
depressive symptoms at both time points, although depressive symptoms in both groups 
reduced over time.  This pattern was also seen in the EDPS depression subscale, with a main 
effect of group (F(1,86)=5.18; p=0.025) and time (F(1,86)=6.20; p=0.015) but no significant 
interaction effect.  Women who reported greater satisfaction with their relationship also lower 
scores on the EPDS total score (F(1,169)=6.11; p=0.014) and depression subscale (F(1,169)=8.97; 
p=0.003). 
There was a significant main effect of time for the EPDS anxiety subscale (F(1,85)=8.74; p=0.004), 
but no group or interaction effect, indicating that anxiety levels improved between late 





This pilot study sought to determine if a longitudinal sleep education intervention for women 
with a history of depression throughout pregnancy was effective in optimising sleep and 
minimising women’s depressive symptoms.  At the end of pregnancy, the intervention group 
had significantly fewer depressive symptoms than the comparison group and none of the 
intervention group had EPDS scores representative of clinically significant depression, compared 
to 21% of the comparison group.  This is particularly pertinent considering that women with a 
history of depression are twice as likely to experience a relapse in pregnancy (Robertson et al., 
2004).  The differences between groups remained significant after controlling for age, 
relationship satisfaction and stressful life events.  These preliminary findings suggest that a 
longitudinal sleep education intervention that spans pregnancy may assist women at risk of 
depression to remain healthy. 
The findings support well-evidenced reciprocal relationships between sleep and depressive 
symptoms (Lawson et al., 2015).  In addition to having significantly fewer depressive symptoms, 
the intervention group also experienced significantly better sleep quality, continuity and sleep 
initiation (latency) in late pregnancy compared to the comparison group, although only sleep 
initiation remained significant after controlling for covariates.  Previous research has shown that 
mothers who find it easier to fall asleep also experience fewer depressive symptoms in both 
pregnancy (Dørheim et al., 2012) and after birth (Marques et al., 2011). 
We posit that though poor sleep may be unavoidable for some women in pregnancy, having an 
understanding of the expected sleep changes and having strategies to counter some of the 
adverse effects of these changes could enhance a woman’s ability to respond and increase their 
capacity to accept the changes.  Felder et al. (2018) suggests that individuals could be less 
psychologically impacted if they have decreased cognitive and emotional reactivity and 
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increased acceptance of difficult sleep experiences.  Information provided in the intervention 
focused on the importance of consistent sleep times, prioritising sleep and strategies for greater 
sleep continuity.  This too could have contributed to a greater stability in sleep, which in turn 
could attenuate the impact of depression.  Women’s mood may also have benefited from the 
extra support provided by the research team and/or the clinical support they received when 
referred (n=4 from the intervention group, n=16 in the comparison group).   
Most of the differences between groups did not persist at 12 weeks postnatal.  It is possible that 
the positive effects of the sleep education weakened over time, however patterns of sleep and 
depressive symptoms in the intervention group appear to remain stable or improve from late 
pregnancy to early postnatal.  The comparison group demonstrated greater improvement on 
some aspects of sleep and depressive symptoms from late pregnancy to 12 weeks postnatal 
which may be a reflection of the usual change in sleep across this timeframe, though it is 
important to note that these improvements may not be linear.  Another explanation may be 
that although both groups were referred to their doctor or maternity health care provider if 
there was evidence of thoughts of self-harm or elevated depressive symptoms, the six months 
of early and continued engagement of women in the intervention group may have contributed 
to the stabilisation and/or improvement in sleep and depressive symptoms at the late pregnancy 
time point.    
Relationship dissatisfaction has been reported to be associated with poorer sleep (Kent, Uchino, 
Cribbet, Bowen, & Smith, 2015) and depressive symptoms (S. W. Whitton & Whisman, 2010).  
Similarly, in the present study sleep duration, sleep quality and sleep continuity and depressive 
symptoms were significantly associated with women reporting less happiness in their partner 
relationship.  Younger maternal age was also associated with poorer sleep quality and more 
nights per week where women woke early or during their sleep.  Unexpectedly, women with 
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greater life stressors had fewer nights per week where they had difficulty getting to sleep.  While 
it is difficult to explain this finding, it may be these women are experiencing greater fatigue in 
late pregnancy or early postnatal and therefore have less difficulty with sleep latency than other 
aspects of sleep throughout this time period. 
In this study, the homogeneity between groups, especially when considering key risk factors for 
perinatal depression (history of diagnosed depression (individual and family), parity, age, BMI, 
planned pregnancy), is a novel strength.  However, the uniqueness of the sample also limits the 
generalisability to other populations, particularly when considering Indigenous New Zealand 
Māori women, who are known to have poorer sleep and greater severity and prevalence of 
mental health problems than women of New Zealand European ethnicity (Paine & Gander, 
2013).  Other study limitations include a study design that did not involve random assignment, 
but instead made use of a matched comparison group from another study, and thus observed 
differences may be due to unidentified differences that were not controlled between groups.  A 
blinded con-current control group is necessary to provide a more robust evaluation of 
intervention effectiveness.  This intervention was a pilot study and the testing of intervention 
feasibility and acceptability and results are described in detail elsewhere. Participation in the 
sleep education intervention was voluntary and required women to approach the study team at 
enrolment.  Participants were thus aware of the intervention and may have included those with 
existing concerns about sleep and who were particularly motivated to improve their sleep.  
However, since the intervention group experienced better sleep and fewer depressive 
symptoms, this would only amplify the efficacy of the intervention. 
Sleep measures were based on self-reported questionnaires that require women to subjectively 
evaluate their sleep and thus are open to recall bias.  While it has been suggested that those 
experiencing depression may be less accurate in perceiving their sleep (Rotenberg, Indursky, 
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Kayumov, Sirota, & Melamed, 2000), others have argued that subjective evaluations of sleep are 
more highly associated with depressive symptoms (Coo, Milgrom, & Trinder, 2014), thus it is 
unclear if women experience altered sleep perceptions or actual sleep disruption.  Stability in 
sleep timing and symptoms of sleep disorders were not considered in this analysis, and both 
have been found to be associated with women experiencing depressive symptoms in pregnancy 
(Signal, 2019, October).  The identification of depressive symptoms was assessed using a well 
validated self-report measure (EPDS) and not clinical interview, so it is unclear how many women 
would receive a diagnosis of depression.  For informed consent and ethical approval, the 
intervention group were required to be antidepressant medication free for three months prior 
to study commencement.  This was not a criteria for the comparison group.  Furthermore, 
antidepressant and sleep medication use were not controlled for during the data collection 
period.  Both limitations may confound results. 
The study also has several strengths.  While sleep education interventions are limited (with many 
concentrating on the early postnatal period, typically focussed on infant sleep), this is the first 
study of its kind to implement a longitudinal sleep education intervention throughout all 
trimesters of pregnancy.  The intervention was designed to capitalise on a life stage where 
change is great, but women are generally amenable to testing new patterns of behaviour 
especially as they are motivated to improve their health for the benefit of their child.  Pinquart 
& Teubert’s (2010) meta-analysis of preventive parenting education programs concluded that 
ideally, intervention length should be three to six months with commencement before problems 
develop.  The 6-month intervention in this study not only provided women with the opportunity 
to learn about sleep and sleep changes in pregnancy, but also allowed for implementation and 
practice of various sleep strategies.  The value of this approach is supported by Brown et al. 
(2002) who showed that practicing good sleep habits, instead of just having the knowledge, was 
strongly related to good overall sleep quality.   Furthermore, it has been shown that women 
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want early, tailored and realistic education delivered in a relevant, timely manner, but not so far 
in advance that it becomes overwhelming (Entsieh & Hallström, 2016; Verbiest et al., 2018).  This 
concept is advocated in two pregnancy sleep interventions by Lee et al. (K. A. Lee & Gay, 2017; 
K. A. Lee et al., 2016) who has also suggested early, rather than late gestational intervention. 
An additional strength of the study was that cut off scores on the EPDS indicate major or 
probable clinical depression, rather than just mild, transient or possible depression (Cox et al., 
1987; Khanlari et al., 2019).  This study also utilises Buysse’s (2014) sleep health model and 
assesses multiple dimensions of sleep, endorsing Paulson & Miller-Graff’s (J. L. Paulson & Miller-
Graff, 2019) recent proposal that various sleep dimensions, or more importantly combinations 
of dimensions, are more predictive of mood changes at particular time points in pregnancy. 
6.6 Conclusion 
This pilot study demonstrates that longitudinal sleep education may be effective in optimising 
sleep and minimising depressive symptoms for nulliparous pregnant women with a history of 
depression, a sub-population that has been surprising under-researched in intervention studies 
considering the strength of findings linking history of depression with perinatal depression 
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Healthy sleep is rapidly becoming recognised as one of the three key pillars of health; of equal 
importance to a nutritious diet and regular exercise.  Healthy sleep across adulthood is an 
important predictor of longevity and wellbeing, while poor sleep is related to an increased all-
cause mortality, and associated with an extensive list of disease and disorder, including heart 
disease, cancer, diabetes and mood disorders (Bertisch et al., 2018; Grandner, Hale, Moore, & 
Patel, 2010; Rod et al., 2011; Yin et al., 2017).  This thesis has focussed on evaluating the 
relationship between sleep and depression across pregnancy (figure 7.1).  The strong bi-
directional relationship between sleep and depression is crucial in pregnancy, which is generally 
considered a time when sleep disruption is common.  Poor sleep and depression are related to 
many well-established risk factors for adverse pregnancy, fetal and child outcomes.   
 
Figure 7.1  Sleep, depression and pregnancy interactions 
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Chapter 1 highlighted important gaps in the current literature.  There is a lack of understanding 
of normal sleep characteristics throughout pregnancy; a shortage of research on sleep and 
depression in the first trimester and longitudinally throughout pregnancy; a paucity of literature 
investigating the longer term patterns of maternal sleep health and depression extending 
beyond 12 months after childbirth, although the limited longitudinal studies indicate chronic 
patterns of depression continuing many years past birth for some women; insufficient evidenced 
based pregnancy sleep information available to women and healthcare providers; and a 
shortage of interventions that attempt to prevent or minimise depression by normalising and 
optimising sleep in pregnancy. 
Thus, the research in this thesis aimed to investigate the relationships between sleep and 
depressive symptoms throughout an extended perinatal period, from early pregnancy to three 
years post birth and was prompted by three research questions.   
1. What does sleep health look like for healthy women in each trimester of pregnancy? 
2. Do patterns of depressive symptoms persist from late pregnancy to three years post 
birth and is this related to sleep? 
3. If there is an association between sleep and depressive symptoms, will an intervention 
optimising sleep throughout pregnancy help women to reach late pregnancy with 
minimal depressive symptoms? 
To answer these questions, three separate studies were undertaken.  Study 1 was a scoped 
review exploring what normal sleep looks like for pregnant women (Chapter 3).  Study 2 
examined the time course of depressive symptoms from late pregnancy to three-year post birth 
(Chapter 4), and Study 3 assessed the feasibility, acceptability (Chapter 5) and efficacy (Chapter 




The Sleep Health conceptual model identified by Buysse (2014) is a common thread throughout 
the studies and provides a comprehensive representation of the multi-dimensionality of sleep.  
Sleep is a complex physiological process and cannot be portrayed by a single measure.  As 
described by Paulson & Miller-Graff (2019) , it may be that various sleep dimensions, or more 
importantly combinations of dimensions, are more predictive of mood changes at particular 
time points in pregnancy.  Though previous maternal sleep research has suggested that sleep 
quality is a dimension of sleep closely related to depressive symptoms (Bei et al., 2010; Dørheim 
et al., 2009; Huang et al., 2004), this research has emphasised the complexity of sleep and 
suggests there are the numerous ways in which it may be associated with mental health.   
Figure 7.2  Theses study design. 
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7.1 Contribution to the Literature 
Key findings, clinical implications and future research recommendations from studies 1, 2 and 3 



























































7.2 Key Findings 
7.2.1 Study 1 – Scoped review 
Developing the concept of sleep as a health asset, the Scoped Review in Chapter 3 focussed on 
examining “what sleep health looks like for pregnant women”.  Thus the 24 studies included in 
the review had all excluded women who had mood, sleep or pregnancy complications, or 
pregnancy-related health issues.   
There were three main findings for this subsample of healthy women.  First, although sleep in 
pregnancy is highly variable among woman, these studies did not find significant changes to 
sleep throughout pregnancy.  Although it is widely considered that pregnancy is a risk factor for 
poor sleep, this might not be the case for all women, although comparisons with pre-pregnancy 
sleep would need to be examined to confirm this.  There has also been a broad over-
generalisation that sleep quality declines as pregnancy progresses, but the lack of trimester one 
studies limits this conclusion.  Additional longitudinal studies that include women in trimester 
one are needed to accurately describe the patterns of change in sleep and depression 
throughout pregnancy.   
Secondly, the review highlighted the limited understanding of what is considered “normal” or 
“healthy” sleep at this life stage, especially considering the limited number of studies with large 
sample sizes and longitudinal designs.  This is an important finding, because without normative 
data, it is difficult to understand the impact of sleep problems on healthy pregnancy or other 
pathologies, such as mental health disorders.   
Thirdly, the review illustrated the lack of understanding of the different dimensions of sleep 
during pregnancy.  Sleep health, as described by Buysse (2014), includes five dimensions of 
sleep, each of which can impact health outcomes.  Pregnancy sleep research has primarily 
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focussed on sleep quality and quantity and to a certain extent continuity (or disturbance). 
Limited studies suggest that daytime sleepiness and sleep timing may be important in healthy 
pregnancy, but there is a scarcity of research investigating these links.  This finding prompted 
the inclusion of Buysse’s five sleep health dimensions into the subsequent research conducted 
as part of this thesis. 
7.2.2 Study 2 – Longitudinal study 
Study 2 examined whether depressive symptoms existing in late pregnancy persisted through 
12 weeks postnatal and until three years post birth, and if these trajectories were associated 
with different dimensions of sleep health.  The findings presented provide New Zealand’s first 
information on longitudinal patterns of depressive symptoms experienced from late pregnancy 
to three years post birth, for both Indigenous Māori and non-Māori women. They also add 
important new evidence to the limited global literature on depression trajectories.  
Furthermore, only a handful of studies have investigated depressive symptoms trajectories in 
relation to sleep.  A unique aspect of Study 2 was the investigation of multiple sleep dimensions 
in association with chronically elevated depressive symptoms.   
Study 2 produced two key findings.  The first was the identification of two distinct depressive 
symptom classes, ‘stable mild’ (SM) and ‘chronic high’ (CH), from late pregnancy to three years 
post birth, revealing that women who were experiencing elevated depressive symptoms in late 
pregnancy were highly likely to continue on an elevated depressive symptom trajectory through 
until three years post birth.  Of equal importance, a woman with minimal levels of depressive 
symptoms in late pregnancy was highly likely to continue on a trajectory of minimal depressive 
symptoms through until three years post birth.  Chronically elevated depressive symptom 
trajectories have previously been identified by a small number of authors, particularly as the 
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popularity of group-based modelling (such as LCA) has grown in recent years (Ashman, Dawson, 
& Panagiotides, 2008; Luoma et al., 2015; G. Wang et al., 2018).  
The ‘chronic high’ pattern was found among both Indigenous Māori and non-Māori women, but 
Māori women had a greater probability of experiencing clinically significant depressive 
symptoms from pregnancy through until their child is three years of age.  These findings support 
previous literature showing that Māori women have greater exposure to factors associated with 
depression and experience significant barriers to accessing high quality pregnancy and postnatal 
health care services (Makowharemahihi et al., 2014).   
The second key finding was that four out of five sleep dimensions were consistently associated 
with being in the ‘chronic high’ trajectory group, namely poorer sleep quality, reduced 
continuity, longer latencies and greater daytime sleepiness at each time point, except daytime 
sleepiness at the three-year post birth timepoint.  Understanding the impact of multiple 
dimensions of sleep on depressive symptoms is useful in the development and application of 
sleep interventions. 
7.2.3 Study 3 – Intervention study 
The insights gained from Studies 1 and 2 guided Study 3. which aimed to determine whether 
providing women with information on general sleep, expected sleep changes in each trimester 
and advice to optimise sleep throughout pregnancy, could alter the risk of experiencing elevated 
depressive symptoms by late pregnancy and hence the possibility of being in a ‘chronic high’ 
depressive trajectory group into their child’s preschool years.  
As discussed  in Chapter 1, sleep is one of only a few modifiable risk factors for depression, and 
sleep education interventions provide a non-intrusive, non-pharmacological and cost-effective 
option for treating depressive symptomology in pregnancy. The need for early sleep 
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interventions has been highlighted by numerous authors (Da Costa et al., 2010; Haney et al., 
2014; K. A. Lee & Gay, 2017; K. A. Lee et al., 2016; Qiu et al., 2014; Ryan et al., 2005; Williams et 
al., 2010; Zhong et al., 2018). 
Furthermore, pregnancy is considered a key teachable life stage, with women keen to improve 
their health for the benefit of their baby (Phelan et al., 2011).  Pregnant women actively seek 
health information, particularly on discomforts, emotional changes, physical changes, and 
expectations and beliefs during their pregnancy (Berman, 2006), and most often in early 
pregnancy (Sayakhot & Carolan-Olah, 2016). However, there is little evidenced-based 
information on sleep available to mothers. 
The design and trial of the Sleep HAPi intervention aimed to answer three questions:  
1) Is an early and longitudinal sleep education intervention feasible and acceptable to 
pregnant women?  
2) Is an early and longitudinal sleep education intervention effective in optimising sleep 
and minimising depressive symptoms for nulliparous pregnant women with a history 
of depression? 
3) How do sleep and depressive symptoms changes over a nine-month period, from 12 
weeks gestation to 12 weeks postnatal? 
The identified lack of research on the first trimester, together with having strict inclusion and 
exclusion criteria, were indicators that recruitment for this study would be challenging.  The time 
and effort required to recruit 22 women was greater than expected, however all who were 
eligible to enrol did so, and once enrolled, they were greatly enthusiastic about their 
participation.  Retention rates were 68% and 64% for pregnancy and the postpartum period 
respectively and 99.7% of study components were completed. This is an endorsement of the 
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study given it occurred at a complex and demanding time in women’s lives, and is normal to high 
compared to other interventions studies in the perinatal period (Bosaeus et al., 2015; Knight & 
Wyatt, 2010; McNulty et al., 2013).   
Various aspects of the intervention were considered highly acceptable, including method, time 
and length of intervention delivery, participant burden, information value, digestibility and 
relevance.  Overall, women felt positive about their participation and stated they would 
definitely recommend the study to others. 
Self-reported sleep duration, quality, timing, continuity and daytime sleepiness remained stable 
throughout pregnancy.  This is consistent with the finding from the Scoped Review (Chapter 3) 
suggesting that changes in sleep across pregnancy in healthy women may not be as marked as 
previously thought.  However, it cannot be excluded that the sleep education intervention 
helped stabilise sleep in our sample, compared to women in other studies who have did not 
receive an intervention to improve their sleep. 
Newland et al. (2016) proposed that it may not be poor sleep per se that contributes to 
depression, but rather the variability or instability of sleep over a period of time. Thus, stabilising 
sleep across pregnancy may have contributed to the Study 3 finding that women with elevated 
depressive symptoms in early pregnancy had improved by the end of pregnancy and those with 
minimal depressive symptoms in early pregnancy remained that way throughout pregnancy.  
The Sleep HAPi intervention may also have reframed pregnancy-related changes to sleep or 
provided realistic expectations of ‘normal’ pregnancy sleep, thus reducing a women’s concern 
and anxiety and enhancing their management of poor sleep. Felder et al. (2018) have suggested 
that individuals with decreased cognitive and emotional reactivity and increased acceptance of 
difficult sleep experiences could be less psychologically impacted.   
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The efficacy of the intervention was evaluated by comparing the 15 women in the Sleep HAPi 
trial with a matched group of 76 women from the E Moe Māmā study (Signal et al., 2016) on the 
same self-reported depressive symptoms and the five sleep dimensions, in the third trimester 
and 12 weeks postnatal.  In late pregnancy, Sleep HAPi mothers had better sleep quality, sleep 
initiation, and sleep continuity.  Sleep HAPi mothers also had fewer depressive symptoms, none 
of which were clinically significant, while 20% of the control group had clinically significant 
symptoms. These results are important, given the trajectory described in Study 2 where women 
who had minimal depressive symptoms in late pregnancy were also less likely to have symptoms 
across the next three years. 
7.3 Limitations 
Specific limitations from each study have been highlighted in the relevant ‘Discussion’ sections 
in each chapter/paper.  Limitations that apply to the research as a whole are considered here. 
Studies 1 and 2 were both longitudinal and all women were community dwelling during their 
participation, so could have been influenced by numerous uncontrolled socio-physiological 
factors.  On the other hand, this means that the findings are sufficiently robust to be applicable 
in everyday life.  The majority of this program of research relies on subjective reports of sleep 
and depressive symptoms.  An exception to this was using actigraphy as an objective measure 
of sleep in Study 3, which showed a high correlation with subjective sleep reports.  It should be 
noted however, that actigraphy has not been validated in a pregnant population.   
The gold standard for assessing psychiatric conditions is a structured clinical interview, but for 
resourcing and financial reasons this was not viable for the studies in this thesis.  The Kessler 
(K10) has also been widely used in population surveys  (Australian Bureau of Statistics, 2002; 
CHAPTER 7 
241 
Kessler & Üstün, 2004; New Zealand Ministry of Health, 2006) and the EPDS and BDI II have been 
used extensively in perinatal populations and diverse ethnic samples including Samoan and 
Tongan women living in New Zealand (Ekeroma et al., 2012). However, neither the EPDS or the 
BDI has not been validated for use with pregnant or postnatal Māori women.  
The BDI-II has been developed to be used on multiple occasions in longitudinal research and for 
tracking changes across treatment periods (Sprinkle et al., 2002).  However, multiple 
completions of the questionnaires may have resulted in increased familiarity with the items or 
women paying less attention to the questions.  Participants in the Sleep HAPi study, were also 
aware that elevated scores on the EPDS or BDI-II resulted in their LMC being contacted.  
Although women did not know how scores were calculated and the cut-offs employed for 
referral, women may have misrepresented their responses if they were concerned about their 
LMC being notified. 
To ensure the scope of this thesis was manageable, the current research did not analyse 
measures of anxiety (other than using the EPDS anxiety subscale of the EPDS in the intervention 
study, see Chapter 6).  Anxiety is associated with both depressive symptoms and poor sleep 
(Alvaro, Roberts, & Harris, 2013) and could be a confounding factor in the present research. 
Future studies would benefit from exploring the relationship between sleep, depressive 
symptoms and symptoms of anxiety.  
The retrospective nature of many sleep measures, depression scales and demographic questions 
may have introduced recall bias or not captured the major changes that can occur for women 
across a relatively short period of time.  In addition, there are differences between measures in 
the timeframes to which the items refer.  For example, the EPDS assesses depressive symptoms 
over the past 7 days, the BDI-II evaluates the past 2 weeks, while the Kessler examines 
psychological distress over the past 30 days.  The PSQI assesses sleep quality over the past 30 
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days, the GSDS and sleep duration question examines sleep over the past 7 days and there is no 
prescribed timeframe for ESS questions.   
Seasonality was not controlled for in any of the studies.  Since the circadian system is strongly 
influenced by photoperiod, it is possible that sleep timing could have changed over the 12 
months of data recording (Beauvalet et al., 2017).  Sleep duration and mood may also be 
affected by seasonality.  Chronotypes and menstrual cycles (of Moe Kura women at 3 years), 
were also not controlled for and are areas where further investigation is recommended. 
The Sleep HAPi intervention has some specific limitations.  Foremost, the small single arm pilot 
study limits the generalisability of the findings and the assessment of efficacy.  The intervention 
focussed on sleep as a positive component of health and thus a health asset, however the 
measures employed in these studies framed sleep as a problem rather than in a positive way.  
For example, measures of sleep including the PSQI, ESS and GSDS generally use terminology that 
tend to ‘problematise’ sleep, such as “trouble” falling asleep, “difficulty” in staying awake.  Such 
an approach is at risk of ‘confirmation bias’ and is a widespread challenge in health research and 
the medical field in general (Althubaiti, 2016; B. C. K. Choi & Pak, 2005).  The study did also not 
include validated measures of sleep hygiene knowledge (such as the Sleep Hygiene 
Questionnaire, SHQ), which could have been utilised as a pre/post intervention measure.  
It is also possible that a “good participant” effect influenced the results of Study 3. It could be 
argued that the success of the intervention was at least partly due to the rapport formed 
between the researcher and participant. Any effects of the demographic of the researcher, as 
an older experienced mother and researcher, are unclear. This is especially relevant if the sleep 
education sessions are to be run by community-based health care providers.  At a minimum they 
would need significant training in sleep science to be able to deliver the intervention. 
CHAPTER 7 
243 
7.4 Clinical implications 
Pregnancy represents a time of high engagement with health care professionals.  The Centre of 
Perinatal Excellence (Australia) has recommended that every woman be screened for mood 
disorders during pregnancy and postnatally (Austin & Highet, 2017), while the USA National 
Institute for Health and Care Excellence (NICE) guidelines (2014) specifically recommends all 
women are routinely screened at their first antenatal appointment.  Though New Zealand 
women typically engage with a LMC in the first trimester, there is no formal or mandated 
perinatal maternal mental health assessment or screening programme in New Zealand (New 
Zealand Ministry of Health, 2018a).  Yet the first trimester offers a unique window of opportunity 
to predict and prevent many adverse maternal and birth outcomes in the short term and may 
also reduce some chronic intergenerational conditions (Poon et al., 2018), thus screening for 
depressive symptoms at this time point is highly recommended.   
The expectation in our society that having a baby should be a joyful experience may result in 
women feeling too embarrassed or ashamed to discuss depression with their health care 
providers.  So too, health care professional workloads often have limited time for raising and 
exploring mood symptomology during antenatal appointments (Hanlon & Beckmann 2015).  It 
is clear from this research and previous literature, that sleep is a clinically useful marker for 
underlying mental health or wellbeing risks (K. A. Lee & Gay, 2004) and therefore an assessment 
of sleep could provide clinicians with “innovative proxy for mood” and a suitable lead-in to more 
in-depth discussions of mood related issues (Stremler et al., 2019). 
Results from Study 2 clearly show that depressive symptomology extends past the traditional 
‘postnatal’ timeframes.  Previous research has shown that women, their child(ren) and families 
benefit if the mother is psychological healthy.  The scope of the maternal care would benefit 
from being extended.  Fahey (2013) states:  
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“The promotion of maternal health cannot end at the birth of the newborn, 
nor at the 6‐week postpartum visit. Women have physical and emotional 
needs directly related to pregnancy and childbirth that take longer than 6 
weeks to resolve.” 
While the perinatal timeframe has now been extended to cover pregnancy, more can be done 
by perinatal organisations to lobby and advocate for the extension of timeframes beyond the 
specified 4 weeks postnatal.  Even without extensions to official timeframes, it is important for 
clinicians (GP’s, health nurses) to be cognisant of the potential for chronicity in poor maternal 
mental health beyond the first-year post birth. 
At the other end of the perinatal spectrum, better early prenatal care is known to be an 
important maternal care policy associated with improved maternal health and pregnancy 
outcomes.  The New Zealand Perinatal and Maternal Mortality Review Committee (PMMRC) 
recommends early initiation of antenatal care (before ten weeks’ gestation) (Perinatal and 
Maternal Mortality Review Committee, 2018).  The rationale for care initiation before ten 
weeks’ gestation includes the time‐sensitive nature of first‐trimester screening tests, and the 
early provision of health promotion, education and nutritional information for pregnant women, 
as well as risk assessment and timely referral to specialist services.  
The present research has added to the existing literature, confirming the strong link between 
sleep and depression in the perinatal period.  Given that poor sleep and depression are 
established risk factors for adverse pregnancy, birth and child and maternal outcomes (O'Brien 
et al., 2019) this indicates that screening for sleep problems coupled with high quality sleep 
education would be a worthwhile addition to the care mothers receive in order to reduce the 
likelihood of poor mental health, and assist in the maintenance of good mental health.  
However, sleep education and training, either in general or specifically in the perinatal period, 
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is limited for maternity care providers (either midwives, childbirth educators or obstetricians).  
Maternity services in New Zealand provide education on nutrition and exercise in pregnancy but 
have not been able to provide evidenced-based sleep information to their clients/patients.  The 
sleep education information developed in Study 3 could prove to be a valuable frontline strategy 
in a stepped care approach to improve maternal mental health care and offers an intervention 
that avoids the medicalisation of (yet another) pregnancy characteristic (Sword et al., 2012). 
7.5 Recommendations for future research 
To date, there are limited studies examining sleep and depressive symptoms in pregnancy 
(including review papers) that include data from the first trimester. This promotes the tendency 
for authors to prematurely describe patterns of sleep and depressive symptoms based on two 
time points.  A recent intensification of early pregnancy research has highlighted just how critical 
the first trimester is in identifying factors in the development of sleep and depression patterns.  
More research spanning the full length of pregnancy is greatly needed so comparative data are 
available across all trimesters. 
Data collection for Study 3 commenced in the first trimester. However, pre-conception would 
be the ideal starting point for the characterisation of maternal sleep and mood symptomology.  
Very little prospective evidence exists on longitudinal patterns from this time point, but it seems 
likely that pre-conception sleep would provide a robust comparison for the changes in 
pregnancy sleep and that poor sleep pre-conception may be relevant to the sleep experience in 
pregnancy or postnatally (figure 7.4). 
Further to the recommendations above, there is a need to incorporate additional data collection 
time points during the perinatal period.  Though participant burden and research resources 
would need to be considered, monthly data collection, such as the study by Mindell et al. (2015), 
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may provide a more valuable understanding of the changes women are experiencing throughout 
pregnancy, as well as insight into the timing of greatest vulnerability for sleep and depression 
changes, especially when large change can occur within a trimester.  Similarly, gestational weeks 
need to be well defined in study populations, so correct comparisons and categorisations can be 
made between studies. 
Additional data time points are also relevant for the postnatal period.  Authors have described 
maternal depressive symptoms as highly variable and heterogeneous in their onset, course, 
duration and severity (Campbell, Matestic, von Stauffenberg, Mohan, & Kirchner, 2007; Nandi 
et al., 2009; Putnam et al., 2015; Van Der Waerden et al., 2015).  There would be great value in 
collecting data at regular time points to elucidate if women are prone to depressive symptoms 
at a particular point in the perinatal period or if periods of poor sleep or depressive symptoms 
exert their effects at later time points (M.-W. Chang et al., 2015; Skouteris et al., 2008).  While 
there are a small number of studies exploring long-term trajectories of depressive symptoms 
(past three years post birth), more studies would be helpful in further understanding the long-
term patterns of sleep and depressive symptoms (figure 7.4).  
Integrating pregnancy and postnatal time points into future research could also allow for a 
cohesive model of perinatal sleep and mental health care to be developed.  Studies to date have 
generally focused on either pregnancy (Sanaati et al., 2017; Rezaei et al., 2015; Tomfohr-Madsen 
et al., 2016) or postnatal (Owais et al., 2018; Kempler et al., 2016) sleep education interventions 
to improve mood, but it does not appear that any intervention studies have combined these two 
important and connected life stages.  Providing women with an integrated package of evidenced 
based sleep and mental health education material, that covers both maternal sleep and mood 
throughout the perinatal period, as well as incorporating information on baby sleep could prove 
to be a valuable addition to maternal health care. 
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It is recommended that the Sleep HAPi study be replicated in a larger randomised controlled trial 
with a more diverse sample to gain a greater understanding of its utility and efficacy.  It would 
be advantageous to test the protocol on diverse populations that have been shown to be more 
vulnerable to experiencing perinatal depression, such as differing ethnic backgrounds 
(specifically in the New Zealand context, Māori  or Pasifika women), teenage mothers, women 
undergoing assisted reproductive technology or women at risk of poor pregnancy outcomes (i.e. 
obese or other comorbidities, multiple pregnancies, unplanned pregnancies).  Parity has also 
been shown in previous research to be a predictor of depression and poor sleep and could 
warrant further investigation (K. A. Lee, Zaffke, et al., 2000; Waters & Lee, 1996).  Furthermore, 
findings from this research have identified that not all groups of pregnant women are equally 
susceptible to large changes in sleep and more detailed studies of diverse groups of women are 
warranted. 
 
Figure 7.4  Future research recommendations pre-conception and postnatally. 
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The effect of partner / paternal contribution to perinatal sleep and depression has been largely 
overlooked to date.  A study by Da Costa (2017) investigating the information seeking behaviour 
of fathers with pregnant partners showed that 89% of fathers spent an average of 6 hours on 
the internet per month searching for information on pregnancy, and additionally, over half the 
fathers in the study are keen for information on sleep.  These findings suggest that interventions 
including partners / fathers could prove beneficial both for fathers and as a support for mothers 
(Entsieh & Hallström, 2016).  Furthermore, including fathers in sleep education could further 
promote, encourage and reinforce healthy family sleep patterns and behaviour, and paternal 
reports of sleep could help corroborate maternal reports. 
Buysse’s Sleep Health model (2014) provided a novel conceptual structure to the research, and 
there would be great benefit in future research continuing to consider sleep in multiple 
dimensions and reveal associations between these dimensions and aspects of health.  However,  
Buysse’s model does not include sleep dimensions specific to pregnancy, such as sleep position.  
For pregnant women, safe sleeping positions are a crucial aspect to their baby’s health and 
should be incorporated into sleep health material for this population.  
Additional data on symptoms of sleep disordered breathing (such as snoring, breathing pauses, 
waking to a gasp) were collected in the E Moe Māmā / Moe Kura and Sleep HAPi questionnaires, 
but were not explored in this program of research.  These symptoms indicate an increased risk 
of suffering Obstructive Sleep Apnea (OSA), which has also been associated with increased odds 
of experiencing depressive symptoms, with a particularly strong effect for women with a history 
of depression (Redhead, 2020).  This suggests that screening for symptoms of OSA in pregnancy 
is important addition in future perinatal sleep research, particularly in identifying women prone 
to future depressive episodes. 
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The present research did not systematically investigate what strategies women used and how 
long they persisted when implementing new strategies.  Feedback from participants regarding 
the sleep strategies they found most helpful were asked in open ended questions and responses 
varied considerably.  This points to sleep strategies and advice being highly individual, and to 
the value of providing women with a broad range of suggestions so that they can choose what 
strategies are most important and helpful at the right time.   
Nevertheless, future intervention studies could examine if women are using and benefitting 
from specific behaviours or strategies or use goal setting techniques to assess the usefulness or 
efficacy of sleep education.  This would enable ongoing improvement of the education material 
and assessment of whether additional referral pathways and stepped-care protocols are needed 
for more complicated issues, such as insomnia or sleep disorders.  Designing a group-based 
intervention could also be considered, given the results from the present research and previous 
literature showing that social support is a key risk factor in experiencing depressive symptoms 
in pregnancy.  Intervention studies that include family members or friends and/or measures of 
social support may allow early detection of poor maternal support systems, increase feelings of 
inclusion, and hence lower the vulnerability to depression (Sattler et al., 2017; Tanner Stapleton 
et al., 2012).   
Feedback from Sleep HAPi could be used to improve the sleep education intervention.  Common 
responses from women included providing electronic versions of questionnaires, sleep diaries 
and study communications and the use of private digital platform technology to simplify and 
improve the speed and accuracy of data management.  Women also suggested having a ‘sexier’ 
and less conspicuous actiwatch.  Two women in the study were displeased by the attractiveness 
and bulkiness of watch, stating they were worried that colleagues would notice and enquire 
about the reasons for wearing it, when they had not yet announced their pregnancy. 
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7.6 Conclusion  
Healthy sleep is vital to wellbeing (Czeisler, 2015) but for some women, achieving restorative 
and satisfying sleep consistently throughout pregnancy is challenging.  As the risk of 
experiencing depressive symptoms increases with poor sleep and poor sleep influences the 
development and trajectory of depressive symptoms, sleep is an important and modifiable 
factor in the prevention and treatment of depression (Franzen & Buysse, 2008). 
Overall, this thesis has added important findings on the longitudinal relationship between sleep 
and depressive symptoms throughout the extended perinatal period, as well as developing and 
piloting a novel sleep education intervention throughout pregnancy.  All three studies provide 
insight and promise for future sleep education interventions with larger and more diverse 
samples.  The Sleep HAPi sleep education information booklet has sparked interest in the wider 
health community, with psychology professionals, sleep researchers, and maternal health care 
providers keen to use the information with clients, patients and as material in future research 
studies.  This interest has led to Massey University Press publishing the information as a book in 
both print and electronic formats, due for release in mid-2020. 
The findings linking sleep and depressive symptoms in the perinatal period are relevant to policy 
makers in the health, and particularly the mental health, sectors.  They confirm that a significant 
number of women in New Zealand experience mood difficulties throughout the perinatal period 
and importantly into their child’s preschool years, which may have multiple and severe 
consequences.  Studies such as the Sleep HAPi study provide impetus for interventions targeting 
both sleep and depression to reduce the risk of further depressive episodes and improving 




Mothers are important too 
After my boys were born, there were appointments. 
To check their latch. 
To check their weight. 
To check their hearing. 
To check the colour of their skin for signs of jaundice. 
There were appointments. 
There were regular pokes and prods. 
Their well-being was front and centre. 
I'd say, when it comes to our health-care system, they were well taken care of. 
Then there was me. 
A first-time mom without a clue. 
Engorged, bleeding, and stitched up. 
Sent home with some painkillers and stool softeners. 
Thrown into motherhood with the expectation my instincts would kick in. 
That I would know how to handle colic and late-night feedings. 
That breastfeeding would come as nature intended. 
That my husband would sense my spiral into depression. 
That I would know how to live in my new and very foreign body. 
That this stomach wouldn't make me feel hideous. 
And my mind wouldn't make me feel less than they deserved. 
No one poked me. 
No one prodded. 
No one checked my stitches, my healing, or my sanity until eight weeks postpartum. 
And even then, it was a pat on the back and I was sent on my way. 
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Our world forgets about mothers. 
We slip through the cracks. 
We become background noise. 
And in that we learn our role...  
Our place in our family unit...  
To always come last. 
Folks, we can't put mothers last. 
Our babies need us. 
To be healthy. 
To know that we are worthy. 
To know that Motherhood, while natural, can sometimes feel like the least natural role in our 
life. 
And that deserves attention. 
That mothers deserve attention. 
We need our world to fuss over us the way they fuss over ten fresh fingers and ten fresh toes. 
We need to be seen. 
We need to be heard. 
We need someone to not only ask if we're okay but to check time and time again, just to be sure. 
We're not just a uterus. 
We're not just a lifeline to a new and precious soul. 
We're mothers. 
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“The sun, has gone, to bed and so must I.”  
— Oscar Hammerstein & Richard Rodgers, Sound of Music, 1959 
 
